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II. Structure of the thesis 
This thesis is divided into three main chapters: The introduction (1), the results (2) and 
the summarizing discussion (3). 
 
(1) The introduction gives an insight into the field of nanoparticle research with the focus 
on iron oxide nanoparticles including the synthesis and characterization of these materials 
and their interaction with cells. The section of cell-interaction also contains a short 
description on the uptake mechanisms of nanoparticles in cells. 
 
(2) The results chapter of this thesis describes the data obtained and investigations made 
during the laboratory work of this thesis. This part is sub-divided into three chapters that 
are presented as publications/manuscripts. The first chapter contains a published article 
describing the synthesis and characterization of fluorescent iron oxide nanoparticles as 
well as their accumulation in C6 glioma cells. The second chapter represents a submitted 
manuscript on a study investigating the uptake and intracellular trafficking of fluorescent 
iron oxide nanoparticles using nanoparticle pulse-chase experiments in C6 glioma cells. 
The third chapter comprises the submitted manuscript of a review article, which sums up 
the special challenges of nanoparticle uptake studies in neural cells. The manuscript 
contains some data collected from experiments studying the effects of an exposure of 
neural cells to fluorescent iron oxide nanoparticles. The published article is inserted as 
portable document format. The submitted manuscripts are adapted to the style of the 
thesis with figures, tables and their legends directly placed after the result chapter or after 
the conclusion. 
 
(3) The summarizing discussion chapter consolidates the key-findings of the thesis, 
brings them in the current context of research and presents an outlook on future 
perspectives regarding the use of the synthesized fluorescent iron oxide nanoparticles. 
In addition to the publication and manuscripts as part of this thesis, I have made 
substantial contribution to the following four publications which are not included in this 
thesis: 
? Rastedt W, Blumrich EM & Dringen R (2017). Metabolism of mannose in 
cultured primary rat neurons. Neurochem Res, 42: 2282-2293. 
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? Stapelfeldt K, Ehrke E, Steinmeier J, Rastedt W & Dringen R (2017). 
Menadione-mediated WST1 reduction assay for the determination of metabolic 
activity of cultured neural cells. Anal Biochem, 538: 42-52. 
 
? Joshi A, Rastedt W, Faber K, Schultz AG, Bulcke F & Dringen R (2016). Uptake 
and toxicity of copper oxide nanoparticles in C6 glioma cells. Neurochem Res, 
41: 3004-3019. 
 
? Zhang YQ, Dringen R, Petters C, Rastedt W, Köser J, Filser J & Stolte S (2016). 
Toxicity of dimercaptosuccinate-coated and un-functionalized magnetic iron 
oxide nanoparticles towards aquatic organisms. Environmental Science-Nano, 3: 
754-767. 
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III. Summary 
Iron oxide nanoparticles (IONPs) have promising features for biomedical applications and 
are already used for some therapeutic and diagnostic approaches. As IONPs can reach the 
brain it is important to study the potential consequences of an exposure to IONPs on brain 
cells. In the presented thesis, fluorescent IONPs were synthesized by functionalizing the 
coating material dimercaptosuccinate (DMSA) of the IONPs with either the green dye 
Oregon Green (OG) or the red dye tetramethylrhodamine (TMR). Comparison to 
previously used BODIPY-labeled DMSA-coated IONPs, OG- and TMR-IONPs revealed 
higher fluorescence signal intensities and improved stability, while these fluorescent 
IONPs had almost identical physicochemical properties and colloidal stability as the 
corresponding non-fluorescent DMSA-coated IONPs. To investigate the accumulation of 
IONPs in brain cells, C6 glioma cells were used as model system. IONPs exposure studies 
revealed that these cells accumulate fluorescent and non-fluorescent IONPs in a time-, 
concentration- and temperature-dependent manner. Due to the strong fluorescence 
observed in cells that had been exposed to OG- or TMR-IONPs and due to the slow 
bleaching of cellular fluorescence, these fluorescent IONPs were considered as suitable 
tools for further studies of cellular uptake and intracellular trafficking of internalized 
IONPs. 
To monitor the intracellular trafficking of fluorescent nanoparticles with improved 
temporal and spatial resolution, single and double nanoparticle pulse-chase experiments 
were established for OG- and TMR-IONPs. As IONPs efficiently adsorb to the cell 
membrane but are not internalized at 4°C, the fluorescent IONPs were bound to the cells 
by a 10 min pulse at 4°C. Subsequently, unbound nanoparticles were removed by washing 
before an increase of the incubation temperature to 37°C started a synchronized 
internalization of the IONPs by the cells. Double nanoparticle pulse-chase experiment 
with the two types of fluorescent IONPs allowed to even monitor the sequential uptake 
of OG- and TMR-IONPs. The usage of nanoparticle pulse-chase experiments in the 
presence of inhibitors of the cytoskeleton integrity revealed an actin-dependent formation 
of IONPs-containing vesicles and a microtubules-dependent transport of these vesicles 
to the perinuclear area. Additionally, the separation of the fluorescent DMSA coat and 
the iron oxide core during the intracellular trafficking was observed in nanoparticle pulse-
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chase experiments. Finally, limitations, requirements and special challenges of studies on 
the exposure of in cultured neural cells with fluorescent IONPs were investigated, and 
are described and discussed. 
 
In conclusion, the data presented in this thesis revealed that the synthesized fluorescent 
IONPs are suitable tools to study the uptake and intracellular fate of DMSA-coated 
IONPs by microscopical approaches and that the established nanoparticles pulse-chase 
setup allows to study internalization and mechanisms involved in intracellular IONPs 
trafficking with improved resolution. 
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IV. Zusammenfassung 
Eisenoxidnanopartikel (iron oxide nanoparticles, IONPs) besitzen vielversprechende 
Eigenschaften im Hinblick auf eine biomedizinische Anwendung und werden bereits 
heute in therapeutischen und diagnostischen Verfahren verwendet. Da IONPs in das 
Gehirn gelangen können, ist es wichtig die potentiellen Konsequenzen einer Exposition 
mit IONPs auf Gehirnzellen zu untersuchen. Für die vorliegende Arbeit wurden 
Fluoreszenz-markierte IONPs durch die Funktionalisierung des Hüllmaterials 
Dimercaptobernsteinsäure (DMSA) der IONPs mit dem grünen Fluoreszenzfarbstoff 
Oregon Green (OG) oder dem roten Fluoreszenzfarbstoff Tetramethylrhodamine (TMR) 
synthetisiert. Der Vergleich zu bereits verwendeten BODIPY-markierten DMSA-
umhüllten IONPs zeigte eine höhere Fluoreszenzintensität und eine erhöhte 
Signalstabilität der OG- und TMR-IONPs, wobei physikochemische Eigenschaften und 
kolloidale Stabilität identisch waren im Vergleich zu entsprechenden nicht-
fluoreszierenden DMSA-IONPs. Um die Akkumulation der IONPs in Gehirnzellen zu 
untersuchen, wurden C6 Gliomzellen als Modelsystem verwendet. IONPs-
Expositionsstudien zeigten, dass diese Zellen nicht-fluoreszierende und fluoreszierende 
IONPs in einer zeit-, konzentrations- und temperaturabhängigen Weise akkumulieren. 
Die beobachteten starken Fluoreszenzsignale in Zellen, die OG- oder TMR-IONPs 
ausgesetzt waren, und die auffällig langsame Abschwächung der zellulären 
Fluoreszenzintensität zeigen, dass diese fluoreszierenden IONPs als geeignetes 
Werkzeug zur Untersuchung der zellulären Aufnahme und den intrazellulären Transport 
von aufgenommenen IONPs genutzt werden können.   
 
Um den intrazellulären Transport dieser fluoreszierenden Nanopartikel mit verbesserter 
zeitlicher und räumlicher Auflösung zu beobachten, wurden Einzel- und Doppel-
Nanopartikel-Pulse-Chase-Experimente etabliert. Aufgrund der Tatsache, dass IONPs 
bei 4°C effizient an die Zellmembran adsorbieren, aber nicht in den Zellen aufgenommen 
werden, wurden IONPs zunächst durch eine 10-minütige Nanopartikel-Pulse-Inkubation 
bei 4°C an die Zellmembrane gebunden. Danach wurden nicht-gebundene Nanopartikel 
durch Waschen entfernt und durch Erhöhung der Inkubationstemperatur auf 37°C eine 
synchronisierte Aufnahme der IONPs in die Zellen initiiert. Doppel-Nanopartikel-Pulse-
Chase-Experimente mit den zwei verschiedenen fluoreszierenden IONPs ermöglichte die 
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Beobachtung der sequentiellen Aufnahme von OG- und TMR-IONPs. Die Durchführung 
dieser Nanopartikel-Pulse-Chase-Experimente in der Gegenwart von Inhibitoren der 
Zytoskelettintegrität führte zum Nachweis einer Aktin-abhängige Bildung von IONPs-
enthaltenden Vesikeln und eines Mikrotubuli-abhängigen Transport dieser Vesikel zum 
perinukleären Bereich der Zellen. Zusätzlich konnte die Auftrennung der 
fluoreszierenden DMSA-Mantels und des Eisenoxidkernes der fluoreszierenden IONPs 
während der intrazellulären Aufnahme mit Hilfe der Nanopartikel-Pulse-Chase-
Experimente beobachtet werden. Abschließend wurden einige Limitierungen, 
Anforderungen und spezielle Herausforderungen der Expositionsstudien von kultivierten 
neuralen Zellen mit fluoreszierenden IONPs untersucht, beschrieben und diskutiert. 
 
Zusammenfassend zeigen die Daten der vorliegenden Dissertationsarbeit, dass die 
synthetisierten fluoreszierenden IONPs geeignete Werkzeuge sind, um die Aufnahme 
und den intrazellulären Verbleib von DMSA-umhüllten IONPs mit Hilfe von 
mikroskopischen Methoden zu untersuchen, und, dass das die etablierten Nanopartikel-
Pulse-Chase-Protokolle die Untersuchung der Aufnahme und der Mechanismen des 
intrazellulären Transports von IONPs mit verbesserter Auflösung ermöglichen. 
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V. Abbreviations and symbols 
% percent 
°C degree Celsius 
μL microliter 
μM micromol 
a.u. arbitrary units 
AAS atomic absorption spectroscopy  
AFM atomic force microscopy 
AgNO3 silver nitrat 
AgNP(s) silver nanoparticle(s) 
ANOVA analysis of variance 
BBB blood-brain barrier 
BP, BODIPY 4,4-difluoro-1,3,5,7,8-pentamethyl-4-bora-3a,4a-diaza-s-indacene 
BP-IONP(s) BODIPY-labeled DMSA-coated IONP(s) 
BSA bovine serum albumin 
CNS central nervous system 
CuONP(s) copper oxide nanoparticle(s) 
cytoD cytochalasin D 
DAPI 4',6-diamidino-2-phenylindole 
DLS dynamic light scattering 
DMEM Dulbecco's modified Eagle's medium 
DMSA dimercaptosuccinate 
EDC 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide 
ed(s). editor(s) 
EDX energy dispersive X-ray spectrometry 
EEA1 early endosome antigen 1 
ELS electrophoretic light scattering 
FCS fetal calf serum 
FDA Food and Drug Administration 
Fig. figure 
GCM glia condition medium 
GFAP glial fibrillary acidic protein 
GSH glutathione 
Abbreviations and symbols X 
 
h hour 
H33342 Hoechst 33342 
HCL hydrochloride acid 
HEPES 4-(2-hydroxyethyl)-1-piperazineethane sulfonic acid 
HNO3 nitric acid 
i.e. that is (Latin: id est) 
IB incubation buffer 
ICP-MS inductively coupled plasma mass spectrometry  
IONP(s) iron oxide nanoparticle(s)  
LAMP1 lysosomal associated membrane protein 1 
LDH lactate dehydrogenase 
LED light emitting diode 
M molar (mol per liter) 
mg milligramm 
min minutes 
mM millimollar 
MRI magnetic resonance imaging 
mV millivolt 
n.d. not detectable 
NaCl sodium chloride 
NADH nicotinamide adenine dinucleotide (reduced) 
NaOH sodium hydroxide 
née born as/ Maiden name 
nf non-fluorescent 
nm nanometer 
NP(s) nanoparticle(s) 
OG Oregon Green 
OG-IONP(s) Oregon Green-labeled-DMSA-coated IONP(s) 
PBS phosphate-buffered saline 
PDI polydispersity index 
PEG polyethylene glycol 
PFA paraformaldehyde 
phalloidin CytoPainter Phalloidin-iFluor 
PI propidium iodide 
Ref. reference 
Abbreviations and symbols XI 
 
RT room temperature 
SD standard deviation 
s second 
SPION(s) superparamagnetic IONP(s) 
t time 
TEM transmission electron microscopy 
TMR tetramethylrhodamine 
TMR-IONP(s) TMR-labeled DMSA-coated IONP(s) 
Tris Tris(hydroxymethyl)-aminomethane 
UV ultraviolet 
w/v weight per volume 
ζ zeta 
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1. Introduction 
1.1 Nanoparticles 
Nanoparticles (NPs) are defined as particles that possess sizes between 1 and 100 nm 
(Auffan et al., 2009) and that differ in at least some of their chemical and physical 
properties in comparison to non-nanoscale particles or the bulk material of the same 
composition (Auffan et al., 2009, Bobo et al., 2016) resulting in their unique physical, 
chemical and biological properties. NPs have been used already for thousands of years 
such as in lead-based cosmetics in ancient Egypt and in nanocrystal-containing hair dyes 
in Greco-Roman times (Walter et al., 2006). The first idea of nanotechnology was placed 
1959 by the physicist Richard Feynman with his presentation “There’s Plenty of Room 
at the Bottom” in which Feynman suggested that it is possible to manipulate materials at 
the level of their atoms and molecules (Santamaria, 2012). Due to their unique properties, 
NPs are gaining more and more interest during the last two decades in industry and 
science as indicated by the huge increase in the number of publications on NPs (Fig. 1.1). 
As a consequence, NPs are also getting more and more access to our daily live (Heiligtag 
and Niederberger, 2013, Khan et al., 2017, Mohammed et al., 2017). 
 
 
Fig. 1.1 Publications on NPs. The number of publications per year was obtained in a PubMed 
search for the term: “Nanoparticle” (done on 04 April 2018).   
NPs can be composed of and engineered from various materials including inorganic 
and/or organic materials such as carbon, metals, metal oxides, silica, liposomes and 
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polymers (Algar et al., 2011, Colombo et al., 2012, De la Fuente and Grazu, 2012). Table 
1.1 provides an overview on some frequently used types of NPs and lists their unique 
properties which make them valuable for industrial or biomedical applications.  
 
Table 1.1 Properties and applications of selected types of NPs  
Nanoparticles Properties Applications 
Carbon-based NPs 
Fullerenes Safe, inert, semiconductor/superconductor, 
transmits light based on intensity 
Polymer industry, automobiles 
Carbon Nano 
Tubes 
High electrical and thermal conductivity, 
tensile strength, flexible and elastic 
Electronic equipment, biosensors, 
water filters 
Metal-based NPs 
Silver Absorbs and scatters light, stable, anti-
bacterial, disinfectant 
Cosmetic products, paint industry, 
food packaging, antimicrobial agents, 
wound dressings, electronics 
Gold Interactive with visible light, reactive Fuel cell, catalyst industry, medical 
diagnostics, photothermal therapy 
Copper Ductile, very high thermal and electrical 
conductivity, highly flammable solids 
Catalyst, biosensor, electrochemical 
sensors 
Zinc Antibacterial, anti-corrosive, antifungal, 
UV filtering 
Coating industry, antimicrobial 
agents 
Metal oxide-based NPs 
Titanium oxide High surface area, inhibits bacterial 
growth 
Cosmetic products, coating industry, 
antimicrobial agents, biosensors 
Iron oxide Magnetic, highly reactive Cosmetic products, biomedical 
applications (see chapter 1.2) 
Silicon dioxide Stable, less toxic, able to be functionalized 
many molecules, biocompatible 
Cosmetic products, paint industry, 
drug delivery, biosensors 
Zinc oxide Antibacterial, anti-corrosive, antifungal 
and UV filtering 
Cosmetic products, paint industry, 
antimicrobial agents, bioimaging 
Cerium oxide Antioxidant, low reduction potential, 
switch between oxidation states 
Fuel cell, catalyst industry, 
biosensors, anticancer agent 
Quantum dots/ Semiconductor NPs 
CdSe/ZnS  High quantum yield, low photobleaching, 
high photochemical stability 
Bioimaging, photovoltaic, LED 
Information was taken from (Phogat et al., 2016, Anu and Saravanakumar, 2017, Khan et al., 2017, 
McNamara and Tofail, 2017) 
 
The production of NPs accounts for 10,000 t/year worldwide in the case of titanium oxide 
and between 100 and 1000 t/year in the case of cerium oxide, iron oxide, aluminum oxide, 
zinc oxide and carbon nanotubes (Piccinno et al., 2012). NPs can be precisely engineered 
for specific approaches by adapting their size, shape and surface properties and thousands 
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of nanomaterial-containing products are already available on the market (Bencsik et al., 
2018). A number of these NPs are directly encountered by humans via inhalation, dermal 
exposure, oral ingestion or intravenous routes (Mu et al., 2014, Zhang et al., 2015b) (Fig. 
1A). Such exposures are associated with the risks that NPs may enter human cells 
resulting in major toxicological consequences (Piccinno et al., 2012) which raises 
concerns on the health and safety aspects of NPs (Zhang et al., 2015b).  
 
Fig. 1.2 Exposure of the human body to NPs according to (Zhang et al., 2015b, Bencsik et al., 
2018). 
The increased production and usage of NPs in industry and for cosmetic products such as 
shampoos and sunscreens has led to an increased release of NPs into the wastewater. As 
some types of NPs are persistent and slowly degraded in the environment, and as some 
NPs can be stored in plants, microbes, and animal organs, humans can be exposed to NPs 
through the consumption of natural products (Mu et al., 2014, Phogat et al., 2016). 
Several studies stated that continuous high exposure to NPs is associated with severe 
damage of the respiratory and cardiovascular system (Pieters et al., 2012, Robertson et 
al., 2012, Patel et al., 2013, Xu et al., 2013, Mu et al., 2014, Bencsik et al., 2018).  
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The physicochemical properties of NPs have been demonstrated to influence the toxic 
manifestations of these NPs (Gatoo et al., 2014). A critical factor influencing the potential 
toxicity of NPs is the parameter size, as it has been observed that smaller NPs have a 
higher toxic potential than larger NPs due to the greater reactivity caused by the higher 
surface area to volume ratio (Mu et al., 2014, De Matteis, 2017). Furthermore, the size 
of the NPs defines how they are taken up, distributed and eliminated in the human body 
(Gatoo et al., 2014).  
 
Besides the size of NPs, there are many other factors such as shape, surface charge, 
morphology and coating, chemical composition and agglomeration state that influence 
and define NPs in their chemical and physical properties (Fig. 1.3), and thereby dictate 
their uptake, fate and toxic potential within the human body (Gatoo et al., 2014, Mu et 
al., 2014). The surface charge that depends on the composition and coating of the NPs 
also has a huge impact on the toxic potential of NPs as it highly influences the interactions 
with the biological system, the colloidal behavior of the NPs, the binding to biological 
compounds such as proteins, the transmembrane permeability and the effect of NPs on 
the blood-brain barrier (BBB) integrity (Gatoo et al., 2014). 
 
 
 
Fig. 1.3 Factors influencing the physicochemical properties of NPs. 
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NPs are complex materials (Christian et al., 2008, Khan et al., 2017) and as they possess 
unique properties relative to the bulk counterpart, a prediction of toxicity from their 
physicochemical properties is not possible (Rivera-Gil et al., 2013, Gatoo et al., 2014). 
Even in the simplest case of NPs composed of a single component such as silver or gold, 
the surface shell of the NPs will behave different from the core material due to the high 
surface to volume ratio and the resulting high reactivity of the surface (Christian et al., 
2008). To further complicate the situation, in most cases NPs are composed of more than 
one component, either due to further functionalization of the core material or simply due 
to adsorption of organic material, which happens as soon as NPs enter biological systems, 
or due to a combination of both (Rivera-Gil et al., 2013, Nazarenus et al., 2014). 
Therefore, NPs in biological environments can consist of various layers as schematically 
illustrated in Fig. 1.4. The core material (Fig. 1.4A) defines the functional physical 
properties of NPs such as plasmonic, superparamagnetic or fluorescent properties (Feliu 
et al., 2016). The shell layer (Fig 1.4B) represents either just the outer layer of the core 
material or a second layer with a completely different structure than the core material 
(Christian et al., 2008, Khan et al., 2017). The engineered surface coating (Fig. 1.4C) is 
generated by functionalization of the NPs surface with small molecules, surfactants or 
polymers (Sapsford et al., 2013) and the organic coating (Fig. 1.4D) is formed as soon as 
NPs are entering a biological environment (Rivera-Gil et al., 2013, Nazarenus et al., 
2014). The outer-most surface defines the physicochemical properties of the NPs in 
relation to their surrounding environment (Christian et al., 2008). 
 
Fig. 1.4 Composition of NPs in biological environment. The simplest NPs are composed of a 
NP core (A) and a NP shell layer (B). Additional layers can be formed by adding an engineered 
surface coat(C) and by the adsorption of material such as proteins and ions from the biological 
environment (D).  
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1.2 Iron oxide nanoparticles 
Superparamagnetic iron oxide NPs (IONPs) have a core made of maghemite (γ-Fe2O3) 
or magnetite (Fe3O4) (Wu et al., 2008). Due to their biocompatibility, their magnetic 
properties and the simple and cost-effective synthesis, IONPs are promising candidates 
for biomedical application and clinical praxis (Gupta and Gupta, 2005, Ali et al., 2016, 
Mohammed et al., 2017) as listed in Table 1.2.  
Table 1.2 Biomedical and biological applications of IONPs  
Application References 
Magnetic resonance imaging (MRI) (Wang, 2015) 
(Weinstein et al., 2010) 
Cancer treatment by induced hyperthermia (Baetke et al., 2015) 
(Shi et al., 2015) 
Targeted Drug-delivery to specific tissues 
including across the blood brain barrier 
(El-Boubbou, 2018) 
(Ivask et al., 2018) 
Cell labeling and tracking (Kolosnjaj-Tabi et al., 2013) 
(Jasmin et al., 2017) 
Cell labeling and magnetic separation (Gordon et al., 2011) 
(Thimiri Govinda Raj and Khan, 2016) 
Magnetotransfection (Jenkins et al., 2011) 
(Scherer et al., 2002) 
 
The majority of IONPs formulations that were approved by the U.S. Food and Drug 
Administration (FDA) such as Venofer®, Ferrlecit®, INFed®, Dexferrum® and 
Ferraheme® are used in iron replacement therapies, for example for the treatment of iron 
deficiency in chronic kidney diseases (Bobo et al., 2016). An emerging field in the 
biomedical application of IONPs is the use as contrast enhancement reagents for 
magnetic resonance imaging (Bobo et al., 2016) as well as the use of IONPs for treatment 
of glioblastomas using magnetically induced hyperthermia (Baetke et al., 2015). For the 
latter the superparamagnetic properties of the IONPs are essential. IONPs consist of 
single magnetic domains and can be magnetized by the application of an external field. 
The magnetization will be lost as soon as the external field is removed (Corr et al., 2008). 
Suspensions of superparamagnetic IONPs behave as ferrofluids (Sapsford et al., 2013). 
For the hyperthermia treatment, the ferrofluid will be directly injected into the tumor and 
an oscillating external magnetic field will be applied leading to the vibration of the 
particles that results in a local heating (Laurent et al., 2011, Banobre-Lopez et al., 2013). 
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NanothermTM, a formulation of aminosilane-coated IONPs, is in the late stage of clinical 
trials in the US. Hyperthermia treatment of glioblastoma with this formulation was 
associated with an increased overall survival of patients for up to 12 months (Thiesen and 
Jordan, 2008, Maier-Hauff et al., 2011, Bobo et al., 2016). The superparamagnetism of 
the IONPs also allows to direct the IONPs to selected tissues by the application of 
external magnetic fields (Akbarzadeh et al., 2012). 
 
Furthermore, IONPs have been applied for cell labeling, cell tracking and magnetic 
separation (Gordon et al., 2011, Kolosnjaj-Tabi et al., 2013). In the field of cell labeling, 
the focus has recently switched to materials that possesses both fluorescent and magnetic 
properties to allow the tracking of the NP-labeled cells by magnetic resonance imaging 
as well as by fluorescent spectroscopy (Corr et al., 2008, Chekina et al., 2011). The 
combination of magnetic and optical imaging provides additional information about the 
cell structure imaged (Chekina et al., 2011, Perillo et al., 2017). 
1.2.1 Synthesis 
IONP can be synthesized by chemical, physical or biological methods (Table 1.2). The 
chemical preparation methods are most commonly used, with a proportion of 90%, due 
to low production cost, high yield and high reproducibility (Ali et al., 2017). A simple 
and effective approach among the numerous chemical approaches, is the chemical co-
precipitation (Ali et al., 2016) that was also performed in this thesis. This method was 
originally developed in 1982 by René Massart (Massart, 1981). Ferrous and ferric ions in 
a molar ratio of 1:2 are precipitated under alkaline conditions to magnetite (Fe3O4) NPs 
(equation 1). Due to the instability and sensitivity of magnetite to oxidation, further 
reaction to maghemite (Fe2O3) or ferric hydroxide (Fe(OH)3) takes place in the presence 
of oxygen (Gupta and Gupta, 2005, Laurent et al., 2008, Ali et al., 2016) (equation 2 and 
3). IONPs synthesized with this method often contain mixtures of magnetite and 
maghemite (Maity and Agrawal, 2007).  
(1) ???? ? ??????? ? ?? ?? ?? ?????? ? ?? ?? 
(2) ????? ? ?? ? ?? ????????? ?????? ????? 
(3)  ????? ? ?????? ? ??????? ??? ? ????????? 
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Large amounts of IONPs can easily be synthesized this way and the size and shape can 
be adjusted by modifications of pH, ionic strength, temperature, the type of iron salts and 
the ratio of ferrous to ferric iron (Laurent et al., 2008). Depending on the conditions 
applied, the resulting particle size can range from 2-15 nm (Laurent et al., 2008) ensuring 
the superparamagnetic properties. A disadvantages of the chemical co-precipitation is the 
resulting broad size distribution of the synthesized particles (Laurent et al., 2008, 
Sapsford et al., 2013). For the synthesis of a narrow size distribution other methods e.g. 
thermal decomposition are more appropriate (Sapsford et al., 2013, Ruiz et al., 2014) 
(Table 1.2). 
 
Table 1.2 IONPs synthesis methods with advantages and disadvantages of the procedures 
Method Advantages Disadvantages 
Chemical  
Co-precipitation Easy, effective, low cost Low shape control, broader size 
distribution 
Hydrothermal Particle size and shape easy to 
control, highly efficient 
High pressure and high reaction 
temperature  
Sol-gel and polyol Easy, precisely controlled size 
and internal structure 
High pressure, complicated 
Microemulsion Precisely control of size and size 
distribution and high surface area 
Complicated, low yield 
Sonochemical Simple, narrow size distribution No shape control, medium yield 
Thermal decomposition Monodispersed NPs, very good 
shape control 
Dissolved in non-polar solvents 
Electrochemical 
decomposition 
Control of particle size Lack in reproducibility, rough 
products, amorphous impurities 
Physical 
Aerosol Relatively narrow size 
distribution 
Complicated 
Gas phase deposition Easy Low size control 
Electron beam lithography Well-controlled interparticle 
spacing 
Expensive and highly complex 
equipment 
Biological 
Bacteria-mediated Good reproducibility and 
scalability, high yield, low cost 
Slow, laborious 
Information was taken from (Campos et al., 2015, Wu et al., 2015, Ali et al., 2016, Ali et al., 2017). 
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1.2.2 Coating 
The application of IONPs for biomedical attempts requires the colloidal stability of the 
IONPs in physiological environments (Akbarzadeh et al., 2012). Uncoated IONPs are 
usually not colloidal stable in biological media (Lodhia et al., 2010, Ali et al., 2016) due 
to strong magnetic attraction between the particles, van der Waals forces and their high 
energy surface (Ali et al., 2016). A common approach to prevent agglomeration of 
IONPs, and thereby also to increase the biocompatibility of the particles in physiological 
environments, is a coating of IONPs with various inorganic and organic coating materials 
(Gupta and Gupta, 2005, Valdiglesias et al., 2015, Ali et al., 2016, Mohammed et al., 
2017). A selective list of common used coating materials is given in Table 1.3 which 
includes also information on the core size of the particle measured by transmission 
electron microscopy (TEM), the average hydrodynamic diameter and the surface charge 
of the IONPs dispersed in water. As size and surface charge are important factors 
determining the uptake of NPs in biological systems (Verma and Stellacci, 2010, 
Nazarenus et al., 2014) it is highly important to characterize engineered IONPs in detail. 
 
Table 1.3 Selective list of inorganic- and organic-coated IONPs including the size of the core 
and the average hydrodynamic diameter and the surface charge of the IONPs dispersed in water 
Coating 
Size 
(TEM, nm) 
Average hydrodynamic 
diameter (nm) 
Surface 
charge 
Reference 
Inorganic 
    
     
Gold 10 22-25 negative (Lim et al., 2009, 
Banerjee et al., 2011) 
Silicia 7.6 150-200 negative (Sun et al., 2005) 
Organic     
     
Citric acid 9-25 53-133 negative (Li et al., 2013) 
Dimercaptosuccinate 4-20 30-60 negative (Bertorelle et al., 2006, 
Petters et al., 2014a) 
Polyvinylalcohol 4.5-5 13-57 positive (Amiri et al., 2011) 
Phosphorylcholine 4.5 <10 positive (Denizot et al., 1999) 
Polyethylengylcol 15 40-50 neutral (Gupta and Wells, 2004) 
Dextran 4.2-4.8 80-150 neutral (Soenen et al., 2011) 
Carboxydextran 4.2 62 negative (Soenen et al., 2011) 
Alginate 11 50-55 negative (Castello et al., 2015) 
Chitosan 11 100 negative (Castello et al., 2015) 
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The introduction of the coating material is either performed during the synthesis or 
directly after preparation of the bare IONPs and the colloidal stabilization by such 
molecular layers can be of electrostatic or of steric nature (Turro et al., 2002, Sapsford et 
al., 2013). An additional advantage of the surface coating is the opportunity to further 
biofunctionalization of the engineered shell (Sapsford et al., 2013, Ali et al., 2016). This 
opens up a range of possible functionalization approaches and specific applications 
(Table 1.4) such as insertion of target-specific antibodies for a directed transport of 
IONPs and/or the addition of drugs for specific treatments (Tietze et al., 2015, El-
Boubbou, 2018). The possibility to combine magnetic with fluorescent properties by the 
synthesis of fluorescently labeled IONPs increases the potential of IONPs for biomedical 
applications even further (Kaewsaneha et al., 2015, Shi et al., 2015). 
 
Table 1.4 Functionalization of the engineered coating of IONPs for precise application 
Coating 
Functionalization 
Application/ Function References 
Molecule Function 
     
DMSA BODIPY Fluorophore Optical detection of IONPs in cellular 
uptake studies 
(Luther et al., 
2013, Petters 
et al., 2016) 
DMSA Fluorescein Fluorophore Fluorescent and magnetic cell 
labeling 
(Bertorelle et 
al., 2006) 
PEG Cy5.5 Fluorophore Specific targeting of glioma cells for 
magnetical and optical detection  
(Veiseh et al., 
2005)  Chlorotoxin Neurotoxin 
PEG anti-TAG-72 Antibody Targeted drug delivery of IONPs to 
colon cancer cells for simultaneous 
MRI and fluorescent imaging 
(Zou et al., 
2010)  5-FAM Fluorophore 
 Doxorubicin Anti-cancer drug 
Dextran Hsp70 Antibody Selective binding to glioma specific 
CD40 receptor and enhancement of 
MRI contrast 
(Shevtsov et 
al., 2014) 
Dextran CD11b-TAC Antibody Purification of microglia preparations 
by selective binding of IONPs to the 
microglia marker protein CD11b 
followed by magnetic separation 
(Gordon et 
al., 2011) 
Dextran Anti-ferritin Antibody Detection of ferritin accumulation in 
Alzheimer’s Disease 
(Fernandez et 
al., 2018) 
Chitosan Ciprofloxacin Antibiotic drug Drug delivery system with 
controllable drug release 
(Kariminia et 
al., 2016) 
DMSA: Dimercaptosuccinate; Hsp70: heat shock protein 70, MRI: magnetic resonance imaging; PEG: 
polyethylenglycol; TAC: tetrameric antibody complexes, TAG: tumor-associated glycoprotein-72 
 
For IONP-cell interaction studies, the small organic molecule meso-2,3-
dimercaptosuccinate (DMSA) has frequently been used as coating material for IONPs 
(Fauconnier et al., 1997, Villanueva et al., 2009, Valois et al., 2010, Geppert et al., 2011, 
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Petters et al., 2014b, Zhang and Liu, 2017). DMSA is an FDA approved agent, which is 
commonly orally administered as metal chelator and shows low toxicity in various 
biological systems (Ercal et al., 1996, Rooney, 2007, Flora and Pachauri, 2010). DMSA 
forms a cage-like structure around the iron core of IONPs through interaction of the 
terminal carboxylate groups with the iron core and additional intermolecular disulfide-
bridges between bound DMSA molecules (Fauconnier et al., 1997, Chen et al., 2008, 
Valois et al., 2010, Soler et al., 2011). The free carboxylate groups of DMSA lead to a 
stabilization of the particles in physiological media and even in solutions that range in 
pH values between 3 to 11 (Fauconnier et al., 1997). Additionally, DMSA accelerates the 
internalization of IONPs in comparison to IONPs coated with uncharged materials like 
dextran, most likely due to the high nonspecific binding of DMSA-IONPs to the cell 
membrane due to the negative surface charges induced by the DMSA coat (Wilhelm et 
al., 2003, Villanueva et al., 2009). DMSA or the DMSA coat around the NPs can be 
further functionalized by adding fluorophores (Luther et al., 2013, Petters et al., 2014a, 
Petters et al., 2016) or drugs, antibodies and other compounds to free thiol- or carboxyl-
groups of the coat which allows to study cell interactions of IONPs in more detail or 
allows a more directed and specific cellular uptake (Shevtsov et al., 2014, Shevtsov et 
al., 2015, Liu et al., 2016, Galli et al., 2017).  
 
In addition to the defined coating during or after the synthesis of the IONPs, it has to be 
considered that, as soon as NPs enter biological environments a variety of molecules will 
adsorb onto the surface of the NPs (Nel et al., 2009, Sakulkhu et al., 2014), and thereby 
modify surface properties. This process depends on the surface chemistry of the particles 
and the composition of the medium that may contain ions, lipids, metabolites, sugars, 
other biomolecules and proteins (Rivera-Gil et al., 2013, Nazarenus et al., 2014, Feliu et 
al., 2016). As proteins are the most abundant biomolecules in biological fluids (Pelaz et 
al., 2013), the formation of a so called protein-corona around the IONPs has been 
intensively studied, showing a huge impact on the size, stability, surface chemistry and, 
thereby, on the interaction and uptake of IONPs in cells (Doak et al., 2009, Wiogo et al., 
2011, Geppert et al., 2013, Mahmoudi et al., 2014, Feliu et al., 2016). The surface coating 
of the IONPs can strongly influence the formation of the protein corona as interaction of 
the proteins with the IONP surface are driven by hydrogen bonds, solvation forces, 
hydrophobic and electrostatic interactions (Saptarshi et al., 2013). For example, the 
protein-coronas formed around negatively charged carboxylated dextran-coated IONPs 
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and positive amino dextran-coated IONPs differ strongly in their composition (Amiri et 
al., 2013), while coating of IONPs with polyethylenegylcol could prevent the formation 
of a protein corona (Torrisi et al., 2014). 
1.2.3 Characterization  
The combination of different synthesis methods and various coating options, generates a 
huge variety of different types of IONPs. As several factors and already minor changes 
in environmental composites can cause severe alterations in the physicochemical 
properties of the IONPs and consequently may have a severe impact on the interaction, 
effects and toxic potential of IONPs on biological systems, it is essential to carefully 
characterize the physicochemical properties of the NPs for the conditions applied 
(Rivera-Gil et al., 2013, Nazarenus et al., 2014, Mohammed et al., 2017). Table 1.5 lists 
important physicochemical parameters of IONPs and commonly used techniques to 
investigate these parameters. 
 
Table 1.5 Methods to determine physicochemical parameters of IONPs  
Parameter investigated Method 
Core size, shape, size distribution Electron microscopy 
Elemental composition Energy dispersive X-ray spectroscopy 
Discrimination between Fe2+ and Fe3+ Mossbauer spectroscopy 
Determination of the iron content Atomic absorption spectroscopy 
Crystal structure X-ray diffraction 
Functional groups (Verification of the coating) Infrared spectroscopy 
Size and size distribution in dispersion Dynamic light scattering 
Surface charge (ζ-potential), colloidal stability Electrical light scattering 
Magnetic properties Vibrating sample magnetometer 
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1.3 The brain and iron oxide nanoparticles 
1.3.1  The blood-brain barrier and the major cell types in the brain 
The blood-brain barrier (BBB) provides a stable environment for neural functions, 
prevents many macromolecules from entering the brain and protects the central nervous 
system (CNS) from neurotoxic substances circulating in the blood. The BBB possesses 
specific transporter systems to ensure an adequate supply of the brain cells with many 
essential water-soluble nutrients and metabolites (Abbott et al., 2010). The BBB is 
formed by the endothelial cells of the brain capillaries, pericytes and the basal lamina 
covered by the endfeets of astrocytes (Abbott et al., 2010, Grabrucker et al., 2016) 
(Sofroniew and Vinters, 2010, Cabezas et al., 2014) (Fig. 1.5).  
 
Fig. 1.5 The blood-brain barrier and the four major cell types in the brain.  
Astrocytes are the most abundant glial cell type in the CNS and play an important role in 
the BBB maintenance and permeability (Colombo and Farina, 2016). Due to their 
location, astrocytes are the first neural cells that encounter compounds passing the BBB 
from blood (Colombo and Farina, 2016). Furthermore, astrocytes regulate brain 
homeostasis as they supply metabolites and growth factors to neurons, maintain the 
extracellular balance of ions, water, metals and neurotransmitters, support synapse 
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formation and plasticity and detoxify xenobiotics (Dringen et al., 2015, Colombo and 
Farina, 2016, Gorshkov et al., 2018, Hirase and Koizumi, 2018) (Fig. 1.5).  
 
Beside astrocytes, the main cell types in the brain are neurons, oligodendrocytes and 
microglia (Fig. 1.5). Neurons are important for signal transduction by the transmission of 
information along their axons and are characterized by the excitability and the release of 
neurotransmitters (Scalettar, 2006, Peters and Connor, 2014). Microglia and 
oligodendrocytes belong together with astrocytes to the glial cells (Peters and Connor, 
2014). Microglia comprise around 10-15% of all glial cells and are the immune competent 
cells of the CNS. Upon activation they clear via phagocytic activity the brain from 
invading pathogens or from cell debris generated by apoptosis or necrosis of neuronal 
cells (Saura et al., 2003, Nayak et al., 2014, Murgoci et al., 2018). Oligodendrocytes 
support and isolate the axons in the CNS by myelination (Bradl and Lassmann, 2010, 
Michalski and Kothary, 2015).  
1.3.2 Consequences of iron oxide nanoparticle exposure to the brain  
Over one and a half billion people worldwide suffer from central neural system (CNS) 
disorders, but the treatment of these diseases is heavily limited due to the poor access of 
therapeutic drugs and genetic material across the BBB into the CNS (Posadas et al., 
2016). The efficient crossing of the BBB is limited to small polar molecules and highly 
hydrophobic molecules that are not recognized by the multidrug resistance proteins 
expressed in the brain endothelial cells of the BBB (Thomsen et al., 2015). As small 
IONPs are capable pf rapidly crossing the BBB (Shubayev et al., 2009, Shi et al., 2016, 
Vinzant et al., 2017) and possess a high biocompatibility as iron ions released from 
IONPs are added to natural/cellular iron deposits (Posadas et al., 2016), the interest in 
IONPs for potential applications in the neurobiomedical field is heavily increasing. They 
are being especially considered for their use as drug-delivery system through the BBB 
(Yang, 2010, Pilakka-Kanthikeel et al., 2013, Vinzant et al., 2017) and for direct 
treatment of brain tumors by hyperthermia (Liu et al., 2016). Besides the direct 
application of IONPs to the brain by injection in tumoral brain tissues (Fig. 1.6A), IONPs 
can enter the brain via several other routes (Petters et al., 2014b, Bencsik et al., 2018). 
After inhalation, IONPs can reach the brain via the olfactory bulb accessible from the 
nasal cavity (Wang et al., 2007, Petters et al., 2014b, Bencsik et al., 2018) (Fig. 1B). 
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Alternatively, IONPs can reach the brain via the bloodstream as soon as IONPs have 
crossed the first barrier such as lung, gastrointestinal tract or skin (Bencsik et al., 
2018)(Fig.1C-D). Depending on the size and surface charge of the NPs they may cross 
the intact BBB either by absorptive transcytosis (Fig. 1.6C), receptor/carrier-mediated 
transport through the endothelial cells (Fig. 1.6D) or by passive diffusion (Fig. 1.6E) 
(Yan et al., 2013, Grabrucker et al., 2016, Bencsik et al., 2018), whereby the latter is 
highly limited due to the structure of the BBB (Grabrucker et al., 2016). Another entry 
mechanism of IONPs into the brain is the passage through damaged region of the BBB 
(Fig1.6F) (Mejias et al., 2010, Petters et al., 2014b), as it occurs in various brain diseases 
such as stroke, nerve trauma or multiple sclerosis (Suh et al., 2009, Weise and Stoll, 2012, 
Krol et al., 2013). 
 
 
Fig. 1.6 Enty routes of IONPs into the brain. (A) Direct injection for clinical treatment (1) and 
via the olfactory bulb after inhalation (2). (B) From the blood stream via trancytosis (1), by 
receptor/carrier-mediated transport (2), by diffussion through the endothelial cells (3) or 
trough damaged regions of the BBB (4).  
Although a lot of effort has been made to design IONPs specific for the use in biomedical 
application with beneficial outcome for the diagnosis and treatment of CNS diseases, is 
has to be noted that IONPs can induce neurotoxic effects or accelerate existing brain 
damage (Valdiglesias et al., 2015, Valdiglesias et al., 2016, Bencsik et al., 2018). In this 
context it has to be considered that IONPs can be metabolized and easily release iron ions 
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(Valdiglesias et al., 2015). Iron plays an important role in many metabolic processes in 
the CNS, for example in myelin synthesis, oxidative phosphorylation, neurotransmitter 
production and nitric oxide metabolism. But, on the other hand, a disturbance in the iron 
homeostasis can cause toxic effects by iron-mediated formation of oxygen radical species 
(ROS) and oxidative stress (Yarjanli et al., 2017). Alterations of the iron homeostasis in 
the brain have been linked to various neurodegenerative diseases (Hare et al., 2013, 
Rouault, 2013, Petters et al., 2014b, Morris et al., 2018). Thus, the increase usage of 
IONPs in biomedical applications makes it highly important to investigate the potential 
cytotoxicity of IONPs on brain cells (Shi et al., 2016) and to understand the uptake 
mechanisms and the intracellular fate of IONPs in brain cells.  
1.3.3 Uptake and metabolism of iron oxide nanoparticles in brain cells 
As soon as IONPs have crossed the BBB, neurons, astrocytes and microglia will 
encounter these particles. Several studies have shown that IONPs can be found in all 
these brain cell types after they have crossed the BBB (van Landeghem et al., 2009, Ku 
et al., 2010, Yan et al., 2013). Although a large number of studies and reviews are 
available dealing with the interaction of IONPs with peripheral mammalian cells 
(Nazarenus et al., 2014, Oh and Park, 2014), more work is needed to understand the 
IONP-cell interactions, uptake and fate of IONPs in neural cells (Kura et al., 2014, Petters 
et al., 2014b, Costa et al., 2016, Dante et al., 2017).  
 
The first step in cellular uptake of IONPs is the interaction of the particle with the cell 
membrane (Wilhelm et al., 2003, Mahmoudi et al., 2014). This interaction has a huge 
impact on the further uptake, internalization and fate of the particles and depends on a 
variety of factors. As the engineered coating or the absorbed biomaterial defines the 
interaction of the NPs with the cells (Pelaz et al., 2013), the surface charge and surface 
chemistry of the IONPs, that depends on the composition of the coating (Table 1.3), plays 
a crucial role in the interactions with the cell membrane (Nel et al., 2009, Lesniak et al., 
2013, Dante et al., 2017). As the plasma membrane is globally negatively charged (Forest 
et al., 2015), positively charged IONPs are taken up more efficiently than negatively 
charge IONPs. Nevertheless, negatively charge IONPs can interact, for example, with 
cationic lipid domains in the lipid raft of the cell membrane and are subsequently 
internalized (Wilhelm et al., 2003, Adjei et al., 2014, Nazarenus et al., 2014). Such 
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IONPs show a higher uptake rate than neutral dextran-coated IONPs (Wilhelm et al., 
2003). The size of the IONPs is also crucial for uptake as it will influence the amount of 
potential binding sites (e.g. specific receptors) between the particle and cells, which may 
even lead to activation of different endocytotic pathways for cellular uptake. In addition, 
the characteristics of the cell membrane the like lipid composition, shape, thickness and 
stiffness, but also membrane protein-expression influence the adhesion of NPs to the cell 
membrane (Laurent et al., 2013, Mahmoudi et al., 2014).  
 
As mentioned above, as soon as IONPs enter a biological environment, the formation of 
a protein corona around the particle is unavoidable (Nel et al., 2009, Sakulkhu et al., 
2014). This can result, for example, in a reduced cellular adhesion and consequently 
reduced cellular uptake (Geppert et al., 2013, Lesniak et al., 2013). The altered uptake of 
protein-coated IONPs could be caused by more specific interactions between the protein-
coated IONPs and the cell membrane that may involve and activate different uptake 
mechanisms (Wilhelm et al., 2003, Lesniak et al., 2013, Mahmoudi et al., 2014) 
 
As reported for other cell types, there are several ways how brain cells are able to take up 
IONPs: (1) Diffusion through the cell membrane, (2) transport through ion channels, (3) 
endocytosis and (4) direct translocation e.g. by the insertion of cell penetrating peptides 
into the coat or by electroporation, magnetofection or microinjection (Mahmoudi et al., 
2014). The first two uptake principles are restricted to very small IONPs with a size of 
just a few nanometers (Mahmoudi et al., 2014). As red blood cells do not possess any 
endocytotic machinery, but are capable of internalizing NPs (Rothen-Rutishauser et al., 
2006, Wang et al., 2012) such endocytotic independent uptake seems to be possible. 
Nonetheless, it is widely accepted that IONPs enter cells mainly via endocytic 
mechanisms (Iversen et al., 2011, Oh and Park, 2014, Petters et al., 2014b, Zhang et al., 
2015a).  
1.3.4 Endocytosis of iron oxide nanoparticles  
Endocytosis is a fundamental energy-dependent process of cells to internalize ions and 
biomolecules (Canton and Battaglia, 2012, Oh and Park, 2014). Bacteria and viruses also 
use the cellular endocytosis mechanisms to enter cells (Cossart and Helenius, 2014). A 
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lot of effort has been taken to understand the mechanisms and the complexity of cellular 
endocytosis pathways. Here, only the most common routes will be shortly described.  
Depending on the size of the molecules taken up and the cell type, two main categories 
of endocytotic uptake mechanisms can be separated: Phagocytosis, which is limited to 
specialized cells like immune cells including microglia cells, and pinocytosis which is 
ubiquitously used by almost all eukaryotic cells and can be sub-categorized into 
macropinocytosis, clathrin- or caveolae-mediated endocytosis and clathrin-/caveolae 
independent mechanisms (Soldati and Schliwa, 2006, Canton and Battaglia, 2012) 
(Fig. 1.7).  
 
Fig. 1.7 Simplified scheme of the cellular endocytosis and the postulated role of actin 
filaments and microtubules in these processes  
 
Endocytotic mechanisms can be described as a sequence of four essential steps: (1) initial 
binding to the cell surface membrane, (2) vesicle formation by plasma membrane 
deformation, (3) detachment of the vesicle from the membrane and (4) trafficking of 
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vesicles to specific subcellular organelles (Qualmann et al., 2000). The time scale of these 
processes is relatively short. Engulfment of biomolecules or NPs and vesicle formation 
is a rapid process and already after 1-5 min vesicles reach the first endosomal 
compartment (Durrbach et al., 1996), namely the early endosome. After 10-15 min the 
internalized molecules arrive in the late endosomes and after additional 15 min lysosomal 
compartments are reached (Canton and Battaglia, 2012, Thimiri Govinda Raj and Khan, 
2016) (Fig. 1.7). During the endocytotic transport the compartments involved are getting 
more and more acidic. While early endosomes still have a more or less neutral pH 
(7.4-6.2), all the later compartments are more acidic reaching a pH of finally 5-4.4 in the 
lysosomes (Fig. 1.7) (Durrbach et al., 1996, Canton and Battaglia, 2012, Cossart and 
Helenius, 2014).  
 
Depending on the endocytotic pathway the vesicles are derived from, the destination of 
the vesicles may vary. Vesicle formed by phagocytosis (so-called phagosomes) fuse 
directly with late endosomes or lysosomes, leading their cargo quickly into the acidic 
environment (Doherty and McMahon, 2009, Canton and Battaglia, 2012). Vesicle 
derived from macropinocytosis or clathrin/caveolin-mediated endocytosis evolve first to 
early endosomes, from where the cargo is either transported to the late endosome and 
lysosome or sorted to the Golgi apparatus, the endoplasmic reticulum or to recycling 
endosomes (Lai et al., 2007, Doherty and McMahon, 2009, Canton and Battaglia, 2012).  
 
For cultured astrocytes, microglia and oligodendrocytes, DMSA-coated IONPs were 
postulated to be taken up by macropinocytosis and clathrin-mediated endocytosis 
(Geppert et al., 2013, Luther et al., 2013, Petters et al., 2014a), whereas in neurons the 
uptake of DMSA-coated IONPs seems to depend on clathrin-mediated endocytosis, but 
not on macropinocytosis (Petters and Dringen, 2015). These endocytotic pathways were 
connetcted to the uptake of protein-coated IONPs, whereas the strong uptake of IONPs 
applied in protein-free medium could not be prevented by known pharmacological 
endocytosis inhibitors (Lamkowsky et al., 2012, Geppert et al., 2013, Petters, 2015). 
Depending on the cell type and the route of internalization, IONPs have distinct toxic 
potential on brain cells (Petters et al., 2014b). In the case of the phagocytic microglia, 
IONPs are rapidly transported to the lysosome which leads to severe toxicity due to the 
quick release of iron ions (Pickard and Chari, 2010, Luther et al., 2013, Petters et al., 
2016), consistent with data reporting that IONPs are dissolved under conditions present 
Introduction  20 
 
in the lysosomal compartments (Skotland et al., 2002, Levy et al., 2010, Mazuel et al., 
2016). In contrast, for cultured astrocytes IONPs have no toxic potential (Geppert et al., 
2011, Geppert et al., 2013, Hohnholt et al., 2013, Petters et al., 2016) and the lysosomal 
release of iron ions from the internalized IONPs is low and taken care of by a strong 
upregulation of the iron storage protein ferritin (Geppert et al., 2012). 
 
The endocytosis processes require a complex protein machinery for the formation of 
vesicles, especially during the receptor-mediated endocytosis, and the control of these 
processes (Qualmann et al., 2000). The cytoskeleton plays a crucial role in endocytosis 
(Fig. 1.7). Microtubules are important for long distance transport (Soldati and Schliwa, 
2006, Granger et al., 2014), but also support short-range movements of vesicles (Granger 
et al., 2014), whereas the flexible actin filaments support the engulfment of membrane 
segments, the formation of vesicles, separation and transport of the vesicles from the 
membrane (Durrbach et al., 1996, Kumari et al., 2010, Mooren et al., 2012). The role of 
actin in certain endocytosis pathways is still under debate. However, there is an 
agreement that actin places an obligatory role in phagocytosis (Granger et al., 2014). It 
is also widely accepted that actin is mandatory for clathrin-mediated endocytosis in yeast, 
but for mammalian cells this picture is not as clear and contradictory results and opinions 
have been reported (Lamaze et al., 1997, Fujimoto et al., 2000, Qualmann et al., 2000, 
Soldati and Schliwa, 2006, Granger et al., 2014). Commonly, accepted is that actin plays 
at least a supportive role in endocytotic vesicle formation, especially if larger force is 
required for budding due to high membrane rigidity or if larger cargoes are ingested 
(Boulant et al., 2011). There is also evidence for the role of actin in the transport of newly 
formed vesicles away from the plasma membrane, at least during clathrin-mediated 
endocytosis (Soldati and Schliwa, 2006, Granger et al., 2014). However, the major role, 
in the transport of the nascent vesicles from the actin-rich cell periphery to their specific 
compartment appears to be played by microtubules, as the switch from the actin-based 
movement to a microtubules-based movement occurs after forming and release of the 
vesicle from the plasma membrane (Granger et al., 2014). Uptake studies for polystyrene 
NPs in various cell lines including brain astrocytoma 1321N1 cells but also tumor 
epithelial HeLa, lung carcinoma A549 and macrophages revealed that the role of actin 
polymerization and microtubules formation in NP-uptake highly depends on the cell type 
investigated (Rejman et al., 2004, Geiser et al., 2005, dos Santos et al., 2011, Kasten et 
al., 2014). Furthermore, the role of the cytoskeleton in the uptake of NPs depends 
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strongly on the size of the NPs (Rejman et al., 2004, dos Santos et al., 2011). For brain 
cells no information is currently available on the role of the cytoskeleton in IONPs uptake 
and trafficking. 
1.4 Cell cultures as model systems for glial cells 
To understand the uptake and cellular trafficking of IONPs and the consequences of 
IONP exposure in biological systems, cell cultures are suitable in vitro tools to gain first 
knowledge on IONP-cell interactions. (Calero et al., 2014, Bencsik et al., 2018). 
Although, cell cultures models cannot capture the whole complexity of living organisms 
due to the lack of three dimensional organization of tissues, the connection to other cell 
types, the lack of the immune system and the altered environment, they are indispensable 
for exploring the basal cytotoxicity and uptake mechanisms of NPs before more complex 
in vivo experiments are performed (Lange et al., 2012, Calero et al., 2014).  
1.4.1 Cultured astrocytes 
Astrocytes can be used as primary or secondary culture (Lange et al., 2012, Petters and 
Dringen, 2014). Primary astrocytes are probably the closest in vitro model for in vivo 
situations (Bregoli et al., 2013) and have been frequently used to study properties and 
functions of brain astrocytes (Lange et al., 2012, Petters et al., 2014b, Tulpule et al., 
2014). Cultured astrocytes are most commonly prepared from brain tissue of mice or rats 
(Hamprecht and Loffler, 1985, Tulpule et al., 2014). These cultures can contain 
contaminations of other types of brain cells such as microglia, neurons, oligodendrocytes, 
endothelial cells and neuronal stem cells (Hamprecht and Loffler, 1985, Lange et al., 
2012, Tulpule et al., 2014). For example, in uptake studies of IONPs using astrocyte 
primary cultures the presence of microglial cells (Petters and Dringen, 2014, Tulpule et 
al., 2014) should be considered and analyzed as co-culture studies observed that IONPs 
are taken up more strongly by microglial cells in co-cultures of microglia and astrocytes 
(Fleige et al., 2001, Pickard and Chari, 2010). The presence of different cell types in 
primary cultures can be investigated by immunocytochemical staining for cell type 
specific markers (Petters and Dringen, 2014, Tulpule et al., 2014). For astrocytes the 
expression of the glial fibrillary acid protein (GFAP) is commonly used marker for 
immunocytochemical characterization (Sofroniew and Vinters, 2010) (Fig. 1.8). GFAP 
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expression in vivo is more or less restricted to reactive astrocytes that are responding to 
CNS injuries (Sofroniew and Vinters, 2010), whereas in culture astrocytes vary in the 
intensity of GFAP-positive staining depending on the culturing conditions. 
 
 
Fig. 1.8 GFAP-expression in primary astrocyte cultures and C6 glioma cells. Primary astrocyte 
cultures and C6 glioma cells were washed twice with cold phosphate-buffered saline, fixed 
with 3.5% (w/v) paraformaldehyde and stained as described (Stapelfeldt et al., 2017) for glial 
fibrillary acidic protein (GFAP, red) by using an rabbit α-GFAP antibody. The nuclei were 
stained with DAPI (blue). 
1.4.2 C6 glioma cells 
C6 glioma cells are widely used as model to study glial cells (Mangoura et al., 1989) and 
brain glioma cells (Grobben et al., 2002). Due to the expression of the glial fibrillary 
acidic protein (GFAP) (Fig. 3.8) and the glutamine synthetase, C6 glioma cells are often 
used as an astrocyte model system (Kumar et al., 1986, Mangoura et al., 1989, Goswami 
et al., 2015). However results obtained in such cell lines as model systems should be 
carefully interpreted for their relevance for normal tissue cells as cell lines are mostly 
transformed, possess lost growth control and genetic and chromosomal changes 
compared to the genuine brain cells (Bregoli et al., 2013). Furthermore, differentiation 
states of the cell culture can change the protein expression patterns. In fact, C6 glioma 
cells express also oligodendroglial marker proteins such as glycerol phosphate 
dehydrogenase and cyclic nucleotide phosphohydrogenase (Bissell et al., 1975, Kumar 
et al., 1986, Mangoura et al., 1989) and should therefore be considered as glia precursor 
cells (Koch et al., 2007). Nevertheless, the advantages of such cell lines are the easy 
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handling and continuous availability of a large number of cells (Bregoli et al., 2013). 
Another advantage of C6 glioma cells as model system is the homogeneity of these cells 
in culture in contrast to primary cultures, where always a small contamination with other 
cells is possible due to the preparation methods (Lange et al., 2012, Petters and Dringen, 
2014). Due to these advantages cell lines are often used for first screening tests, even 
though the primary cultures are more precise in reflecting properties of the respective 
brain cells (Kaur and Dufour, 2012, Bregoli et al., 2013, Gordon et al., 2013).  
1.5 Aim of the thesis 
Dimercaptosuccinate (DMSA)-coated IONPs have previously been functionalized with 
the fluorescence dye BODIPY (BP) to study the cellular uptake and intracellular 
localization of IONPs in brain cells by fluorescence microscopy (Luther et al., 2013, 
Petters et al., 2014a, Petters et al., 2016). However, a strong disadvantage of these BP-
IONPs is a rapid photo bleaching which limited the possible applications of these 
particles for studies on the intracellular fate of IONPs in neural cells. 
 
The aim of the present thesis is to generate more stable fluorescent IONPs by attaching 
fluorescence dyes to the SH groups of the DMSA. To improve fluorescence intensity and 
stability of the fluorescent IONPs, the DMSA coat will be functionalized with Oregon 
Green (OG) or tetramethylrhodamine (TMR) as these dyes are available as 
iodoacetamides for easy coupling to the SH-group of the DMSA (Fig. 1.9) and possess 
suitable absorption and emission maxima matching the settings of the available wide-
field epifluorescence microscope.  
 
OG-DMSA-coated and TMR-DMSA-coated IONPs will be synthesized, characterized 
for their physicochemical properties (size, shape, size distribution, charge and 
fluorescence) and compared to non-fluorescent and BODIPY-labeled IONPs. 
Additionally, the fluorescent IONPs will be compared to non-fluorescent IONPs 
regarding interaction with cells to investigate whether the insertion of the fluorescence 
dyes has any effect on the binding and the cellular accumulation using C6 glioma cells. 
To study the internalization and intracellular fate of fluorescent IONPs nanoparticle 
pulse-chase set up will be established to improve cellular resolution of these IONPs in 
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C6 glioma cells and other neural cell cultures. Finally, these optimized settings for 
nanoparticle pulse-chase will be used to analyze the role of the cytoskeleton in the uptake 
and intracellular trafficking of IONPs and to investigate the intracellular separation of the 
coating material and the core of the internalized fluorescent IONPs. 
 
 
Fig. 1.9 Synthesis of fluorescently labeled IONPs. The synthesis of fluorescent IONPs is a 
three step process: (A) The synthesis of bare IONPs via the chemical coprecipitation method, 
(B) synthesis of fluorescent DMSA by formation of a thioether-bound between the 
iodoacetamide group of the fluorescence dye and the SH-group of the DMSA and (C) coating 
of the bare IONPs with the fluorescent DMSA. 
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Abstract 
Iron oxide nanoparticles (IONPs) are used for various biomedical and therapeutic 
approaches. To investigate the uptake and the intracellular trafficking of IONPs in 
neural cells we have performed nanoparticle pulse-chase experiments to visualize the 
internalization and the fate of fluorescent IONPs in C6 glioma cells. Already a short 
exposure to IONPs for 10 min at 4°C (nanoparticle pulse) allowed binding of substantial 
amounts of nanoparticles to the cells, while internalization of IONPs into the cell was 
prevented. The uptake of bound IONPs and the intracellular trafficking was started by 
increasing the temperature to 37°C (chase period). While hardly any cellular 
fluorescence nor any iron staining was detectable directly after the nanoparticle pulse, 
dotted cellular fluorescence and iron patterns appeared already within a few minutes 
after start of the chase incubation and became intensified in the perinuclear region 
during further incubation for up to 90 min. Longer chase incubations resulted in 
separation of the fluorescent coat from the core of the internalized IONPs. Disruption 
of actin filaments strongly impaired the internalization of IONPs, whereas 
destabilization of microtubules traped IONP-containing vesicles to the plasma 
membrane. In conclusion, nanoparticle pulse-chase experiments allowed to synchronize 
the cellular uptake of fluorescent IONPs and to identify for C6 cells an actin-dependent 
early and a microtubules-dependent later process in the intracellular trafficking of 
fluorescent IONPs. 
 
Keywords: actin; iron; microtubules; nanoparticles; pulse-chase; trafficking 
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1. Introduction 
Superparamagnetic iron oxide nanoparticles (IONPs) are used for several 
neurobiomedical applications, for example for magnetic resonance imaging (MRI), for 
treatment of brain tumors by magnetic hyperthermia (Liu et al., 2016) or as drug 
delivery tools for passing the blood-brain barrier (Vinzant et al., 2017). Such 
applications make it essential to investigate the cytotoxic potential of IONPs (Shi et al., 
2016) and to understand the uptake and the intracellular metabolism of IONPs in brain 
cells. To increase the biocompatibility in physiological environments and to prevent 
agglomeration, IONPs are normally coated with organic materials (Ali et al., 2016, Feliu 
et al., 2016), which modify the physicochemical parameters of the nanoparticles such 
as size, charge and shape, and thereby, can modulate also the interactions between 
nanoparticles and cells as well as the endocytotic uptake of nanoparticles into cells 
(Nazarenus et al., 2014, Oh and Park, 2014). Depending on the cell type investigated, 
different endocytotic pathway are involved in the uptake of nanoparticles, including 
macropinocytosis, pinocytosis, clathrin-dependent, clathrin-independent, degradative or 
non-degradative pathways (Lai et al., 2007, Iversen et al., 2011, Nazarenus et al., 2014, 
Zhang et al., 2015b). The cellular uptake of nanoparticles is a two-step process (Wilhelm 
et al., 2003). First the nanoparticles bind to the cells and subsequently the nanoparticles 
are internalized by endocytosis (Wilhelm et al., 2003). Both processes take place at 
physiological temperature. In contrast, at 4°C only the adsorption of nanoparticles to the 
cell membrane is observed, while the internalization of bound nanoparticles is prevented 
at this low temperature (Wilhelm et al., 2003, Bertorelle et al., 2006, Geppert et al., 
2011, Rastedt et al., 2017). 
Depending on the kind of exposure nanoparticles can reach the brain via various routes, 
such as inhalation, ingestion or the cutaneous route (Bencsik et al., 2018). After crossing 
the first tissue barrier and entering the blood they may cross the blood-brain barrier from 
blood into brain. More direct ways of nanoparticles to reach the brain are after inhalation 
via the olfactory bulb that is directly accessible from the nasal fossae or by direct 
injection into the brain for tumor treatment (Petters et al., 2014, Bencsik et al., 2018). 
Several studies have shown that IONPs can be found in brain in various cell types, 
including neurons, astrocytes and microglia (van Landeghem et al., 2009, Ku et al., 
2010, Yan et al., 2013). As for peripheral cells, IONPs are also taken up in neural cells 
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via endocytotic pathways (Petters et al., 2014). Cultured astrocytes and microglia take 
up protein-coated IONPs by macropinocytosis and clathrin-mediated endocytosis 
(Pickard et al., 2011, Geppert et al., 2013, Luther et al., 2013), whereas cultured neurons 
internalize such IONPs by clathrin-mediated endocytosis (Petters and Dringen, 2015). 
Depending on the cell type investigated IONPs differ strongly in their cytotoxic 
potential (Petters et al., 2014, Petters et al., 2016). Whereas cultured astrocytes are not 
damaged even days after exposure to large amounts of IONPs (Geppert et al., 2012), the 
viability of cultured microglia cells is strongly compromised already within hours after 
exposure to IONPs (Pickard and Chari, 2010, Luther et al., 2013, Petters et al., 2016). 
C6 glioma cells are widely used as model to study glial cells (Mangoura et al., 1989). 
Due to the expression of the glial fibrillary acidic protein (GFAP) and the glutamine 
synthetase C6 glioma cells are often considered as astrocyte model system (Kumar et 
al., 1986, Mangoura et al., 1989, Goswami et al., 2015). The uptake of various types of 
nanoparticles have previously been investigated for C6 glioma cells (Mamani et al., 
2012, Shevtsov et al., 2015, Joshi et al., 2016). These cells accumulate IONPs in a time, 
concentration- and temperature dependent manner (Rastedt et al., 2017) by processes 
that strongly depend on the composition of the particle coat and on the presence of serum 
(Mamani et al., 2012, Shevtsov et al., 2015, Rastedt et al., 2017). 
For peripheral cells it has been reported that the formation of endocytotic vesicle at the 
membrane appears to involve actin polymerization (Smythe and Ayscough, 2006, 
Mooren et al., 2012, Granger et al., 2014), while microtubules-based processes are 
involved in the further intracellular trafficking of nanoparticle-containing vesicles 
(Granger et al., 2014, Yameen et al., 2014). During the intracellular trafficking the 
nanoparticle-containing vesicles are thought to be passed to more acidic vesicular 
environments, which can lead to the degradation of the engineered surface coat and/or 
of the core of the nanoparticle (See et al., 2009, Lunov et al., 2010, Feliu et al., 2016). 
In contrast to peripheral cells, only little is known on the intracellular trafficking and the 
metabolism of IONPs in brain cells (Petters et al., 2014, Costa et al., 2016) and the 
involvement of the cytoskeleton in the intracellular trafficking of IONPs in neural cells 
has to our knowledge not been reported so far.  
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Recently, we have synthesized dimercaptosuccinate (DMSA)-coated IONPs that 
contain the fluorescence dyes Oregon Green (OG) or tetramethylrhodamine (TMR) 
covalently bound to the coat and have demonstrated that the incorporation of the 
fluorescence dye into the coating material does not alter the physicochemical properties, 
the colloidal stability in different media, the biocompatibility or the cellular uptake in 
comparison to non-fluorescent DMSA-coated IONPs (Rastedt et al., 2017). These 
fluorescent IONPs were now used as tools to study internalization and cytoskeleton-
dependent intracellular trafficking of IONPs in C6 glioma cells in nanoparticle pulse-
chase experiments with improved spatial resolution by epi-fluorescence microscopy. 
2. Experimental Section  
Materials 
Fetal calf serum (FCS), trypsin solution and penicillin/streptomycin solution were 
obtained from Biochrom (Berlin, Germany). Dulbecco’s modified Eagle’s medium 
(DMEM) was from Gibco (Karlsruhe, Germany). Bovine serum albumin (BSA) and 
nicotinamide adenine dinucleotide (NADH) were purchased from Applichem 
(Darmstadt, Germany). Oregon Green®488 iodoacetamide (mixed isomers) and 
tetramethyl rhodamine-5-iodoacetamide dihydroiodide (single isomer) were obtained 
from Invitrogen (Darmstadt, Germany). Other chemicals of highest purity were 
purchased from Merck (Darmstadt, Germany), Sigma-Aldrich (Steinheim, Germany) or 
Fluka (Buchs, Switzerland). 24-well cell culture plates and 96-well microtiter plates 
were obtained from Sarstedt (Nümbrecht, Germany) and black 96-well plates were 
purchased from VWR (Darmstadt, Germany).  
Synthesis and characterization of iron oxide nanoparticles 
Fluorescent DMSA-coated IONPs containing the fluorophores Oregon Green (OG) or 
tetramethylrhodamine (TMR) in the coat were synthesized and intensively characterized 
as recently described in detail (Rastedt et al., 2017). Transmission electron microscopy 
analysis revealed a particle size of 5-10 nm. In the incubation buffer (IB) that was also 
used for cell incubations in the present study the fluorescent IONPs had a hydrodynamic 
diameter of around 60 nm and a ζ-potential of -20 mV (Rastedt et al., 2017). The 
concentrations of IONPs given for experiments and cell incubations represent the 
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concentration of total iron in the IONP-containing media and not the concentration of 
the nanoparticles. 
Cell cultures 
The C6 glioma cell line is widely used as cell model to study functions and properties 
of brain glial cells (Goswami et al., 2015, Joshi et al., 2016) and brain glioma (Grobben 
et al., 2002). They express astrocyte marker proteins such as glial fibrillary acidic 
protein (Bissell et al., 1975, Stapelfeldt et al., 2017) and glutamine synthetase (Kumar 
et al., 1986). C6 cells have been shown to efficiently bind and take up various types of 
nanoparticle (Huerta-Garcia et al., 2015, Shevtsov et al., 2015, Joshi et al., 2016, 
Rastedt et al., 2017). The C6 glioma cell line used for our study was kindly provided by 
Dr. Frank Dietz (University of Bremen). The C6 glioma cells were subcultured as 
recently described in detail (Joshi et al., 2016). For experiments, harvested cells were 
seeded in 1 mL cell culture medium (90% DMEM containing 25 mM glucose, 10% fetal 
calf serum, 18 U/mL penicillin G, 18 μg/mL streptomycin sulfate and 1 mM sodium 
pyruvate) in a density of 100,000 cells per well into wells of a 24-well plate or on glas 
coverslips (12 mm in diameter, Roth, Karlsruhe) in wells of 24-well dishes. The cultures 
were used for experiments 24 h after seeding.  
Basal experimental incubations 
For basal particle uptake experiments, C6 glioma cells grown on coverslips or in wells 
of 24-well dishes were washed with 1 mL ice-cold (4°C) or pre-warmed (37°C) 
incubation buffer (IB; 20 mM HEPES, 145 mM NaCl, 5 mM D-glucose, 1.8 mM CaCl2, 
5.4 mM KCl, 1 mM MgCl2, adjusted with NaOH to pH 7.4) and incubated in 200 μL IB 
containing 1 mM OG-IONPs or TMR-IONPs in the humidified atmosphere of an 
incubator at 37°C or on ice at 4°C for the time periods indicated in the legends of the 
figures. 
Nanoparticle pulse-chase experiments  
The pulse-chase strategy was originally developed to study the post-translational fate of 
proteins and to investigate the role of subcellular compartments in protein trafficking 
using radioactive labeling (Jamieson and Palade, 1967b, Jamieson and Palade, 1967a, 
Hou et al., 2013). Recently, this strategy has also been adopted to study nanoparticle 
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endocytosis mechanisms and for subcellular compartment isolation (Thimiri Govinda 
Raj and Khan, 2016). Depending on the cell system, the nanoparticle applied and the 
question addressed, several protocols have been applied that differ substantially 
concerning the incubation conditions (Bertorelle et al., 2006, Baltazar et al., 2012, 
Iversen et al., 2012, Sandin et al., 2012). Here we describe a protocol optimized for C6 
glioma cells that separates binding of fluorescent IONPs to the cells from uptake into 
the cells by alteration of the incubation temperature (Fig. 1).  
For nanoparticle pulse-chase experiments (Fig.1A,C), the cultures were washed with 
ice-cold IB, incubated with 1 mM OG-IONPs for 10 min at 4°C (nanoparticle pulse), 
washed twice with 1 mL ice-cold IB and were then incubated in 200 μL pre-warmed 
(37°C) IB in the humidified atmosphere of an incubator at 37°C for the indicated time 
(chase period). 
For sequential uptake studies, the nanoparticle pulse-chase experiment was modified to 
a double nanoparticle pulse-chase setting (Fig. 1B,C). After the first nanoparticle pulse 
with 1 mM OG-IONPs at 4°C and a first chase period of 30 min at 37°C, the second 
nanoparticle pulse was initiated by washing the cells with 1 mL ice-cold IB and 
incubating the cells with 1 mM TMR-IONPs for 10 min at 4°C (second nanoparticle 
pulse). Subsequently, the cells were washed twice with 1 mL ice-cold IB and then 
incubated in 200 μL pre-warmed (37°C) IB in the humidified atmosphere of an 
incubator at 37°C (second chase period). 
To study the role of the cytoskeleton in the uptake of IONPs, cells were preincubated 
without or with 10 μg/mL cytochalasin D (cytoD) and/or 1.25 μM colchicine in IB for 
60 min at 37°C before the cells were exposed to IONPs in nanoparticle pulse-chase 
experiments. The cytoskeleton-destabilizing compounds were also present during the 
chase periods of the experiments, but had to be omitted from the buffers used for the 
4°C nanoparticle pulses and the 4°C washing steps to prevent artifacts caused by 
agglomeration of IONPs in the presence of colchicine or cytoD (data not shown). 
After the given incubation periods the incubation media were harvested and used for the 
determination of extracellular lactate dehydrogenase activity (LDH) as indicator for 
potential cell damage, while the cells were washed with ice-cold (4°C) phosphate-
buffered saline (PBS; 10 mM potassium phosphate buffer pH 7.4 containing 150 mM 
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NaCl) and lysed in 400 μL 50 mM NaOH. This lysate was used for the quantification 
of cellular iron, fluorescence and protein contents. For microscopical analysis of cellular 
fluorescence and cellular iron localization, the cells were washed with ice-cold PBS and 
treated as describe below.  
 
Quantification of cellular iron, fluorescence and protein content 
For the determination of the contents of cellular iron, fluorescence and protein, cells 
were lysed in 400 μL 50 mM NaOH for 30 min at room temperature (RT). The total 
iron content of cells was determined by a modification of the ferrozine-based 
colorimetric iron assay (Riemer et al., 2004) as described previously in detail (Geppert 
et al., 2009). Cellular fluorescence of the lysates was determined for 150 μL cell lysate 
that had been mixed with 150 μL 50 mM NaOH in wells of black microtiter plates. OG 
fluorescence was measured at an excitation wavelength of 485 nm and an emission 
wavelength of 520 nm and the TMR fluorescence at an excitation wavelength of 544 nm 
and an emission wavelength of 590 nm using the Fluoroskan Ascent Microtiterplate 
Fluorimeter (ThermoFisher, Darmstadt, Germany). The cellular protein content of the 
lysate was determined according to the Lowry method (Lowry et al., 1951) using BSA 
as protein standard. The specific cellular iron contents and fluorescence signals were 
calculated by normalizing the total cellular iron content per well and the total 
fluorescence signal per well, respectively, to the cellular protein content determined for 
the respective well.  
For the cytochemical visualization of cellular iron in cultured cells a modification of the 
histochemical Perls’ staining (Moos and Mollgard, 1993, Bishop and Robinson, 2001) 
with a diaminobenzidine/nickel staining intensification was performed as described 
previously in detail (Geppert et al., 2009). Subsequently the cells were washed three 
times with 1 mL 0.1 M potassium phosphate buffer pH 7.2 for 10 min and kept in this 
buffer overnight at 4°C to clear the iron staining. Finally, the nuclei were stained with 
30 μL 1 μg/mL 4’,6-diamidino-2-phenylindole dihydrochloride (DAPI) in PBS for 
5 min at RT and the cells were washed three times with PBS prior to embedding the 
fixed cells in Mowiol mounting medium (2.4 g polyvinyl alcohol and 6 g glycerol 
dissolved in 18 mL 150 mM Tris/HCl buffer pH 8.5).  
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Determination of cell viability  
Cell viability after a given treatment was investigated by measuring the extracellular 
presence of the cytosolic enzyme lactate dehydrogenase (LDH) which is an indicator 
for a loss in cell membrane integrity. The LDH activity in the incubation medium was 
determined using a microtiter plate assay as previously described in detail and was 
compared to the initial cellular LDH activity of untreated cells that had been lysed with 
1% (w/v) Triton X-100 in IB (100% LDH release) (Dringen et al., 1998, Tulpule et al., 
2014). 
 
Presentation of data 
The quantitative data are means ± standard deviation of values that had been obtained 
in at least three independent experiments on different passages of C6 cells. Microscopic 
images are derived from a representative experiment that had been reproduced at least 
twice with comparable results. Statistical analysis of data from multiple sets of 
quantitative data was carried out by ANOVA followed by the Bonferroni’s post hoc test. 
Significance differences between two sets of data was analyzed by the Student’s t-test. 
Values of p>0.05 were considered as not significant. 
 
3. Results 
3.1. Accumulation of fluorescent IONPs by C6 glioma cells 
To investigate the temperature-dependence of the accumulation of OG-IONPs, C6 
glioma cells were incubated with 1 mM OG-IONPs for up to 1 h at 37°C or at 4°C 
(Fig. 2). For both incubation temperatures the specific cellular iron content (Fig. 2A) 
and the cellular fluorescence (Fig. 2B) increased rapidly during the initial phase of the 
incubation. Already after 5 min of incubation, substantial amounts of cellular OG-
IONPs were determined as demonstrated by specific cellular iron contents of 
308 ± 27 nmol/mg protein (37°C) and 224 ± 33 nmol/mg protein (4°C) (Fig. 2A) and 
by cellular fluorescence values of 147 ± 28 a.u./mg protein (37°C) and 117 ± 16 a.u./mg 
protein (4°C) (Fig. 2B). For both temperatures, the increase in cellular iron content and 
fluorescence was slowed after the initial 10 min of incubation. After an incubation 
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period of 60 min, the OG-IONP-exposed cells contained specific iron contents of 
936 ± 196 nmol/mg protein (37°C) and 612 ± 42 nmol/mg protein (4°C) and specific 
cellular fluorescence values of 409 ± 55 a.u./mg protein (37°C) and 263 ± 25 a.u./mg 
protein (4°C) (Fig. 2B). For each time point investigated, the values obtained for the 
4°C incubations represented around 65-80% of the amounts determined for the 
respective 37°C experiments. None of the investigated incubation conditions 
compromised the cell viability as demonstrated by the absence of any increase in 
extracellular LDH activity (Fig. 2C). Comparison of the specific cellular iron contents 
with the respective specific cellular fluorescence values obtained for lysates of cells that 
had been exposed to OG-IONPs (Fig. 2A,B) revealed an excellent correlation of both 
values (Fig. 2D). 
A direct comparison of data from a large number of independent experiments exposing 
cells with 1 mM OG-IONPs for 10 min or 60 min at 37°C revealed that cellular iron 
contents and cellular fluorescence were almost doubled after 60 min incubations 
compared with 10 min incubations (Fig. 3A,B). This difference was also found by 
fluorescence microscopy, showing for cells that had been incubated with OG-IONPs at 
37°C for 10 min a dotted staining (Fig. 3E), which was found strongly intensified in 
cells that had been exposed to the nanoparticles for 60 min (Fig. 3F). Incubations of C6 
cells with OG-IONPs at 4°C for 10 min or 60 min revealed specific cellular iron contents 
and specific cellular fluorescence values that were significantly lower by around 30 to 
50% compared to the data determined for the respective 37°C incubations (Fig. 3A,B). 
However, hardly any fluorescence was detectable by fluorescence microscopy for cells 
that had been incubated with OG-IONPs at 4°C for 10 min or 60 min (Fig. 3C,D). 
These data are consistent with the reported efficient binding of IONPs to cells at 4°C, 
while this low temperature prevented the internalization and packaging of the bound 
IONPs into intracellular vesicles (Geppert et al., 2011, Rastedt et al., 2017). The 
substantial cellular iron contents quantified already after 10 min incubations at 4°C with 
1 mM fluorescent IONPs was considered as sufficient to further investigate the 
internalization and intracellular trafficking of the bound IONPs after an subsequent 
increase in the incubation temperature to 37°C in nanoparticle pulse-chase experiments 
(Fig. 1). 
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3.2. Nanoparticle pulse-chase experiments allow to synchronize cellular OG-
IONPs uptake and trafficking 
The internalization of IONPs that had bound to the cells during a 10 min exposure to 
OG-IONPs at 4°C was synchronized in nanoparticle pulse chase experiment (Fig. 1A) 
by applying 37°C prewarmed IB. The intracellular trafficking of the internalized OG-
IONPs was monitored during the further chase incubation at 37°C for up to 240 min. 
During such incubations, the cell viability was not compromised as demonstrated by the 
absence of any increase in extracellular LDH activity during the chase incubation (Fig. 
4A). Also the specific cellular iron content of the cells after the nanoparticle pulse was 
not significantly lowered during the chase incubation (Fig. 4B). In contrast, substantial 
changes were observed for the distribution of cellular OG fluorescence and the 
localization of cellular iron during the chase incubation following the nanoparticle pulse 
(Fig. 4C-V). Directly after the pulse, OG fluorescence (Fig. 4C) and iron staining 
(Fig. 4H) were not detectable, but already 5 min after the increase in incubation 
temperature to 37°C first dot-like fluorescence (Fig. 4D) and iron stainings (Fig. 4I) 
became visible in the cells. The intensities of these stainings increased substantially 
during longer incubations and became localized predominately in the perinuclear region 
of the cells (Fig. 4). Maximal fluorescence signals were observed after around 90 min 
chase incubation at 37°C (Fig. 4N), while during longer incubations the dot-like 
perinuclear fluorescence signals became weaker, the fluorescence signal became more 
blurry and a weak fluorescence signals was observed throughout the cells (Fig. 4O-Q). 
This finding of a transient increase in cellular OG fluorescence contrasted with results 
obtained for the cellular iron staining which remained very prominent in the perinuclear 
region even during long chase incubations of up to 240 min (Fig. 4T-V). Identical results 
to those recorded for OG-IONPs were also observed in nanoparticle pulse-chase 
experiments performed with 1 mM TMR-IONPs (data not shown). Simultaneous 
exposure of C6 cells with both OG-IONPs and TMR-IONPs during the pulse-phase 
revealed within minutes after onset of the chase incubation a rapid appearance of 
fluorescent structures that contained both types of fluorescent nanoparticles colocalized, 
while hardly any structures were observed that contained predominately OG or TMR 
fluorescence (data not shown). 
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3.3. Effects of cytoskeleton disruption on cellular uptake and intracellular 
trafficking of OG-IONPs 
To investigate the involvement of the cytoskeleton in the internalization and trafficking 
of OG-IONPs in C6 glioma cells, the cells were incubated without or with cytochalasin 
D (cytoD), an inhibitor of the actin reorganization (Spector et al., 1999) and/or 
colchicine, a microtubules destabilizing agent (Banerjee et al., 2016) before nanoparticle 
pulse-chase experiments were performed with OG-IONPs. Immunocytochemical 
staining for tubulin and phalloidin staining for actin confirmed that colchicine and cytoD 
caused a disintegration of the microtuble network and of the actin filaments, 
respectively, under the conditions applied (data not shown). 
Fig. 5 shows the results of a pulse-chase experiment with OG-IONPs on C6 glioma cells 
that had been preincubated without or with colchicine and/or cytoD. None of these 
conditions caused any signficant increase in extracellular LDH activity (Fig. 5A), nor 
any signficant loss in the cellular protein content (Fig. 5B) nor in the specific cellular 
iron content (Fig. 5C), suggesting that the cells were not damage by the conditions 
applied. In cells that had been exposed to colchicine to destabilize microtubules a rapid 
appearance of a dotted fluorescence pattern was observed (Fig. 5N-Q) as also found for 
control cells that had been treated in the absence of cytoskeleton destabilizing 
compounds (Fig. 5D-G). However, this punctated staining pattern for fluorescence and 
iron was distributed all over the cells and appeared to be membrane associated as 
trafficking of fluorescent and iron-containing structures to the perinuclear region of the 
cells was not observed (Fig. 5N-R). In contrast, for cultures that had been exposed to 
cytoD alone (Fig. 5I-M) to destabilize actin filaments or to the combination of cytoD 
plus colchicine (Fig. 5S-W) only few and weak fluorescent or iron-positive structures 
were detectable in cells during the chase incubation, the morphology of the cells was 
strongly affected as indicated by cell shrinking and the cell nuclei appeared to be 
condensed (Fig. 5).  
3.4. Sequential uptake of fluorescent IONPs in double nanoparticle pulse-chase 
experiments 
To further investigate the importance of the cytoskeleton for the internalization and the 
trafficking of fluorescent IONPs, double nanoparticle pulse-chase experiments were 
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performed to study the sequential uptake of OG-IONPs and TMR-IONPs (Fig. 1B,C). 
For this, C6 cells were preincubated without or with colchicine and/or cytoD and 
exposed in a first nanoparticle pulse to OG-IONPs. After a first chase period of 30 min 
at 37°C, TMR-IONPs were applied in a second nanoparticle pulse at 4°C before finally 
cellular fluorescence was monitored during the second chase incubation (Fig. 6). Double 
nanoparticle pulse-chase experiments in the absence or presence of cytoD or/and 
colchicine did not cause any significant change in the cellular protein content (Fig. 6A) 
nor any obvious increase in LDH release during the incubations (data not shown) or 
within the second chase period (Fig. 6C). As expected, exposure to the second 
nanoparticle pulse resulted in an almost doubling of the specific cellular iron content for 
all conditions applied (Fig. 6B) and this content was not significantly lowered during 
the second chase incubation within 60 min (Fig. 6B) or up to 240 min (data not shown).  
Microscopical analysis of the cells at the onset of the second chase period directly after 
the second nanoparticle pulse revealed clearly the presence of punctured OG 
fluorescence in the cells (Fig. 6D), as expected for cells that had been incubated for a 
chase period of 30 min following an OG-IONP pulse (Fig. 4F; Fig. 5E), while no red 
TMR fluorescence was detectable for this time point (Fig. 6D). However, with 
increasing incubation time during the second chase period an additional dotted red 
staining pattern of TMR fluorescence appeared (Fig. 6E) and during further incubation 
substantial amounts of the OG (green dots) and TMR fluorescence (red dots) were 
detectable, mainly found colocalized in the perinuclear region of the cells (as indicated 
in yellow), although also individual dotted red and green structures remained visible in 
the cells (Fig. 6F-H).  
In cells that had been exposed to cytoD (Fig. 6J) or cytoD plus colchicine (Fig. 6L), 
hardly any dotted fluorescence staining was observed for OG and TMR during the 
second chase period, while for colchicine-treated cells dotted fluorescent structures were 
observed in large numbers for both OG (green) and TMR (red) that were distributed all 
over the cells (Fig. 6K). Interestingly, the majority of these OG- and TMR-stainings 
remained separated from each other and only little colocalization of OG- and TMR-
fluorescence was observed (Fig. 6K). 
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4. Scheme and figures 
 
 
Fig. 1 Experimental protocols for nanoparticle pulse-chase experiments (A; steps 0-6 in C) and 
double nanoparticle pulse-chase experiments (B; steps 1-10 in C) with the individual 
incubations steps (C). 1: Cells are seeded and cultured for 24 h in culture medium. 2: The cells 
are cooled down to 4°C by washing the cells with ice-cold incubation buffer. 3: The cells are 
incubated for 10 min at 4°C with OG-IONPs (nanoparticle pulse) to facilitate attachment of 
nanoparticles to the cell membrane while preventing internalization. 4: Unbound nanoparticles 
are removed by washing the cells with ice-cold incubation buffer. 5: The cells are warmed up 
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by application of prewarmed (37°C) incubation buffer to start uptake of the bound nanoparticles. 
6: The cells are further incubated at 37°C (chase period) for the given chase periods before the 
cells are analyzed. Alternatively, for double nanoparticle pulse-chase experiments the chase 
period is terminated after 30 min of incubation and steps 7-10 follow. 7: The cells are cooled 
down to 4°C by washing the cells with ice-cold incubation buffer. 8: The cells are incubated for 
10 min at 4°C with TMR-IONPs (second nanoparticle pulse) to facilitate attachment of these 
nanoparticles to the cell membrane while preventing their internalization. 9: Unbound 
nanoparticles are removed by washing the cells with ice-cold incubation buffer. 10: The cells 
are warmed up by application of prewarmed (37°C) incubation buffer to start uptake of the 
nanoparticles bound to the cells during the second nanoparticle pulse and the cells are further 
incubated at 37°C for the given second chase periods to monitor the intracellular trafficking of 
both types of fluorescent nanoparticles. 
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Fig. 2 Time- and temperature-dependent accumulation of OG-IONPs in C6 glioma cells. The 
cells were incubated with 1 mM OG-IONPs for up to 60 min at 37°C or at 4°C before the specific 
cellular iron content (A), the specific cellular OG fluorescence (B) and the extracellular LDH 
activity (C) were determined. Panel D shows the correlation between the specific cellular iron 
content and the specific cellular OG fluorescence for the cell lysates analyzed. The data shown 
represents means ± SD of values obtained in 3 (37°C conditions in panels a-d and 4°C condition 
in panel D) or 6 (4°C condition in panels A-C) independent experiments. The significance of 
differences between the values obtained for cells that had been incubated at 37°C and 4°C is 
indicated in panels a and b by #p<0.05; ##p<0.01 and ###p<0.001. 
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Fig. 3 Accumulation of OG-IONPs by C6 glioma cells. The cells were incubated with 1 mM 
OG-IONPs for 10 min or 60 min at 37°C or 4°C before the specific cellular iron content (A) and 
the specific cellular fluorescence (B) were determined or fluorescence images were recorded 
(C-F). The quantitative data shown (A,B) represent means ± SD of values obtained in 24 (10 
min at 4°C) and 8 (10 min at 37°C; 60 min at 4°C; 60 min at 37°C) independent experiments. 
The significance of differences between the values obtained for cells that had been incubated at 
37°C and 4°C (#p<0.05; ##p<0.01; ###p<0.001) or that had been incubated at a given temperature 
for 10 and 60 min (*p<0.05; **p<0.01; ***p<0.001) are indicated in panels A and B. The scale 
bar in panel C represents 10 μm and applies to panels C-F. 
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Fig. 4 Nanoparticle pulse-chase experiments with OG-IONPs on C6 glioma cells. The cells were 
incubated with 1 mM OG-IONPs for 10 min at 4°C to allow binding of OG-IONPs to the cells. 
Unbound IONPs were washed away and the cells were further incubated at 37°C for the 
indicated chase periods of up to 240 min. Extracellular LDH activity (A) and the specific cellular 
iron contents (B) were determined for the indicated time points. The quantitative data (A,B) 
represent means ± SD of values obtained in 4 independent experiments. No significant 
differences were found for the values obtained for chase periods of 0 min and longer time 
periods of up to 240 min (p>0.05). The cellular localization of OG was monitored by 
fluorescence microscopy (C-G, M-Q) and the localization of cellular iron was analyzed by the 
cytochemical iron staining (H-L, R-V). The cell nuclei were stained with DAPI (blue). The size 
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bars in panels c and m represents 10 μm and apply to the panels C-L and panels M-V, 
respectively.  
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Fig. 5 Influence of disturbances of the cytoskeleton on the OG-IONPs trafficking in C6 glioma 
cells. Cells were pre-incubated in the absence or the presence of cytochalasin D (CytoD) and/or 
colchicine for 1 h at 37°C to disrupt actin filaments and/or to destabilize microtubules, before 
they were exposed to 1 mM OG-IONPs for 10 min at 4°C (nanoparticle pulse). Subsequently, 
the cells were washed and incubated at 37°C (chase period) for up to 90 min. Extracellular LDH 
activity (A), protein content (B) and specific iron content (C) were determined for the indicated 
chase periods. The quantiative data (A-C) represent means ± SD of values obtained in 3 
independent experiments. No significant differences were observed between the data obtained 
for chase periods of 0 min and 90 min within one incubation condition nor for the values 
obtained for one chase period after the different treatments (p>0.05). For the indicated chase 
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periods images of cellular fluorescence and cytochemical iron staining were taken (D-W). The 
size bar in panel d represents 10 μm and applies to the panels D-W.  
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Fig. 6 Double nanoparticle pulse-chase experiments to study sequential uptake of fluorescence 
IONPs and the influence of cytoskeleton disruption on intracellular particle trafficking. C6 cells 
were pre-incubated in the absence or the presence of cytochalasin D (cytoD) and/or colchicine 
for 1 h at 37°C. Subsequently, a first nanoparticle pulse at 4°C with 1 mM OG-IONPs was 
applied. After 30 min chase incubation at 37°C in the absence or the presence of the inhibitors, 
a second nanoparticle pulse at 4°C was applied using 1 mM TMR-IONPs which was followed 
by the second chase incubation at 37°C for the indicated time periods. Protein content per well 
(A), specific cellular iron content (B) and extracellular LDH activity (C) were determined for 
the indicated time points. The quantiative data (A-C) represent means ± SD of values obtained 
in 3 independent experiments. In a and c, no significant differences were observed between the 
data obtained for cells treated without or with the test substances (p>0.05). The second pulse 
with TMR-IONP increased significantly the specific cellular iron content (B) of cells that had 
been exposed in the first pulse with OG-IONPs (p<0.05). Fluorescence images for OG and TMR 
(D-H) were taken at the indicated time points of the second chase period of control cells 
(preincubation without cytoD and colchicine). Panels (I-L) show fluorescence images taken 60 
min after start of the second chase period for cells that had been preincubated without (I) or with 
cytoD and/or colchicine (I-L) before a double nanoparticle pulse-chase experiment was 
performed. The size bars in panels D and I represent 10 μm and apply for panels D-H and panels 
I-L, respectively.  
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5. Discussion 
Fluorescent DMSA-coated IONPs have been shown as suitable tool to investigate basal 
mechanisms involved in the accumulation of IONPs by cultured neural cells (Petters et 
al., 2014, Petters et al., 2016, Rastedt et al., 2017), but little is known on the intracellular 
trafficking of nanoparticles in such cells. C6 glioma cells are widely used as model to 
study glia cells (Mangoura et al., 1989) and brain glioma (Grobben et al., 2002). 
Recently we demonstrated that C6 glioma cells effiently accumulate DMSA-coated 
IONPs in a time- and concentration-dependent manner by a mechnism which is strongly 
affected by the temperature (Rastedt et al., 2017). In the current study, we have 
established protocols for nanoparticle pulse-chase experiments to improve the temporal 
and spatial resolution in order to monitor uptake and intracellular trafficking of 
fluorescent IONPs and have used these experimental approaches to investigate the 
importance of the cellular cytoskeleton in nanoparticle trafficking in C6 glioma cells.  
 
The cellular uptake of nanoparticles is a two-step process that includes binding of the 
nanoparticles to the cell and subsequent internalization into and trafficking within the 
cell (Wilhelm et al., 2003, Lesniak et al., 2013). As internalization of bound 
nanoparticles is prevented at 4°C (Geppert et al., 2011, Lesniak et al., 2013, Rastedt et 
al., 2017), we separated in our pulse-chase settings the binding and internalization of 
IONPs by exposing the cells to fluorescent IONPs for a short 10 min nanoparticle pulse 
at 4°C that was followed, after washing away unbound nanoparticles, by the uptake of 
IONPs that was synchronized by an increase in the incubation temperature. The 
synchronized start of the nanoparticle internalization in such a pulse-chase experiment 
allowed to study with good spatial resolution the intracellular trafficking of only those 
particles during the chase phase that had been bound to cells during the pulse phase 
(Iversen et al., 2012, Thimiri Govinda Raj and Khan, 2016).  
 
Binding of IONPs to cells is a rapid process. Already during a 10 min pulse incubation 
at 4°C with OG-IONPs or TMR-IONPs large amounts of nanoparticles had bound to 
the membranes of the cells, representing around 70% of the values found for the 
respective 37°C incubations. These amounts of adsorbed fluorescent IONPs were 
sufficiently high to monitor alterations in the cellular localization of fluorescence and 
iron during chase incubations. Analysis of the extracellular LDH activity as indicator 
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for a potential impairment of the cell membrane, the cellular protein content, the cellular 
iron contents per well as well as the cell morphology revealed that none of the conditions 
applied (temperature shifts, presence of cytoskeleton-destabilizing compounds, long 
chase periods, double pulses) compromised the cell integrity and viability. Thus, the 
nanoparticle pulse-chase protocols applied are suitable to investigate uptake and 
intracellular trafficking of IONPs in viable C6 glioma cells. 
 
The negative charges introduced to the IONPs by the DMSA coating results in a strong 
nonspecific binding of the IONPs to the cell membrane (Wilhelm et al., 2003, 
Villanueva et al., 2009, Rastedt et al., 2017), which cannot be removed by more 
extensive washing procedures including even acidic or reducing conditions (data not 
shown). As during the chase incubation, the cellular iron contents of cells was 
maintained, a potential detachment of bound IONPs and/or release of IONPs or iron 
from the cells can be excluded for the incubation conditions applied. 
 
Directly after the particle pulse at 4°C, which allowed binding of fluorescent IONPs to 
the cells, substantial amounts of cellular iron and cellular fluorescence were quantified 
in lysates but fluorescence microscopic images did not reveal specific fluorescence 
signals nor was positive iron staining observed by microscopic analysis for this 
condition. This initial lack of detectable staining patterns for fluorescence or iron 
confirms literature data (Geppert et al., 2011, Rastedt et al., 2017) and is most likely 
due to the very low local density of the fluorescence dyes and iron-containing 
nanoparticles at the cell membrane and the limitation of detection of the used widefield 
epifluorescence microscope. In contrast, already after a few minutes of incubation at the 
chase temperature of 37°C dotted fluorescence and iron stainings were detectable, 
suggesting that the internalization of the bound IONPs leads rapidly to the formation of 
intracellular vesicular structures which contain OG-IONPs in concentrations that are 
sufficiently high to allow detection and cellular localization of fluorescence and iron by 
the staining methods applied.  
 
Maximal fluorescence in the perinuclear space of the cells were observed after around 
60-90 min of chase incubation which was accompanied by maximal staining intensity 
for iron. During longer incubations the number and intensity of detectable fluorescent 
vesicles was lowered and a blurry fluorescence staining of the entire cells was observed. 
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In contrast, the perinuclear iron staining and its intensity was maintained during longer 
chase incubations for up to 240 min. These observations suggest an intracellular 
separation of the fluorescent DMSA coat from the iron oxide core of the internalized 
fluorescent IONPs during the chase incubation. The apparent high stability of the iron 
oxide core of the internalized fluorescent IONPs in the perinuclear area of the cells is 
consistent with results reported for cultured astrocytes that contained large amounts of 
agglomerated IONPs even days after exposure to IONPs (Geppert et al., 2012). 
 
The DMSA coat of the IONPs used contains only in low number thioether-attached 
fluorescent molecules (Rastedt et al., 2017)  and forms a disulfide cage around the iron 
oxide core (Fauconnier et al., 1997, Valois et al., 2010). Thus, processes that allow 
reduction of disulfide bridges can disintegrate the DMSA coat and are likely to be 
involved in the observed separation of the fluorescent coat from the iron oxide core. 
After endocytosis nanoparticle are passed to more and more acidic vesicles (Nazarenus 
et al., 2014) and are likely to encounter the lysosomal thiol reductase that has been 
suggested to reduce DMSA disulfides in the coat and to release DMSA (Chen et al., 
2008, Zhang et al., 2015a, Zhang and Liu, 2017). Additionally, DMSA may also be 
liberated during the trafficking process by ligand exchange processes with glutathione 
or other thiol-containing endogenous biomolecules (Hong et al., 2006, See et al., 2009). 
Further studies are now required to investigate in detail the molecular mechanisms 
responsible for the observed separation of coat and core of the intracellular fluorescent 
IONPs. Nanoparticle pulse-chase experiments can be a suitable experimental paradigm 
that will help to address such questions.  
 
Double nanoparticle pulse-chase experiment were performed to study the sequential 
uptake and trafficking of two types of fluorescent IONPs. Only for the initial phase of 
the second chase period a clear separation of green OG-containing vesicles and red 
TMR-containing vesicles was observed in C6 glioma cells, while during longer 
incubation the fluorescence became colocalized as indicated by the yellow fluorescence 
overlay. These findings suggest that a sequential uptake and trafficking of two types of 
fluorescent IONPs can indeed be studied by the double nanoparticle pulse-chase setting, 
but that the intracellular trafficking of the internalized IONPs leads to a rapid 
colocalization of the fluorescent vesicles in the perinuclear space which may include 
fusion of green and red vesicles. However, an apparent colocalization could also be the 
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consequence of insufficient microscopical resolution in combination with high 
fluorescence signals which does not allow to discriminate between a real colocalisation 
of both types of fluorescence signals in one vesicle and a close proximity of vesicle that 
contain separate fluorescent dyes (Iversen et al., 2011). 
 
Uptake of IONPs in cells is mediated mainly by endocytotic processes (Luther et al., 
2013, Zhang et al., 2015b, Chen et al., 2017). For example, macropinocytosis and 
clathrin-mediated endocytosis have been reported to be involved in the uptake of 
protein-coated IONPs in cultured glial cells (Geppert et al., 2013, Luther et al., 2013). 
As actin polymerization appears to play an important role in several endocytotic process 
in mammalian cells (Smythe and Ayscough, 2006, Mooren et al., 2012, Granger et al., 
2014), we investigated whether cytochalasin D, a compound that prevents 
polymerization of actin filaments and leads to the disassembly of the actin network 
(Spector et al., 1999), affects IONP internalization and trafficking in nanoparticle pulse-
chase experiments. Exposure of C6 glioma cells to cytochalasin D did not affect the 
binding of OG-IONPs to the cells during the particle pulse, but almost completely 
prevented the formation of fluorescent dots which are likely to represent intracellular 
vesicles that contain large amounts of internalized OG-IONPs, suggesting that actin 
polymerization is crucial for the endocytotic uptake and the packaging of OG-IONPs 
into intracellular vesicles. This actin-dependent internalization is consistent with results 
from previous studies on the uptake of carboxylated polystrene particles, silica 
nanoparticles or quantum dots in several cell lines, although the degree of the effects 
observed depended strongly ion the type of nanoparticle and the cell line investigated 
(dos Santos et al., 2011, Iversen et al., 2012, Nowak et al., 2014, Prietl et al., 2014). 
After endocytotic vesicle formation, the vesicles are transported away from the plasma 
membrane and a switch from actin-based movement to microtubules-based movement 
takes place (Granger et al., 2014). After successful disruption of microtubules by 
colchicine exposure in a nanoparticle pulse-chase experiment, extensive formation of 
IONP-containing vesicles was observed all over the cells. However, the florescent 
IONP-containing vesicles appeared to be trapped near the plasma membrane and 
trafficking of the vesicles to the perinuclear space was not observed. This observation 
is consistent with results obtained for the transport of fluorescent microspheres in 
murine melanoma cells and has been interpreted as evidence for a discruption of the 
microtuble-dependent trafficking from the early to the late endosome (Rejman et al., 
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2004). Also the sequential double nanoparticle pulse-chase experiments on colchicine-
treated C6 cells revealed that both the green vesicles derived from the OG-IONP pulse 
and the red vesicles derived from the TMR-IONP pulse remained separately trapped at 
the cell membrane showing hardly any colocalization of the fluorescence signals, 
thereby demonstrating that the intracellular trafficking of internalized IONPs to the 
perinuclear region and the fusion of different types of nanoparticle-containing vesicles 
depends on intact microtubules. 
 
In conclusion, nanoparticle pulse-chase protocols were established that make use of the 
efficient adsorption, but not internalization, of IONPs to cells at 4°C while an increase 
in temperature to 37°C synchronizes uptake and intracellular trafficking of the bound 
nanoparticles. The conditions applied did not affect cell viability and allowed a robust 
and reproducible analysis of IONP trafficking in cultured C6 glioma cells. In addition, 
the importance of the cytoskeleton for IONP uptake and trafficking was demonstrated 
by the dependence of nanoparticle internalization on actin polymerization and by the 
inhibition of intracellular trafficking by disintegration of microtubules. Furthermore, the 
synchronization of nanoparticle uptake and trafficking by the pulse-chase approach 
allowed to detect a separation of the fluorescent DMSA coat from the iron oxide core 
of the internalized IONPs during the chase incubations. Further studies are now required 
to elucidate in more detail the actin-dependent endocytotic pathways that are involved 
in the internalization of IONPs in the absence or the presence of protein by glial cells, 
the types of endosomal compartments involved in the trafficking of IONP-containing 
vesicles from the plasma membrane to the perinuclear regions of the cells, the 
mechanisms involved in the removal of the DMSA coat from the internalized IONPs, 
and the cellular fate of coat components that are removed from the particles during the 
trafficking. Nanoparticle pulse-chase experiments are well suited to address such 
questions already with simple epifluorescence microscopy with good spacial and 
temporal resolution, which could be further improved by using confocal microscopy to 
study the intracellular localization and the fate of internalized IONPs. 
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Abstract 
Due to their exciting properties, engineered nanoparticles have obtained substantial 
attention over the last two decades. As many types of nanoparticles are already used for 
technical and biomedical applications, the chances that cells in the brain will encounter 
nanoparticles has strongly increased. To test for potential consequences of an exposure 
of brain cells to engineered nanoparticles, cell culture models for different types of neural 
cells are frequently used. In this review article we will discuss experimental strategies 
and important controls that should be used to investigate the physicochemical properties 
of nanoparticles for the cell incubation conditions applied as well as for studies on the 
biocompatibility and the cellular uptake of nanoparticles in neural cells. The main focus 
of this article will be the interaction of cultured neural cells with iron oxide nanoparticles, 
but similar considerations are important for studying the consequences of an exposure of 
other types of nanoparticles with other types of cultured cells. Our article aims to improve 
the understanding of the special challenges of working with nanoparticles on cultured 
neural cells, to identify potential artifacts and to prevent misinterpretation of data on the 
potential adverse or beneficial consequences of a treatment of cultured cells with 
nanoparticles.  
 
 
 
Keywords: adsorption; biocompatibility; cell cultures; endocytosis; experimental 
strategies; iron oxide nanoparticles 
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1. Introduction 
Nanoparticles (NPs) have obtained increasing attention over the last two decades as the 
use of engineered NPs for various technical approaches, industrial and commercial 
purposes as well as for biomedical applications has severely increased (Patil et al., 2015, 
Mohammed et al., 2017). NPs are defined as particles that have a size less than 100 nm 
in at least two dimension (Auffan et al., 2009). Due to their small size and the resulting 
high surface to volume ratio, NPs differ in some of their chemical and physical properties 
from non-nanoscale particles or the bulk material of the same composition (Auffan et al., 
2009, Bobo et al., 2016). NPs can be composed of inorganic and/or organic materials, 
including carbon, metals, metal oxides, silica, liposomes and polymers (Algar et al., 
2011, Colombo et al., 2012, De la Fuente and Grazu, 2012). The basic NP material, the 
core, defines functional physical features of NPs such as plasmonic, superparamagnetic 
or fluorescent properties (Feliu et al., 2016).  
 
In biological environments, most NPs are not colloidally stable and tend to agglomerate 
or even precipitate (Akbarzadeh et al., 2012, Feliu et al., 2016). A common approach to 
prevent agglomeration of NPs and to increase the biocompatible of NPs in physiological 
environments is the encapsulation of the NP core with a coat that consists of organic 
coating materials such as lipids, proteins, or synthetic polymers (Gupta and Gupta, 2005, 
Valdiglesias et al., 2015, Ali et al., 2016, Mohammed et al., 2017). Such a coating of 
NPs provides additional opportunities to further functionalize the NPs, for example with 
fluorescent dyes, drugs, antibodies and other compounds which enable better monitoring 
of the NPs and improve their use for specific applications (Sperling and Parak, 2010, 
Akbarzadeh et al., 2012, Ali et al., 2016, Mohammed et al., 2017). Due to the high 
variability in core and coat, NPs have become exciting tools for many biomedical 
applications including drug delivery and bioimaging (Oh and Park, 2014, McNamara and 
Tofail, 2017). 
 
The increased usage of NPs and the intended or unintended release of NPs in the 
environment (Rivera-Gil et al., 2013, Nazarenus et al., 2014, Patil et al., 2015) makes it 
essential to study potential adverse and toxic consequences of NPs on mammalian cells. 
A large number of studies deals with the interaction between NPs and peripheral 
mammalian cells (Nazarenus et al., 2014, Oh and Park, 2014), but less is known on the 
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consequences of a NP exposure of brain cells (Petters et al., 2014b, Costa et al., 2016). 
As frequently stated it is difficult to compare results described in different articles (Calero 
et al., 2014, Kura et al., 2014, Patil et al., 2015, Soenen et al., 2015, Valdiglesias et al., 
2016, Meindl et al., 2017), as experimental conditions differ strongly between reported 
studies. In addition, each component of the test system applied (media components, 
buffer, temperature, incubation time, inhibitors, coatings etc.) may severely affect the 
interaction between NPs and cultured cells by modulating either the physicochemical 
properties of the NPs (such as shape, size and surface charge), the properties of the cell 
cultures investigated or both NP properties and cell behavior. The list of potential 
modulators of NP-cell interaction is long and, accordingly, standardizes protocols to 
enable a reliable comparison of different studies and to allow a valid risk assessment of 
NP have been requested (Worle-Knirsch et al., 2006, Bregoli et al., 2013, Rivera-Gil et 
al., 2013, Meindl et al., 2017). 
 
Among the different types of engineered NPs, IONPs have gained a huge interest due to 
their use for several biomedical and clinical applications. IONPs possess 
superparamagnetic properties at room temperature (therefore they are also abbreviated as 
SPIONs), have a high surface-to-volume ratio and are non-toxic to most cell systems 
(Akbarzadeh et al., 2012, Petters et al., 2014b, Ali et al., 2016, Mohammed et al., 2017). 
These properties make IONPs useful for a number of biomedical applications 
(Mohammed et al., 2017), e.g. as contrast agent for magnetic resonance imaging 
(Weinstein et al., 2010, Wang, 2015), for cancer treatment by induced hyperthermia 
(Baetke et al., 2015, Shi et al., 2015), and as therapeutic agents for targeted drug delivery 
(Akbarzadeh et al., 2012, Tietze et al., 2015, El-Boubbou, 2018) across the blood-brain 
barrier (Yang, 2010, Ivask et al., 2018). The combination of magnetic and fluorescent 
properties in fluorescently labeled IONPs has even further increased the potential of 
IONPs for biomedical applications (Kaewsaneha et al., 2015, Shi et al., 2015).  
 
The promising use of IONPs for diagnostic and therapeutic applications with the potential 
of such IONPs to enter the brain, makes it mandatory to study the consequences of an 
exposure of brain cells to IONPs (Shi et al., 2016). In particular, the uptake, intracellular 
trafficking and the fate of intracellular IONPs should be investigated as a potential release 
of large amounts of redox active iron in brain cells may cause oxidative stress and should 
Results 94 
 
be considered in the context of the reported disturbances of brain iron homeostasis for 
neurodegenerative diseases (Hare et al., 2013, Rouault, 2013, Morris et al., 2018). 
 
In this review article we will discuss basic problems and challenges of an exposure of 
cultured neural cells with NPs. Our main focus will be on the interactions of cultured 
neural cells with dimercaptosuccinate (DMSA)-coated IONPs (DMSA-IONPs). We 
would like to draw attention to problems and limitations which we have encountered 
during our studies and which we recommend to consider for designing and performing 
experiments in order to gain reliable, conclusive and reproducible results and to prevent 
misinterpretation of the cell data obtained after exposure of neural cells to NPs. Such 
aspects are also important to consider for studies on the interactions of other type of NPs 
with other types of cultured cells. 
 
 
2. Testing for physicochemical properties of nanoparticles for incubation 
conditions 
Cell binding and uptake of NPs depends on various factors, including the size, the charge 
and the shape of the NPs (Rivera-Gil et al., 2013, Mahmoudi et al., 2014, Nazarenus et 
al., 2014, Mohammed et al., 2017). For example, small NPs appear to be internalized 
quicker than large NPs (Nazarenus et al., 2014, Shang et al., 2014). Also the colloidal 
stability of NPs depends on the size, charge and surface chemistry of the NPs 
(Akbarzadeh et al., 2012, Nazarenus et al., 2014, Ali et al., 2016) and is strongly affected 
by media composition and experimental conditions such as pH, salt concentrations and 
protein availability (Petri-Fink et al., 2008, Rivera-Gil et al., 2013, Nazarenus et al., 
2014, Feliu et al., 2016). Thus, physiochemical characterization of NPs for the conditions 
applied is crucial to understand and interpret the results that will be obtained in cell 
culture studies.  
 
Many groups have the knowledge to synthesize and characterize the NPs of interest and 
many companies offer NPs with special features which make them interesting for cell 
based studies. Nevertheless, for each type of NPs, for each new compound added to the 
medium, for each cell culture type, and for each other alteration of incubation conditions 
it should be investigated whether the new condition may affect the physicochemical 
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properties and the colloidal stability of the NPs. Several techniques are frequently used 
to characterizes IONPs (Ali et al., 2016) and other types of NPs (Bhatia, 2016, Kumar 
and Dixit, 2017). Although the determination of each recommended parameter may be 
difficult due to unavailability of the required equipment, insufficient experience or high 
costs, a certain knowledge on physicochemical properties and confirmation of the 
colloidal stability of NPs for the incubation conditions used is essential to avoid artifacts 
and to prevent misinterpretations.  
 
As it cannot be excluded that minor amounts of contaminants may still be present from 
the synthesis procedure in the NP preparation provided by the supplier or that components 
of the NPs may have been released from the NPs during storage or handling (for example 
iron ions from IONPs), it is strongly recommended to test for potentials presence and 
potential side effects of such contaminants. This can for example be done by removing 
the NPs from the dispersion by filtration or high speed centrifugation (Kowalczyk et al., 
2011, Wang et al., 2011) and by subsequent testing of appropriate amounts of the NP-
free filtrate or supernatant in the biological test system used for NP experiments. 
 
Uncoated IONPs are frequently not stable as colloidal dispersion in physiological media 
due to strong magnetic attraction between the particles, van der Waals forces and their 
high energy surface (Lodhia et al., 2010, Ali et al., 2016). Therefore, IONPs are normally 
coated for applications in physiological conditions. In addition, substantial differences 
exists in physiochemical properties and the stability of available IONPs due to variations 
in the synthesis procedure, the selection of an appropriate coat and the large number of 
additional functionalization of the IONPs (Ali et al., 2016, Mohammed et al., 2017). As 
physicochemical properties and colloidal stability of NPs may strongly differ between 
dispersions in different solvents and incubation media, the determination of such 
parameters is essential for NP dispersed in the physiological medium that will be used 
for cell incubations. Table 1 shows the summary of the physicochemical characterization 
of DMSA-IONPs in a physiological incubation buffer (IB) that we have frequently used 
to study uptake of IONPs into cultured neural cells. 
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2.1 Test for size, elemental composition and successful coating of NPs  
The nanoscale size of NPs can be best determined by electron microscopy. Here the 
elemental composition of the NP core is important as the electron density of the core 
material determines the intensity of the signals obtained (Westsson and Koper, 2014). 
Especially transmission electron microscopy (TEM) is the method of choice for size and 
shape determination of NPs that contain metals or metal oxides (Laurent et al., 2008, 
Lodhia et al., 2010, Lim et al., 2013, Ali et al., 2016). Regarding the size distribution, 
NPs preparations can be monodisperse (uniform; composed of NPs of the same size, 
shape and mass) or polydisperse (non-uniform) depending on the synthesis and the 
coating used (Laurent et al., 2008, Stepto, 2009, Lim et al., 2013). The polydispersity 
index (PDI; dispersity) gives a number on the heterogeneity of the NP population in a 
given NP dispersion (Lim et al., 2013, Stetefeld et al., 2016, Kumar and Dixit, 2017). 
Information on the dispersity can be obtained by dynamic light scattering (DLS), which 
gives information about the size, the colloidal stability and the size distribution of NPs 
dispersed in a given solvent (Xu, 2008, Lodhia et al., 2010, Ali et al., 2016). An important 
parameter of dispersed NPs is also the surface charge that is frequently analyzed by 
determination of the ζ-potential (Tantra et al., 2010, Clogston and Patri, 2011). Valuable 
information on the elemental composition of the NP core and coat can also be obtained 
from TEM analysis, if the equipment used allows elemental analysis by energy-dispersive 
X-ray spectroscopy (EDX) (Rades et al., 2014, Slater et al., 2016, Kumar and Dixit, 
2017).  
 
Successful coating of NPs will modify physicochemical properties of NPs. For example 
the  change of the surface charge (Tantra et al., 2010, Clogston and Patri, 2011) or the 
colloidal stability in physiological medium are a good first indication for a successful 
coating. Further evidence for the presence of a coat around NPs can be obtained by 
identification of elements from the coat by EDX (Luther et al., 2013, Petters et al., 2014a, 
Rades et al., 2014), by the demonstration of functional groups of the coat by infrared 
spectroscopy or by the presence of fluorophores as demonstrated by fluorescence 
spectroscopy (Bertorelle et al., 2006, Luther et al., 2013, Herrmann et al., 2014, Lopez-
Lorente and Mizaikoff, 2016, Rastedt et al., 2017). 
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For DMSA-IONPs, TEM analysis revealed a polydispersed size distribution of 5-20 nm 
(Table 1, Fig. 1). Dispersed in physiological incubation buffer (IB) these IONPs had an 
average hydrodynamic diameter of around 60 nm (Fig. 1, Table 1), suggesting that some 
agglomeration of the primary particles had occurred. A polydispersity index of 0.257 
demonstrated polydisperse size distribution in IB. The magnetic properties of the IONPs 
were used for magnetic separation during the synthesis process and were confirmed by 
recording a magnetization curve in a vibrating sample magnetometer (Petters et al., 
2014b). The negative ζ-potential due to the carboxylate groups in the DMSA coat as well 
as the identification of sulfur by EDX (Geppert et al., 2011, Petters et al., 2014a, Rastedt 
et al., 2017) confirmed the successful coating of IONPs with DMSA (Table 1). For 
fluorescent DMSA-IONPs the presence of the introduced fluorophores in the obtained 
IONPs also confirmed successful coating of IONPs with fluorescent DMSA (Luther et 
al., 2013, Rastedt et al., 2017). 
 
 
2.2 Quantify the NP content of a NP dispersion  
For metal-containing NP such as IONPs, CuONPs or AgNPs the metal content of the 
dispersions can be determined for example by atomic absorption spectroscopy (AAS) or 
inductively coupled plasma mass spectrometry (ICP-MS) (Lodhia et al., 2010, Patil et 
al., 2015). The iron content of IONP dispersions can also be determined reliably and 
sensitive by a ferrozine-based colometric assay (Geppert et al., 2013, Petters et al., 2016, 
Rastedt et al., 2017). However, for reliable quantification of metal contents of a NP 
dispersion the complete liberation of the metal from the NPs is required that will include 
the application of concentrated acids and may involve some ashing procedures (Geppert 
et al., 2009, Luther et al., 2011, Bulcke et al., 2014, Joshi et al., 2016). 
 
If the NP possess fluorescent properties these fluorescent properties can be used to 
quantify the NPs in dispersion and in cells by fluorescence spectroscopy, flow cytometry 
or fluorescence imaging techniques (Drasler et al., 2017). A drawback in the fluorescent 
quantification is the possible bleaching or quenching of the fluorescent signal, which 
could result in an incorrect quantification (Corr et al., 2008, Waters, 2009, Drasler et al., 
2017). In addition, the type of fluorescence labeling can affect the fluorescent properties 
of the NPs. Fluorophores can either be encapsulated within the NPs or immobilized to 
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the polymer coat of the NPs (Ruedas-Rama et al., 2012, Kaewsaneha et al., 2015, 
Wolfbeis, 2015). The distance between fluorophore and core can lead to quenching or 
alteration of the fluorescent signal (Kaewsaneha et al., 2015). Here it is important to 
compare the fluorescence spectra of the fluorescent NPs with those of the free fluorescent 
dyes (Bertorelle et al., 2006, Luther et al., 2013, Rastedt et al., 2017). 
 
 
2.3 Modulation of NP properties by variation of the coating materials 
The coating of the NPs provides opportunities to further functionalize the particles for 
example with fluorescence dyes (Ruedas-Rama et al., 2012, Petters et al., 2014a, 
Kaewsaneha et al., 2015, Rastedt et al., 2017), with drugs, antibodies or other compounds 
(Shevtsov et al., 2014, Shevtsov et al., 2015, Galli et al., 2017) that may modify 
physicochemical properties and colloidal stability of the NPs and thereby the interaction 
with cultured cells. Thus, for each type of coating the NPs should be carefully 
characterized. For example, the use of different coating materials during the synthesis of 
IONPs caused strong differences in the hydrodynamic diameter of the NPs ranging from 
20 to 200 nm (Shi et al., 2014, Shi et al., 2016). Such alterations in particle size but also 
size distribution, shape and surface charge are likely to affect binding to and uptake of 
NPs into cells.  
 
Uncoated IONPs have a strongly positive zeta potential of around +40 mV and are 
colloidal stable in water, but they precipitate rapidly in salt-containing physiological 
media such as basal incubation buffer (Geppert et al., 2011). Such IONPs can be 
stabilized by coating with citrate (Geppert et al., 2009) or DMSA (Geppert et al., 2011). 
DMSA-coating does not significantly increase the diameter of the IONPs, but generates 
in water a negative zeta potential (-60 mV) which maintains the coated IONPs in 
dispersion (Table 2). Modification of the DMSA coat by low amounts of fluorescent dyes 
(around 1% of thiol groups present in DMSA used for coating) did not alter the 
physicochemical properties of the IONPs nor their binding or internalization into cultured 
neural cells (Luther et al., 2013, Petters et al., 2014a, Rastedt et al., 2017), thereby 
defining such fluorescent IONPs as suitable tool to trace by fluorescence microscopy the 
internalization and the intracellular trafficking of DMSA-IONPs in cultured brain cells 
(Luther et al., 2013, Petters et al., 2014a, Rastedt et al., 2017). 
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2.4 Modulation of NP properties by the components added to the incubation media 
 
In complex biological environments a variety of the molecules are present including 
lipids, sugars and proteins that may adsorb onto the surface of the NPs (Rivera-Gil et al., 
2013, Nazarenus et al., 2014, Feliu et al., 2016), but even simple physiological buffers 
contain ions and other compounds that may affect the properties of dispersed NPs. In 
fact, as it is difficult to predict which compounds may severely affect the stability and the 
properties of NPs, analysis of such parameters is recommended for each incubation 
medium used for cell exposure to NPs.  
 
Table 2 shows the consequences of the presence of various compounds in a given 
incubation media on the size (hydrodynamic diameter) and the surface charge 
(ζ-potential) of dispersed DMSA-IONPs. Compared to water as dispersant, the use of a 
physiological HEPES-buffered incubation buffer (Table 2) does not alter the average 
hydrodynamic diameter of the IONPs but increases the ζ-potential from -60 mV to -16 
mV. The size of the NPs is moderately increased in the presence of proteins such as 
bovine serum albumin (BSA) or fetal calf serum (FCS), while the ζ-potential is further 
increased in the presence of proteins to around -10 mV (Table 2). In contrast, already the 
presence of 0.8 mM phosphate, a component that is frequently present in physiological 
buffers used for metabolic studies on cultured brain cells (Tulpule et al., 2014), causes 
rapid agglomeration and precipitation of the IONPs as demonstrated by the micromolar 
diameter of the particle agglomerates. Similarly, also dispersion of IONPs in DMEM 
culture medium that contains 0.9 mM phosphate are not stable and rapid agglomeration 
was observed which was prevented by the presence of 10% FCS, but not by BSA 
application (Table 2). Thus, the presence of proteins or protein mixtures can prevent 
agglomeration of IONPs, most likely by forming a protein coat around the DMSA-IONPs 
that affects NP properties and stability as well as their interactions with the cell surface 
(Doak et al., 2009, Nel et al., 2009, Feliu et al., 2016). 
 
To study the mechanisms of cellular uptake of NPs and to identify the endocytotic 
pathways involved in the internalization of NPs, a battery of more or less specific 
inhibitors for given endocytotic pathways are available and have been used (Iversen et 
al., 2011). This strategy has already been critically discussed due to the lack of specificity 
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and severe side effects of some inhibitors (Iversen et al., 2011, Dutta and Donaldson, 
2012, Kuhn et al., 2014, Guo et al., 2015). In addition, a further disadvantage of some 
endocytosis inhibitors is their effect on the stability of NPs. Examples for such effects are 
shown in Table 2. Dynasore (Macia et al., 2006, Kirchhausen et al., 2008) and 
chlorpromazine (Dutta and Donaldson, 2012) are frequently applied to test for an 
involvement of clathrin-mediated endocytosis in the cellular uptake of NPs. However, 
the presence of dynasore leads to agglomeration and precipitation of IONPs, whereas the 
presence of chlorpromazine does not affect particle size and colloidal stability (Table 2). 
Furthermore, the agglomeration of IONPs by dynasore is almost completely prevented in 
the additional presence of 10 % FCS (Table 2). These results underline the importance to 
investigate the potential effects of each compound that will be added to the given 
incubation medium to study the accumulation of NPs by cells, as modulation of the 
physiochemical properties and the stability of the IONPs may strongly affect the 
interaction between particles and cells as well as the biocompatibility or cytotoxicity of 
NPs (Frohlich, 2012, Kroll et al., 2012, Yang et al., 2013). 
 
 
2.5 Alteration of NP properties by cell-derived components  
 
Last but not least, it has also to be considered that during the incubation of cells with NPs 
physicochemical properties and the colloidal stability of NPs could be changed by 
compounds that are released from the exposed cells during the incubation. For example, 
substances that are released from viable cultured astrocytes and are present in conditioned 
media lead to an agglomeration of IONPs and can therefore alter the binding to or the 
internalization of the IONPs into the cells (Geppert et al., 2011, Geppert et al., 2012, 
Lamkowsky et al., 2012, Geppert et al., 2013). Such effects may be even more dramatic, 
if NPs have some toxic potential. As soon as the first cells have died and have released 
their content, the surface of the applied NPs can be covered by cellular biomolecules and 
cell debris that is likely to alter the interaction between NPs and cells. Therefore, it should 
be considered to characterize the extracellular NPs also during or after a given incubation 
of cells to learn whether cell-derived material has modulated the properties of the NPs 
during the incubation.  
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3. Using an appropriate cell culture test system for NP studies  
 
3.1 Cell lines and primary cultures 
In addition to the properties of NPs, also cellular parameters and the type of cell culture 
models chosen for NP interactions studies are important. Here, biomechanical properties 
of the cell membrane including membrane tension and bending modulus, composition 
and thickness of the phospholipid bilayer, cell size, proliferation rate, growth pattern as 
well the environmental factors like cell-cell-interaction play an important role in the NP 
adhesion and uptake (Iversen et al., 2011, Mahmoudi et al., 2014, Zhang et al., 2015, 
Meindl et al., 2017). As the mechanisms of NP uptake depend on the cell type and the 
culture model investigated, it is important to select an appropriate test system for studying 
the consequences of an exposure of neural brain cells to NPs. Here, the characterization 
of the cell culture model system chosen is very important, as such models differ strongly 
in cell density, media requirements and sensitivity to given incubation conditions that are 
required for incubations with NPs.  
 
For first screening tests on the biocompatibility or toxicity of a given type of NP, 
immortalized cell lines of neural origin are frequently used. Such cell lines are easy to 
handle, can be sub-cultured, batch-to-batch variability is considered to be low and the 
costs of such studies are reasonable (Bregoli et al., 2013). However, as cell lines are 
mostly transformed, have a disturbed proliferation control mechanisms, and possess 
when compared to the genuine brain cells genetic and chromosomal aberrations that may 
even increase with passage number (Bregoli et al., 2013), an interpretation of data 
obtained on cell lines for potential consequences of a respective NP incubation of genuine 
brain cells is problematic. In addition, due to the long handling of immortalized cell lines 
evolution of cells over the passaging procedure, potential contamination with 
mycoplasma as well as potential cross-contamination with other cell lines should be 
considered and/or excluded (Freedman et al., 2015, Drexler et al., 2017). Thus, cell lines 
used for NP studies should be characterized concerning their properties and authenticity, 
for example by testing for expression of the cell type specific markers and/or by genetic 
testing to confirm the cell line origin (Freedman et al., 2015). 
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Primary cultures of brain cells, for example, primary cultures of astrocytes or neurons, 
have frequently been used to study properties and functions of the respective brain cell 
types in vitro (Sunol et al., 2008, Lange et al., 2012, Gordon et al., 2013, Petters et al., 
2014b, Tulpule et al., 2014). Compared to cell lines, such cultures have a limited life 
span, show substantial variability between different culture preparations, require the 
access to living animals as cell donors and are more expensive. Nevertheless, primary 
cultures of brain cells are likely to reflect properties of the respective cell type in vivo 
more strongly than immortalized cell lines (Kaur and Dufour, 2012, Bregoli et al., 2013, 
Gordon et al., 2013). Thus, for studies to investigate the basic mechanisms of NP uptake, 
intracellular trafficking or the fate of internalized NPs in brain cells, primary cultures of 
brain cells, which are strongly enriched for one type of brain cells, appear to be a better 
model than cell lines of neural origin. If using primary cultures of brain cells, the cultures 
obtained should be characterized for the cell types present by immunocytochemical 
staining for cell type specific markers (Petters and Dringen, 2014, Tulpule et al., 2014) 
in order to learn about the enrichment of the desired cell type in these cultures but also 
about contaminations with other types of brain cells.  
 
 
3.2 Potential problems with cell density and proliferation state 
Depending on the cell cultures and the culturing conditions selected, the density of cells 
in cell cultures can substantially vary. Primary cultures of astrocytes as well as cell lines 
of neural origin can be investigated during the proliferation period and different cell 
densities can be established by variation of the number of cells seeded per dish. Primary 
astrocyte cultures will reach after a given culture time confluency, while cultures of 
neurons will not become confluent due to the post mitotic status of these cells (Tulpule 
et al., 2014).  
 
Differences in cell density, cell-cell contacts, membrane tension and cell cycle phases 
have been described to strongly affect NP uptake (Snijder et al., 2009, Kim et al., 2011, 
Wang et al., 2016). An example for the effects of cell density on the cellular uptake of 
fluorescent Oregon Green (OG)-DMSA-IONPs is shown for C6 glioma cells (Fig. 2). 
With increasing seeding density, the protein content of the cultures increases almost 
linearly within a 24 h incubation period (Fig. 2A). Also the amount of iron and 
Results 103 
 
fluorescence accumulated by the cultured cells during a 1 h exposure to IONPs increased 
almost linearly, but only for low cell densities, while hardly any differences in 
accumulated iron or fluorescence was observed for cultures generated by seeding the cells 
at densities of 200,000 or 400,000 cells per well (Fig. 2B,C). 
 
During the cell cycle the ratio of cholesterol and phospholipid, the expression of 
membrane proteins, surface antigens and receptors can vary (Boucrot and Kirchhausen, 
2007, Mahmoudi et al., 2014, Tang et al., 2015), thereby influencing the interaction of 
cells with NPs and subsequently the uptake of NPs (Tang et al., 2015). Accordingly, in 
synchronized cells the uptake of NPs can vary depending on the cell cycle phases (Kim 
et al., 2011, Patel et al., 2016). As most cultured cells used for NP uptake studies are not 
synchronized for their cell cycle, it should be considered that the data obtained on such 
cultures represent average values derived from cells in different phases of the cell cycle 
(Kim et al., 2011). 
 
 
3.3 Potential problem due to unspecific binding to NPs to the culture plates 
To improve binding of cells to cell culture plates, manufacturers use frequently chemical 
and/or physical surface modifications to alter the polystyrene surface of the culture plates 
(Curtis et al., 1983, Roder et al., 2015). In addition, some cell types require special dish 
coatings to ensure cell attachment or to facilitate cell differentiation. For example, coating 
of cell culture dishes with collagen or poly-D-lysine is frequently used for primary 
neurons, hepatocytes or stem cells (Aday et al., 2011, Gordon et al., 2013, Tulpule et al., 
2014, Salzig et al., 2016). As such coatings of plastic surfaces have the potential to bind 
NPs, a potential cell-independent adsorption of NPs to the surface of the culture dishes 
has to be considered. Data for such a cell-independent binding of NPs to coated dishes 
are shown in Table 3. While uncoated dishes hardly contain any detectable iron or 
fluorescence after incubation with fluorescent OG-DMSA-IONPs, substantial amounts 
of iron and OG fluorescence were determined for culture plates that had been 
preincubated (coated) with DMEM containing proteins or with a poly-D-lysine solution 
(Table 3). Such unspecific interactions between the NPs and the treated culture materials 
may strongly contribute to quantitative data obtained for the potential uptake of IONPs 
in cultures of low cell density.  
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4. Test for the consequences of an exposure of cultured neural cells to NPs  
4.1 Test for biocompatibility or toxic potential of NPs 
To study the cellular uptake mechanisms of NPs into neural cells, the potential cytotoxic 
potential of the chosen incubation conditions must be investigated in order to confirm 
that indeed the uptake and internalization of NP is monitored for viable cells. The size, 
shape, agglomeration state and surface coating play an important role in the cytotoxicity 
of NPs (Frohlich, 2012, Kroll et al., 2012, Yang et al., 2013), because these factors highly 
influence the binding to the cells and their internalization. In this context it is important 
to considered that already partial cell toxicity will lead to substantial release of 
biomolecules from damaged cells which in turn can bind to the NPs, and thereby alter 
their physicochemical properties.  
 
For IONPs, the cytotoxic potential is controversially discussed (Patil et al., 2015, 
Valdiglesias et al., 2015, Costa et al., 2016). Several studies state that IONPs have a low 
toxic potential (Dunning et al., 2004, Villanueva et al., 2009, Kunzmann et al., 2011, 
Calero et al., 2014, Feng et al., 2018), whereas other studies observed a cytotoxic 
potential of IONPs depending on cell type and surface coating of the NPs (Chen et al., 
2008, Sun et al., 2013, Petters et al., 2016, Feng et al., 2018). Smaller NPs have an 
increased reactive surface in relation to their volume and are usually faster internalized 
that may contribute to their higher cytotoxic potential (Rivera-Gil et al., 2013). Likely 
reasons for the controversial observations may be the use of different coating materials 
and different physicochemical properties of the IONPs applied that will affect binding to 
the cells and subsequent uptake (Warheit, 2008, Hong et al., 2011) as shown for 
differently coated IONPs on cultured primary neurons (Rivet et al., 2012). In addition, 
also cell-type differences strongly affect the toxic potential of IONPs. For example, 
DMSA-IONPs were not toxic for cultured astrocytes or neurons even in millimolar 
concentrations, but showed strong toxic potential to cultured microglial cells (Petters et 
al., 2016).  
 
To investigate the biocompatibility or the toxicity of a given treatment, a large number 
of viability assays is available and frequently used that address mostly either membrane 
integrity or metabolic functions (Kroll et al., 2009, Kroll et al., 2012, Hohnholt et al., 
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2015). For studies of potential toxicity of NPs it is recommended to apply at least two 
different viability assays that have independent underlying principles, in order to become 
aware of potential disturbances by NPs on the viability assay systems used. 
 
 
4.2 Test for potential interferences of NPs with the assay systems used to determine 
cell viability or toxicity 
The determination of cellular viability during or after an exposure of cells to NPs is 
important but not always easy as NPs may interfere with the viability assay applied. 
Similarly, also the quantification of cellular NPs or of cellular parameters and functions 
can be disturbed in the presence of NPs as their unique physicochemical properties, their 
high reactivity and their high adsorptive capacity may interfere with components of the 
test system applied (Doak et al., 2009, Stone et al., 2009, Galdiero et al., 2015, Costa et 
al., 2016). This can result in artifacts and a false-positive or false-negative 
misinterpretation of the data obtained.  
 
A large number of viability or toxicity assays are based on colorimetic and fluorimetric 
dyes and depend on the light absorption and/or emission at a specific wavelength. It is 
obvious that the use of fluorescence labeled IONPs limits the applicable number of these 
assay regarding interference of absorption and emission spectra. For example, measuring 
the generation of reactive oxygen species using Rhodamine123 (Almeida et al., 2002) 
would not be suitable after exposure of cells to OG-DMSA-IONPs due to the overlap of 
the excitation and emission spectra of these both dyes. But besides this obvious problems, 
nanomaterials have widely been shown to interfere with assays by altering the optical 
properties of dyes leading to under- or overestimation of the NP toxicity (Bregoli et al., 
2013, Patil et al., 2015). For example, determination of the release of cellular LDH is 
considered as a good indicator for a loss in membrane integrity of cultured cells (Tulpule 
et al., 2014). However, this assay should not be used for analysis of cellular consequences 
of CuONPs, as such NPs inactivate LDH (Bulcke et al., 2014). Thereby, a quantification 
of released LDH is prevented which will lead to false negative results suggesting absence 
of any cell toxicity of CuONPs. 
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To identify potential artifacts by NPs on the assay systems applied, several controls are 
recommended such as (1) exposing cells with NPs but without assay reagents (Hoskins 
et al., 2012), (2) applying a cell free control incubation (Doak et al., 2009), (3) removing 
or lowering the amount of NPs present in samples by centrifugation (Stone et al., 2009) 
and (4) intensive washing after the cell incubation before applying the assay system 
(Hoskins et al., 2012). But even all these precautions cannot fully exclude interference in 
the results due to membrane adhesion and internalization of NPs by cells (Hoskins et al., 
2012, Costa et al., 2016). Therefore, it is strongly recommended to run always additional 
controls including the addition of a standard concentration of NPs to cell samples that 
were obtained of viable cells and a toxic control condition.  
 
4.3 Test for adsorption of NP to the cells and/or uptake of NPs into cells 
The cellular uptake of NPs is a two-step process (Wilhelm et al., 2002, Wilhelm et al., 
2003). First the NPs adsorb to the cell membrane and then the internalization by 
endocytosis takes place (Wilhelm et al., 2003, Lamkowsky et al., 2012, Lesniak et al., 
2013). The surface properties are the crucial factor in cell-nanoparticle interaction as the 
engineered surface is first recognized by a cell (Pelaz et al., 2013, Mahmoudi et al., 
2014). This will mediate the binding of NPs to the cells before internalization of the NPs 
can take place. Uptake of NPs in cultured brain cells can be verified depending on the 
type of NP investigated by electron, fluorescence or light microscopy.  
 
The successful uptake of NPs into cells and the intracellular localization of NPs can be 
visualized by TEM. Concerning IONPs in cultured brain cells, a vesicular localization of 
electron dense material was reported for IONP-treated cultured primary astrocytes 
(Geppert et al., 2009, Geppert et al., 2011, Geppert et al., 2012). For such staining even 
elemental analysis of the cellular NPs can be done and the material taken up into the cells 
can be confirmed. Fluorescence microscopy of neural cells that had been exposed to 
fluorescent IONPs allows also a qualitative view on the internalization of such NPs 
(Luther et al., 2013, Petters et al., 2014a, Petters and Dringen, 2015, Petters et al., 2016, 
Rastedt et al., 2017). Finally cytochemical staining of the exposed cells for iron allows a 
qualitative view on the cellular presence of IONPs in cultured neural cells (Geppert et 
al., 2009, Geppert et al., 2011, Hohnholt et al., 2011, Luther et al., 2013, Petters et al., 
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2014a, Calero et al., 2015). For cytochemical or fluorescence analysis of the uptake of 
IONPs into cells it is important to consider that the signals obtained in light or 
fluorescence microscopic images do not represent the signals derived from individual 
fluorescent NPs but that rather a given amount of NPs has to be packed into vesicular 
structures in order to generate sufficient local density of NPs to allow detection.  
 
Various methods can be applied to quantify cellular contents of NP as long as the assay 
of choice is sufficiently sensitive for quantifying the low amounts of material that has 
been internalized into the cells by NP uptake. For NPs containing copper or silver, we 
have used highly sensitive AAS methods (Geppert et al., 2009, Luther et al., 2011, 
Bulcke et al., 2014, Joshi et al., 2016), and for IONPs a sensitive ferrozine-based 
colorimetric assay in microtiter plates (Geppert et al., 2009, Geppert et al., 2011, Geppert 
et al., 2013, Petters et al., 2016, Rastedt et al., 2017). However, for reliable quantification 
of metal contents of cellular NP the complete liberation of the metal from the NPs is 
required which will include the application of concentrated acids and involves some 
ashing procedures. Concerning the NP quantification, it should be kept in mind, that the 
NP amount determined reflects the total amount of NPs in a well that consists of the 
amount of internalized NPs plus the amount of NPs bound extracellularly to cells plus 
the amount of NPs bound to the plastic of the dish in a cell-independent process.  
 
In order to quantify the amount of internalized NP it is important to discriminate between 
NPs that are adsorbed to the cells (and/or the culture plate) and the NPs that had been 
taken up by cellular endocytosis. This can be achieved by performing control adsorption 
experiments at 4°C. This low temperature prevents the energy-dependent NP 
internalization, but does hardly affect adsorption and desorption processes (Wilhelm et 
al., 2002, Wilhelm et al., 2003, Bertorelle et al., 2006, Lamkowsky et al., 2012). Thus, 
after a 4°C incubation only the extracellularly adsorbed NPs are quantified as NP uptake 
is prevented, while the values obtained for a respective incubation at 37°C represents the 
sum of adsorbed plus internalized NPs. The temperature dependence of IONP uptake in 
order to discriminate between adsorbed and internalized IONPs has been performed for 
several types of neural cell cultures and revealed that the amounts of adsorbed NPs after 
exposure of the cells to DMSA-IONPs represents between 50% and 70% of the total 
amount of IONPs (Hohnholt et al., 2013, Petters et al., 2014a, Petters and Dringen, 2014, 
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Petters and Dringen, 2015, Rastedt et al., 2017). Similar results were found for non-neural 
cells (Wilhelm et al., 2002, dos Santos et al., 2011). 
 
Most of this extracellular adsorption of IONPs to neural cells may be caused by unspecific 
electrostatic interactions between the coat of the NPs and cell surface molecules which 
cannot be simply removed by additional washing steps. However, the binding of NPs to 
cells can also be made more specific by introducing cell receptor specific ligands, signal 
peptides or antibodies (Ahrens et al., 2003, Pilakka-Kanthikeel et al., 2013, Galli et al., 
2017, Lachowicz et al., 2017). In some cases, the presence of protein can reduce the 
adsorption of NPs to the cell membrane (Wilhelm et al., 2003, Lesniak et al., 2013, 
Rastedt et al., 2017) and thereby also dramatically lower the cellular uptake. 
 
After internalization into cells, NPs are encountering changes in their environment that 
can affect the stability and the cellular metabolism of the intracellular NPs. Uptake by 
endocytosis delivers NPs into endosomal compartments that is characterized by a slightly 
acidic pH  (Rejman et al., 2016). This may lead to degradation of the core and/or the coat 
of the NPs that may affect cellular parameters, cell viability but also the interpretation of 
the results obtained.  Therefore, it is important to verify whether the internalized NPs are 
still intact and/or whether the coat is still colocalized with the core of the NPs (Nazarenus 
et al., 2014, Feliu et al., 2016). If the NPs are disintegrated or the coat is separated from 
the core of the NP it has to be considered that components of core or coat are liberated 
from the NPs that can affect properties and functions of cells (Rejman et al., 2016). For 
example, IONP uptake causes severe toxicity of cultured microglia due to iron-mediated 
oxidative stress caused by lysosomal liberation of iron ions from the internalized IONPs 
(Luther et al., 2013, Petters et al., 2016, Zhang et al., 2016). 
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4.4 An example how to analyse the uptake of fluorescent DMSA- IONPs in cultured 
neural cells  
Fig. 3 shows experimental data that were obtained for an exposure of C6 glioma cells 
with OG-DMSA-IONPs. The fluorescent IONPs have been carefully characterized for 
their physicochemical properties and their colloidal stability in the incubation buffer (IB) 
used for the incubations (Rastedt et al., 2017). Compared to the non-fluorescent DMSA-
IONPs (Table 1), the presence of the low amounts of the fluorescent dye OG in the coat 
of the IONPs does not affect the physicochemical properties of the IONPs nor their 
interaction with cells (Rastedt et al., 2017). For the cell experiments 100,000 C6-glioma 
cells were seeded per well of a 24-well plate in 1 mL of DMEM with 10% FCS. After 24 
h incubation the cells were washed twice with IB and subsequently incubated for 1 h with 
given concentrations of OG-DMSA-IONPs in 200 μL IB at 4°C or at 37°C. The 
concentrations given for the IONPs represent the concentration of iron present in the 
IONPs applied and not the particle concentration.  
 
Analysis of cell morphology did not reveal any obvious alteration after exposure to the 
IONPs (data not shown) and also the quantification of extracellular LDH activity after 
the 1 h exposure time did not show any increase in extracellular LDH (Fig. 3A). The lack 
of any influence of the NPs applied on the LDH assay performed was investigated by 
applying IONPs to lysates generated from cultured C6 cells before measuring LDH 
activity for the lysates. Even in final concentrations of up to 3 mM iron as IONPs, the 
presence of IONPs did not affect the measurement of LDH activity in cell lysates 
(Fig. 3D), thereby excluding that a potential toxicity (LDH release) of the treatment could 
have been masked by inactivation of liberated LDH by IONPs. Analysis of the unspecific 
binding of IONPs to protein-coated cell culture plates (24 h preincubation with DMEM 
+ 10% FCS) revealed by quantification of iron and fluorescence that the cell-independent 
binding of IONPs was low and even substantially lower that the adsorption of IONPs to 
the cells at 4°C (Fig. 3E,F).  
 
Analysis of the cellular fluorescence and cellular iron contents in cell lysates obtained 
from cells after exposure to OG-IONPs at 4°C and 37°C allows to discriminate between 
adsorbed IONPs and internalized IONPs (Fig. 3B,C). For incubations with 1 mM and 3 
mM IONPs, the specific iron contents and the specific cellular fluorescence determined 
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after 4°C incubations represented around 65% of the values observed for the respective 
37°C incubations, demonstrating that after a 37°C incubation only around 35% of the 
cellular IONPs had been taken up into the cells (Fig. 3B,C). Despite of the substantial 
amounts of iron and fluorescence determined in lysates generated from cells after 
exposure to OG-IONPs at 4°C, hardly any cellular fluorescence or iron signals were 
observed for this treatment (Fig. 3M-P), due to insufficient local density of the 
extracellularly adsorbed fluorescent IONPs to allow detection of iron or fluorescence 
(Waters, 2009, Nazarenus et al., 2014, Drasler et al., 2017). In contrast, after the 
respective incubations at 37°C, strong fluorescence signals and a strong cellular iron 
staining were detectable (Fig. 3H-K), indicating cellular uptake and intracellular 
packaging of the fluorescent IONPs to local concentrations that are sufficiently high to 
allow detection of the internalization of OD-DMSA-IONPs by iron staining and 
florescence microscopy. 
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5. Conclusion 
To test and screen for potential consequences of an exposure of brain cells to NPs, 
cultures of neural cells are good and easy to use model systems. However, due to their 
unique properties NPs will strongly interact with components of physiological media, 
with biomolecules and with cells. This can affect the physicochemical properties of the 
NPs but also the properties and the viability of cells. Therefore, it is important to analyze 
in detail the physicochemical properties of the NPs in the physiological media used for 
cell experiments, the potential effect of cell components on the NPs as well as the 
consequences of an NPs exposure to the cells. A number of special control experiments 
are recommended to avoid artifacts and misinterpretations of data on the consequences 
of an exposure of brain cells to NPs. These dos and don´t forgets will help to appropriately 
address the special challenges connected with studying the interactions between NPs and 
cultured cells and will help to avoid unnecessary artifacts in order to deliver robust and 
reproducible data and reliable and correct interpretations of the data obtained on the 
potential toxicity, uptake and intracellular fate of NPs in neural cells.  
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7. Table and figures 
 
Table 1. Characterization of DMSA-IONPs  
Parameter Method  Values 
Shape Transmission electron microscopy   spherical 
Size Transmission electron microscopy  5-20 nm 
Size distribution 
Transmission electron microscopy 
Dynamic light scattering  
 polydisperse 
Hydrodynamic diameter Dynamic light scattering  61 ± 5 nm  
Surface charge  
(ζ-potential) Electrophoretic light scattering   -20 ± 5 mV 
Element content Energy dispersive X-ray spectrometry  iron, oxygen, sulfur 
Magnetism Vibrating sample magnetometer  superparamagnetic 
Coating present 
Energy dispersive X-ray spectrometry  presence of sulfur 
peak 
Electrophoretic light scattering  
negative surface 
charge in water 
The data shown in this table have been taken from the articles (Geppert et al., 2011, Petters et al., 2014a, 
Petters et al., 2014b, Rastedt et al., 2017).  
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Table 2. Modulation of physicochemical parameters of DMSA-IONPs by media components  
Solvent Test compound  Hydrodynamic diameter (nm)  
ζ-potential  
(mV) 
H2O 
 
 54 ± 11   -61 ± 13  
IB    60 ± 8   -16 ± 4  
IB phosphate (0.8 mM)   >1000 ***     n.d.   
IB  BSA (0.5 mg/mL)  75 ± 4 *  -9 ± 2 * 
IB FCS (10%)  95 ± 14 *  -9 ± 2 * 
IB  
chlorpromazine (20 
μM)  
72 ± 11  
 
-18 ± 7  
IB dynasore (100 μM)   >1000 ***    n.d.   
IB 
FCS (10%) +  
dynasore (100 μM)  
111 ± 5 ** 
 
-9 ± 1 * 
DMEM    >1000     n.d.   
DMEM BSA (0.5 mg/mL)   >1000     n.d.   
DMEM FCS (10%)  148 ± 22 **  -10 ± 1  
DMSA-IONPs were dispersed in a final concentration of 1 mM iron in the indicated solvents (water, or 
incubation buffer (IB; 20 mM HEPES, 145 mM NaCL, 5 mM D-glucose, 1.8 mM CaCl2, 5.4 mM KCl, 
1 mM MgCl2, adjusted with NaOH to pH 7.4) or Dulbecco’s modified Eagle´s medium (DMEM; 
containing 20 U/mL penicillin G, 20 μg/mL streptomycin sulfate, 25 mM glucose and 1 mM sodium 
pyruvate) in the absence or the presence of the indicated test compounds before the average hydrodynamic 
diameter and the ζ-potential were determined. The data represent mean values ± SD of data obtained in 3 
experiments performed on independently prepared batches of DMSA-IONPs. The significance of 
differences between the values obtained for the IONP-containing medium without or with the indicated 
test compounds is indicated by *p<0.05; **p<0.01 and ***p<0.001. BSA: bovine serum albumin, FCS: 
fetal calf serum, n.d.: not detectable.  
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Table 3. Binding of fluorescence OG-DMSA-IONPs to cell culture plates 
Preincubation medium  
Iron content 
(nmol/well) 
 Fluorescence (a.u./well) 
none 
 
0.3 ± 0.1 
 
1.6 ± 0.2 
DMEM 
 
2.3 ± 0.4** 
 
3.3 ± 2.5 
DMEM + BSA (0.5 mg/mL) 
 
7.4 ± 1.8** 
 
16.8 ± 7.1** 
DMEM + FCS (10%) 
 
6.0 ± 1.5** 
 
13.6 ± 0.3*** 
Poly-D-lysine (15 μg/mL in 
H2O) 
 
22.0 ± 6.1** 
 
23.0 ± 1.7*** 
24-well cell culture plates were preincubated for 24 h with 1 mL of the indicated solutions in a humidified 
atmosphere of an incubator at 37°C for 24 h. Subsequently, the wells were washed twice with IB, incubated 
with 200 μL of 1 mM Oregon Green (OG)-DMSA-IONPs (200 nmol iron per well and 262 ± 26 a.u. 
fluorescence per well) in IB at 37°C for 1 h, were washed twice with 1 mL phosphate-buffered saline and 
were treated with 400 μL 50 mM NaOH to solubilize bound IONPs that were subsequently quantified by 
determining the contents of iron and OG fluorescence (Geppert et al., 2009, Rastedt et al., 2017). The data 
represent mean values ± SD of data obtained in 3 experiments performed on independently prepared batche 
s of OG-DMSA-IONPs. The significance of differences between the data obtained for uncoated (none) and 
preincubated wells is indicated by **p<0.01 and ***p<0.001. DMEM, Dulbecco’s modified Eagle´s 
medium; BSA, bovine serum albumin; FCS, fetal calf serum 
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Fig. 1 DMSA-IONPs. The panels show a transmission electron microscopic (TEM) image (A) 
and the hydrodynamic diameter distribution curve (B) for 1 mM IONPs dissolved in physiological 
incubation buffer (IB) that were obtained as previously descibed (Tulpule et al., 2014, Rastedt et 
al., 2017). The scale bar in the TEM image represent 20 nm. The TEM image (A) was kindly 
provided by Dr. Karsten Thiel (Fraunhofer IFAM, Bremen). 
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Fig. 2 Cell density-dependent accumulation of OG-DMSA-IONPs in C6 glioma cells. The cells 
were seeded in different densities and grown for 24 h before an 1 h incubation in IB with 1 mM 
fluorescent OG-DMSA-IONPs (Rastedt et al., 2017) was performed at 37°C or 4°C. The OG-
DMSA-IONP incubation was terminated by washing the cells twice with ice-cold phosphate-
buffered saline. The cells were lysed in 400 μL 50 mM NaOH and the lysates were used to 
determine the protein content (A), the cellular iron content (B) and the cellular OG fluorescence 
(C) using established assays as described before (Lowry et al., 1951, Geppert et al., 2009, Rastedt 
et al., 2017). The data shown represents means ± SD of values obtained in 4 independent 
experiments. The significance of differences between the values obtained for cells that had been 
incubated at 37°C and 4°C is indicated by #p<0.05; ##p<0.01 and ###p<0.001. 
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Fig. 3 Concentration-dependent accumulation of OG-DMSA-IONPs in C6 glioma cells. Per well, 
100,000 cells were seeded and grown for 24 h before the cells were incubated for 1 h with the 
indicated concentrations of OG-DMSA-IONPs at 37°C or 4°C. The cell viability was investigated 
by testing for impaired membrane integrity by measuring the release of the cytosolic enzyme 
LDH (A) as previously described (Dringen et al., 1998, Tulpule et al., 2014). The cellular iron 
content (B) and the cellular OG fluorescence (C) were determined from NaOH lysates (400 μL 
50 mM) as recently described (Geppert et al., 2009, Rastedt et al., 2017). Potential disturbances 
by IONPs on the LDH assay used were excluded by determining LDH activity in 1% Triton X-
100 cell lysate in the presence of the given final concentrations of IONPs (D). The extend of cell-
independent binding of OG-DMSA-IONPs to protein-coated wells (wells exposed to culture 
medium containing 10% FCS for 24 h) was determined in parallel to cell incubations (1 h at 37°C 
or 4°C with 1 mM IONPs) by measuring iron content (E) and fluorescence (F). The data shown 
represents means ± SD of values obtained in 3 independent experiments. The significance of 
differences between values obtained for incubations at 37°C and 4°C or for incubations in the 
presence or absence of cells is indicated by #p<0.05; ##p<0.01 and ###p<0.001. Fluorescence 
microscopy was used to localize cellular OG fluorescence after 1 h incubation of cells with the 
indicated concentrations of OG-DMSA-IONPs at 37°C (G.I) or 4°C (L-O) and the cellular iron 
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was localized by cytochemical Perls staining (K,P) as previously described (Geppert et al., 2009, 
Rastedt et al., 2017). The cell nuclei were stained with DAPI (blue) (G-P). The size bar in panel 
g represents 10 μm and applies for the panels (G-P).  
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3  Summarizing discussion 
3.1 Synthesis and characterization of fluorescent iron oxide 
nanoparticles 
The synthesized fluorescent IONPs were intensively characterized and the effect of the 
insertion of the fluorescence dyes into the coat of the IONPs on the accumulation of the 
particles by cells were investigated using C6 glioma cells as model system (chapter 2.1). 
Table 3.1 contains some key data obtained on the physicochemical properties of the 
synthesized IONPs.  
Table 3.1 Characterization of fluorescent and non-fluorescent IONPs 
Parameter 
investigated 
Method 
used 
OG-DMSA-
IONPs 
TMR-DMSA-
IONPS 
BP-DMSA-
IONPS 
DMSA- 
IONPs 
size TEM 5-10 nm 5-10 nm 5-10 nm 5-10 nm 
size distribution TEM/DLS polydisperse polydisperse polydisperse polydisperse 
hydrodynamic 
diameter (nm, IB) 
DLS 61 ± 7  (9) 69 ± 11 (6) 68 ± 4 (4) 60 ± 12 (8) 
ζ-potential (mV, IB) ELS -21 ± 5 (5) -25 ± 3 (4) -24 ± 5 (4) -16 ± 4 (6) 
element content EDX iron, oxygen, 
sulfur 
iron, oxygen, 
sulfur 
iron, oxygen, 
sulfur 
iron, oxygen, 
sulfur 
λmax (nm, Ex/Em) Fluorescence 
spectroscopy 
492/516 549/574 500/510 none 
cellular iron content (nmol/ mg protein) ( 1h exposure of C6 cells to 1mM IONPs) 
4°C incubation in 
absence of serum (5) 
iron assay 461 ± 92  512 ± 40  486 ± 92  417 ± 57  
37°C incubation in  
absence of serum (5) 
iron assay 255 ± 68 280 ± 61 266  ± 40 283 ± 32  
Reduction in the 
presence of serum (5) 
iron assay 80-90% 80-90% 80-90% 80-90% 
Most of the data shown are derived from chapter 2.1. Additional data are included for the hydrodynamic 
diameter and the ζ-potential of the IONPs in IB. The numbers in brackets represent the number of 
independent measurements performed on individually prepared IONPs dispersions. C6 cells were exposed 
to IONPs for 1 h to 1 mM IONPs at 4°C and 37°C and the cellular iron contents were determined as 
described in chapter 2.1. The incubation in the presence of serum led to a reduction in the accumulation of 
IONPs measured by the cellular iron content to around 80-90% of the values obtained in the absence of 
serum as described in chapter 2.1. 
 
For the synthesized fluorescent IONPs, the presence of the sulfur peak in the EDX 
measurements and the stability of the IONPs in the physiological medium IB confirmed 
the successful coating of the IONPs (Geppert et al., 2011). Furthermore, for none of the 
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fluorescent IONPs differences in the physicochemical properties were observed in 
comparison to the non-fluorescent IONPs (Table 3.1). The successful insertion of the 
fluorescence dyes into the DMSA-coat of IONPs was confirmed by fluorescence 
spectroscopic analysis showing the expected excitation and emission spectra (chapter 2.1) 
and emission and excitation maxima (Table 3.1) recorded for the underivatized dyes (data 
not shown) and for the dyes coupled to DMSA, as exemplary shown for OG-IONPs and 
OG-DMSA (supplementary data Fig. 4.1B). 
Accumulation studies in C6 glioma cells revealed that the accumulation of the DMSA-
coated IONPs was not influenced by the insertion of the fluorescence dyes (Table 3.1), 
which is in line with comparative accumulation studies of BP-IONPs and DMSA-IONPs 
in oligodendroglial cells (Petters et al., 2014a). Incubations of C6 glioma cells with the 
fluorescent IONPs at 37°C resulted in a dot like pattern for all three types of fluorescent 
dyes most likely due to the formation of IONPs-containing vesicles. Comparison of 
fluorescence intensity and stability of the three types of fluorescent IONPs demonstrated 
the desired higher fluorescence intensity and stability for the OG-IONPs and the TMR-
IONPs, while analysis of cellular fluorescence after exposure of cell to BP-IONPs 
suffered from strong photo bleaching (chapter 2.1). 
Charlotte Petters (Petters, 2015; personal communication) reported that after exposure of 
cells to BP-IONPs, BP-fluorescence was detected outside of the vesicular pattern for 
example in the nucleus and concluded that this may be caused by residual amounts of 
free fluorescent coating material or by the liberation of coating material from the IONPs 
over time within the cells. However, as the incubation of C6 cells with a large 
concentration of OG-functionalized DMSA (OG-DMSA) in the absence of any NPs did 
not cause any obvious cellular fluorescence (supplementary data Fig. 4.1), the dot-like 
fluorescence pattern observed after incubation of C6 cells with OG-IONPs is likely to 
result from IONP-containing vesicles, as also confirmed by the cytochemical stainings 
for iron that led to a similar pattern (chapter 2.2). As it is unlikely that DMSA is capable 
to cross the cell membrane (Aposhian and Aposhian, 1990, Zhang et al., 2015a) also its 
fluorescent derivates may not enter the cells. Thus, the observation of BP-fluorescence 
(Petters, 2015) or OG-fluorescence (chapter 2.2) outside of the vesicle-structures (after 
extended incubation periods) is probably due to liberation of the fluorescent coat from 
the NPs within the cell.  
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Taken together, the insertion of the fluorescence dyes OG or TMR into the DMSA coat 
of IONPs did not alter the physiochemical properties and the colloidal stability of the 
IONPs nor the cellular accumulation in comparison to the non-fluorescent IONPs. 
However, OG- and TMR-IONPs possessed high fluorescent intensity and stability 
compared to BP-IONPs. Therefore, OG- and TMR-IONPs were considered as suitable 
tool to further investigate uptake and fate of DMSA-IONPs in neural cells by making use 
of the fluorescence properties suitable for the available fluorescence wide-field 
epifluorescence microscope. 
3.2 Accumulation of fluorescent iron oxide nanoparticles in neural 
cells 
C6 glioma cells were used in this study as model for glial cells, to characterized the newly 
synthesized fluorescent IONPs in comparison to the BP-IONPs and non-fluorescent 
IONPs and to establish conditions for an improved investigation of uptake mechanisms 
and intracellular trafficking.  
C6 glioma cells efficiently accumulate both fluorescent and non-fluorescent DMSA-
coated IONPs by a time-, concentration- and temperature dependent manner, whereby 
the accumulation rate slowed down with longer incubation times (chapter 2.1), which is 
in line with the accumulation of DMSA-coated IONPs in other brain cells (Hohnholt et 
al., 2011, Geppert et al., 2013, Petters and Dringen, 2015) or non-neural cells (Wilhelm 
et al., 2002). This decline of accumulation with time may be caused by the saturation of 
available binding sites (Wilhelm et al., 2002), the release of compounds from the cells, 
which can alter the size, charge and surface chemistry of the particles (Geppert, 2012, 
Petters and Dringen, 2015), and/or by the alteration of the composition of the membrane 
due to the binding and uptake of particles (Mahmoudi et al., 2014).  
As adhesion of NPs to the cell membrane is the first step during the uptake of NPs 
(Wilhelm et al., 2002), the extracellular binding is a crucial factor in cellular uptake 
studies (Lesniak et al., 2013, Mahmoudi et al., 2014). Incubations at 4°C are often used 
to determine the amount of NPs extracellularly bound material (Geppert et al., 2011, 
Smith et al., 2012, Bulcke et al., 2014). For C6 glioma cells a substantial adsorption of 
DMSA-coated IONPs at low temperature was observed which accounted for arround 
Summarizing Diskussion 134 
 
70% of the iron amounts measured after incubation at 37°C (chapter 2 and Table 3.1). 
This is in line with data obtained in studies on astrocytes, oligodendrocytes and neurons, 
all reporting high specific cellular amounts of IONPs after 4°C incubations (Geppert et 
al., 2011, Petters et al., 2014a, Petters and Dringen, 2015).  
In the presence of serum, the accumulation of DMSA-coated IONPs was drastically 
lowered down to 80-90% of the values observed in serum-free medium. This observation 
is consistent with the accumulation of DMSA-coated IONPs in the absence or presence 
of serum in other neural cells (Geppert et al., 2013, Petters et al., 2014a, Petters and 
Dringen, 2015), and has also been reported for other cell types and other types of NPs 
(Wilhelm et al., 2003, Petri-Fink et al., 2008, Safi et al., 2011, Lesniak et al., 2013). The 
accumulation in the presence of serum was strongly reduced for non-fluorescent and 
fluorescent IONPs, suggesting that the insertion of the dye into the coat did not affect the 
formation and the composition of the protein corona around the IONPs. Fluorescence 
microscopic analysis of C6 cells exposed to fluorescent IONPs at 4°C showed hardly any 
fluorescence signals, whereas incubations at 37°C led to bright dotted-like fluorescence 
pattern. This observation strongly contrasted with the quantitative calculation of cellular 
iron and fluorescence content after IONP exposure. While quantification from lysates 
revealed a linear correlation between iron content and fluorescence content no matter if 
incubations were performed at 37°C or 4°C, calculation of fluorescence from microscopic 
pictures in correlation to cellular iron content from lysates showed a clear difference in 
the correlation of values obtained at 37°C and 4°C (chapter 2.1). Therefore, the 
calculation of cellular IONPs from fluorescence intensities in microscopic images can 
lead to an underestimation due to the non-visible amount of IONPs extracellularly bound. 
The likely explanation for this discrepancy is the limited resolution of the epifluorescence 
microscope used. Thus, the microscope is not able to detect the high proportion of 
extracellularly attached NPs, most likely to their more or less individual distribution 
along the cell membrane (Nazarenus et al., 2014) extracellularly attached to the 
membrane, whereas the signal of agglomerated NPs within vesicles can be easily 
monitored.  
The efficient acute accumulation of large amounts of iron after exposure of C6 cells to 
IONPs, especially in the serum-free media, did not hamper cellular viability as confirmed 
by determination of extracellular LDH activity and by propidium iodide staining (chapter 
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2.1) nor any formation of reactive oxygen species has been detected (data no shown). The 
lack of toxicity is in line with observations made for IONPs accumulation in astrocytes, 
neurons and oligodendrocytes (Geppert et al., 2011, Petters et al., 2014a, Petters and 
Dringen, 2015). Furthermore, loading the cells for 1 h with 1 mM OG-IONPs and 
monitoring the cellular localization of the IONPs for up to 3 days revealed no delayed 
cytotoxic potential as no change in cell morphology or influence on the cell proliferation 
in comparison to control cells was observed (supplementary data Fig. 4.2). These 
observations of a low toxic potential of OG-IONPs are in line with the findings for 
IONPs-treated astrocytes, which remained viable even 7 days after loading the cells with 
large amounts of DMSA-coated IONPs (Geppert et al., 2012) or oligodendroglial cell 
line showing no loss in viability even after 3 days of culturing in continuous presence of 
DMSA-IONPs (Hohnholt et al., 2011). In contrast, for IONPs-treated neurons a delayed 
toxicity was observed after 24 h (Sun et al., 2013, Petters and Dringen, 2015). For 
microglia cells the potential toxicity is even higher, as already short time exposure with 
IONPs led to severe loss in viability of cultured microglia cells (Luther et al., 2013, 
Petters et al., 2016). 
C6 glioma cells express astrocyte marker proteins and are often considered as model for 
astrocytes. The comparison of data obtained for the accumulation of IONPs in C6 cells 
with literature data obtained for primary astrocytes under comparable experimental 
conditions (Table 3.2) revealed similar results for both types of cultured cells.  
For studies of IONP uptake in C6 glioma cells it was important to optimize the 
experimental protocol especially regarding the cell density and the unspecific binding of 
IONPs to the cell membrane as well as to the cell culture plates as discussed in chapter 
3.3.  
In contrast to confluent primary astrocytes, for C6 cells the cell cycle appears to play an 
important role, as a synchronization of the cell cycle by serum starvation or by application 
of pharmacological inhibitors led to different localization pattern of OG-IONPs within 
these cells (supplementary data Fig. 4.3). These observations are in line with previous 
studies on NPs accumulation in different cell types, showing dependency of NP uptake 
on the cell cycle (Kim et al., 2011, Patel et al., 2016). This is most likely due to changes 
in the membrane composition such as ratio of cholesterol and phospholipids, the 
expression of membrane proteins, surface antigens and receptors during the cell cycle 
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(Boucrot and Kirchhausen, 2007, Bregoli et al., 2013, Mahmoudi et al., 2014, Tang et 
al., 2015). 
Table 3.2 Accumulation of DMSA-coated IONPs in C6 glioma cells and primary astrocytes 
parameters 
investigated 
C6 glioma cells Ref. primary astrocytes Ref. 
     
iron content after 
incubation at 37°C 
(4 h, 1 mM) 
1.317 ± 220 nmol iron/mg 
protein  
[1] 1.375 ± 260 nmol iron /mg 
protein 
[4] 
iron content after 
incubation at 4°C 
(4 h, 1 mM)  
825 ± 86 nmol iron/mg protein  [1] 726 ± 214 nmol iron/ mg 
protein 
[4] 
influence of serum reduction of iron content of 
around 80-90% 
[2,3] reduction of iron content of 
around 80-90% 
[4,5] 
toxicity no acute toxicity (6 h, 3 mM) 
no delayed toxicity (1 h, 1 mM 
loading, 3 days monitoring) 
[1] no acute toxicity (6 h, 3 mM) 
no delayed toxicity (4 h, 1 mM 
loading, 7 days monitoring) 
[6,7] 
intracellular 
location 
perinuclear [2,3] perinuclear [6,7,8] 
1= unpublished data; 2= chapter 2.1; 3= chapter 2.2; 4= Hohnholt et al. 2011; 5= Geppert et al. 2013; 6= 
Geppert et al. 2012; 7= Geppert et al. 2011; 8= Petters et al. 2017 
 
It is widely accepted that NPs are taken up by endocytotic pathways (Oh and Park, 2014, 
Zhang et al., 2015b). Also DMSA-IONPs are internalized by endocytosis in brain cells 
(Geppert et al., 2013, Luther et al., 2013, Petters et al., 2014b, Petters and Dringen, 2015). 
An obvious and commonly used attempt to study the role of endocytosis in the uptake of 
IONPs would be the inhibition of specific endocytotic pathways by pharmacological 
inhibitors (Iversen et al., 2011) as critically discussed in chapter 2.3. Within the presented 
project, several attempts were made to block the uptake of fluorescent IONPs dispersed 
in serum-free medium into C6 glioma cells by the application of various different 
endocytosis inhibitors, both for continuous incubations for 1 h with 1 mM of OG-IONPs 
as well as for pulse-chase experiments. In none of these experiments the presence of 
endocytosis inhibitors caused any significant decrease of the cellular iron content or 
fluorescence signal monitored by fluorescence microscopy (data not shown). This 
confirms literature data on cultured astrocytes, oligodendrocytes and neurons showing 
that in the absence of serum endocytosis inhibitors did not impair IONP accumulation 
(Lamkowsky et al., 2012, Geppert et al., 2013, Petters et al., 2014a, Petters, 2015, Petters 
and Dringen, 2015). Reasons for that could be: (1) The activation of other endocytotic 
pathways due to the inhibition of one specific pathway (dos Santos et al., 2011). (2) 
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Uptake via an endocytosis pathway, that is not blocked by the used inhibitors, and (3) 
endocytosis-independent mechanisms leading to the uptake of IONPs in vesicular 
structures. The latter has for example been observed in red blood cells that do not possess 
an endocytosis machinery (Shang et al., 2014) but are still capable to take up NPs of 
different size (Rothen-Rutishauser et al., 2006, Wang et al., 2012, Shang et al., 2014). 
Furthermore, Lai et al. (2007) postulated a non-clathrin-, non-caveolae-dependent uptake 
mechanism that leads to non-degradative accumulation of fluorescent polystyrene NP in 
the perinuclear area of HeLa cell. Such a non-degradative pathway could also explain the 
inability of the pharmacological endocytosis inhibitors to lower IONPs accumulation in 
the absence of serum in C6 cells as well as in astrocytes (Lamkowsky et al., 2012, 
Geppert et al., 2013, Petters, 2015). 
3.3 Nanoparticle pulse-chase experiments to improve temporal and 
spatial resolution of iron oxide nanoparticles uptake and 
trafficking  
Nanoparticle pulse-chase experiments were performed in order to investigated the uptake 
and intracellular trafficking of IONPs with improved temporal and spatial resolution 
(chapter 2.3). The nanoparticle pulse-chase protocol established for the presented thesis 
on C6 glioma cells combined a 10 min pulse of fluorescent IONPs at 4°C to allow 
extracellular binding of NPs, with a subsequent chasing period to monitor internalization 
and subsequent intracellular trafficking (Fig. 3.1). 
Fig. 3.1 Principle of nanoparticle pulse-chase experiments. For detailed description see 
chapter 2.2. 
Although substantial amounts of cellular iron and fluorescence were quantified after the 
nanoparticle pulse (incubation at 4°C), the local density of the fluorescent IONPs 
extracellularly attached to the cell membrane was insufficient to detect adsorbed IONPs 
by fluorescence microscopy or cytochemical iron staining using the available wide-field 
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epifluorescence microscope. In contrast, already a few minutes after starting the chase 
monitoring at 37°C dot-like structures were detected, most likely representing vesicular 
structures that contain increased density of fluorescent IONPs. The rapid appearance of 
these structures is consistent with the reported rapid endocytosis and vesicle formation in 
the minute range (Durrbach et al., 1996). Longer chase periods revealed an increase in 
fluorescence and iron signals and a final perinuclear localization in C6 glioma cells 
consistent with studies on other neural cells such as astrocytes (Geppert et al., 2011) but 
also non-neural cells (Jarockyte et al., 2016). However, the nanoparticle pulse-chase 
protocol revealed a loss in the fluorescence pattern already after 90 min of chasing period, 
whereas the perinuclear cyctochemical iron staining was preserved.  
The conditions established for nanoparticle pulse-chase experiment on C6 cells were also 
suitable for studies on viable primary and secondary astrocyte cultures (supplementary 
data Fig. 4.4) revealing after exposure to OG-IONPs similar staining patterns for 
fluorescence and iron as found for C6 glioma cells. In contrast, for viable cerebellar 
granule neuron (supplementary data Fig. 4.5) no clear distinguished fluorescence pattern 
nor cyctochemical iron staining of the IONPs were determined and no clear perinuclear 
localization of IONPs was observed due to the small somata of the neurons 
(supplementary data Fig. 4.5) (Petters et al., 2016) which makes such a localization 
difficult to record. For microglia, the nanoparticle pulse chase setting could not be applied 
as severe toxicity was observed during the chase period (supplementary data Fig. 4.6). 
Double nanoparticle pulse-chase experiments in C6 glioma cells allowed to study the 
sequential uptake of IONPs labeled with OG and TMR (chapter 2.2) showing a rapid 
colocalisation of the fluorescent vesicles in the perinuclear area. For further studies 
confocal Laser Scanning Microscope (LSM) with a better resolution would be required 
to get better information about the intracellular localization of the IONPs-containing 
vesicles. Nevertheless, the optimized parameters for single and double nanoparticle 
pulse-chase could be a helpful paradigms to study the intracellular trafficking of IONPs 
in cultured cells with the simple wide-field epifluorescence microscope available.  
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3.4 Involvement of cytoskeleton in uptake and trafficking of iron 
oxide nanoparticles 
To test for the role of actin filaments and microtubules in the uptake of IONPs in C6 
glioma cells, these structure were disrupted using pharmacological inhibitors prior to the 
nanoparticle pulse chase experiments (chapter 2.2). The disruption of the actin filaments 
in C6 glioma cells drastically lowered, but not totally diminished, the internalization of 
IONPs consistent with studies on several types of NPs in different cell lines (dos Santos 
et al., 2011, Iversen et al., 2012, Nowak et al., 2014, Prietl et al., 2014). In C6 glioma 
cells the internalization of IONPs seems to highly depend on actin which would be in line 
with several studies suggesting an important role of actin in the engulfment of the 
membrane segment and the formation of vesicle (Durrbach et al., 1996, Kumari et al., 
2010, Mooren et al., 2012). However, the results obtained have to be carefully 
interpreted, due to the alteration in the shape of the C6 glioma cells after treatment with 
cytochalasin D, an inhibitor of actin polymerization (Mortensen and Larsson, 2003). 
Even though the treatment of C6 glioma cells with cytochalasin D did not cause any loss 
in membrane integrity during the complete nanoparticle pulse-chase experiment and the 
amount of IONPs extracellularly bound to the cell membrane was not affected, the effect 
of cytochalasin D treatment on the cell shape of C6 glioma cells under the chosen 
condition may also have caused unintended side effects on the cellular uptake of IONPs. 
Therefore, a more precise inhibition of the actin polymerization without effecting cell 
shape and microtubules (Durrbach et al., 1996), could help to get an even better 
understanding of the role of actin.  
While the release of vesicles from the plasma membrane into the cytosol is supported by 
actin, a switch from an actin-based movement to a tubulin-based movement occurs to 
transport the vesicle down the endocytotic pathways to their final destination (Granger et 
al., 2014). In C6 glioma cells the disruption of the microtubules in C6 glioma cells 
strongly disturbed this transport as the IONPs-containing vesicle seemed to be trapped at 
the cell membrane. This is in line with observations made in mouse melanoma cells 
reporting that the disruption of the microtubules disturbed the transport of 50-100 nm 
microspheres from early to late endosome (Rejman et al., 2004).  
In conclusion, the investigation of the impact of the cytoskeleton on the OG-IONPs 
uptake by C6 glioma cells revealed that actin plays an essential role in the vesicle 
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formation and vesicle release from the membrane into the cytoplasm, whereas the 
microtubules are important for the subsequent intracellular transport of the vesicles to the 
perinuclear area (Fig. 3.2). 
 
Fig. 3.2 Schematic representation of the role of actin and microtuble filaments in the uptake 
and intracellular trafficking of IONPs in C6 glioma cells. 
3.5 Degradation of internalized iron oxide nanoparticles 
The insertion of fluorescence dyes into the coat of NPs is a commonly used tool to study 
the uptake and intracellular fate of NPs (Bertorelle et al., 2006, Kaewsaneha et al., 2014, 
Kaewsaneha et al., 2015). Several studies already stated the degradation of the coating 
material in vitro and in vivo (Zhang et al., 2015a, Feliu et al., 2016, Zhang and Liu, 2017). 
During the endocytosis the particles are passed to more and more acidic vesicles 
following a degradative pathway (Nazarenus et al., 2014, Soenen et al., 2015). Several 
studies reported a degradation of the surface coating during trafficking of NPs in the 
endocytotic pathway (See et al., 2009, Lunov et al., 2010, Feliu et al., 2016). However, 
also the iron core of IONPs is disintegrated over time in vitro and in vivo (Briley-Saebo 
et al., 2006, Mazuel et al., 2016) and it was observed that IONPs can be solubilized in 
the absence of any enzymes at a pH similar to that found in endosomes and lysosomes 
(Skotland et al., 2002, Mazuel et al., 2016, Volatron et al., 2017).  
Nanoparticle pulse-chase experiment revealed a separation of the fluorescence DMSA-
coat and the iron-core after chasing periods longer than 90 min in C6 cells (chapter 2.3.) 
as well as in astrocytes cultures (supplementary data 4.4). In OG-IONPs, the DMSA 
forms a cage-like structure around the iron oxide core cross-linked by disulfide bridges 
(Fauconnier et al., 1997, Valois et al., 2010) containing a low number of fluorescent 
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molecules formed by thioether bonds (Petters et al., 2014a, chapter 2.1) between the free 
thiol groups of the DMSA cage and the functional iodoacetamide group of the dyes. The 
covalent thioether link between the coating material and the fluorescent dye is relative 
stable, but the disulfide bridges of the DMSA cage can be easily reduced which will cause 
disintegration of the coat. Processes that could be involved in this degradation are acidic 
environments (Soenen et al., 2015), enzymatic activities (Chen et al., 2008, Zhang et al., 
2016, Zhang and Liu, 2017) and the exchange with thiol-containing endogenous 
biomolecules (Hong et al., 2006, See et al., 2009). Concerning the mechanismus involved 
in the separation of core and coat of internalized OG-IONPs in C6 cells preliminary 
experiments were performed to neutralize acidic compartments, to deplete the cellular 
glutathione content and to inhibit cellular transport of IONPs-containing vesicles to the 
lysosome (Table 3.2).  
Table 3.3 Experiments to prevent degradation of the coating material 
Target 
 
Procedure 
 
Result 
Lysosome 
 
Neutralization of lysosome using 
Bafilomycin A1, an inhibitor of the 
H+-ATPase (Teplova et al., 2007), 
during the pulse-chase experiment 
 ?Neutralization of lysosome 
confirmed by lysotracker staining 
(Petters et al., 2016) 
?no toxicity 
? no prevention of degradation 
Glutathione 
content 
 
Depletion of cells on glutathione using 
iodoacetamide (Schmidt and Dringen, 
2009) prior to the pulse-chase 
experiment 
 
?GSH depletion confirmed by GSH 
quantification (Tulpule et al., 2014) 
? toxicity after 120 min chase 
? no prevention of degradation 
Transport of 
vesicles to more 
acidic 
compartments 
 
Disruption of the microtubules using 
colchicine prior and during the pulse-
chase experiment as described in 
chapter 2.2 
 ?Microtubules disruption confirmed 
by immunocytochemistry 
?Inhibition of transport 
?no toxicity 
? no prevention of degradation 
To target the lysosomes, nanoparticle pulse-chase experiments were performed as described in chapter 2.1 
in the presence of 100 nM Bafilomycin A1 using TMR-IONPs. To ensure that the neutralization of the 
lysosome was successful, cells were incubated with 100 nM of the lysotracker DND-99 (Life technologies, 
Darmstadt, Germany) for 15 min, washed twice and were directly analyzed under the fluorescence 
microscope. To investigate the role of glutathione in the disintegration of the OG-IONPs, C6 glioma cells 
were incubated with 0.1 mM iodoacetamide (IAA) in IB for 30 min at 37°C to deplete the cells on 
glutathione, which was confirmed by GSH quantification as recently described (Tulpule et al., 2014). 
Subsequently nanoparticle pulse-chase experiments were performed as described in chapter 2.2. The 
inhibition of the transport of vesicles to more acidic compartments was performed as described in chapter 
2.2. 
 
However, none of these attempts prevented the loss in cellular fluorescence signal of C6 
cells that were exposed to OG-IONPs. As also the inhibition of the transport of the OG-
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IONP-containing vesicles to the perinuclear area by microtubules disruption (chapter 2.2) 
did not prevent the degradation of the fluorescent-coat nor the separation of core and coat, 
quick processes seem to play a role in this separation of OG-DMSA and iron core. 
In contrast to the fluorescent signals, the iron signal in C6 glioma cells after OG-IONPs 
exposure was rather stable throughout the complete chase period (chapter 2.2). and even 
three days after uptake of large amounts of IONPs in the C6 cells, the cell viability was 
not impaired, the cellular iron contents remained stable and clear perinuclear pattern of 
iron could be detected (supplementary data Fig. 4.2). Interestingly, the IONPs-containing 
vesicles in C6 cells were distributed during cell division to the daughter cells and the high 
content of IONPs did not impair the cell division, which is in line for IONPs accumulation 
in proliferative and endocytotic active primary-derived rat cortical astrocytes (Tickle et 
al., 2016). As observed for cultured astrocytes (Geppert et al., 2012), C6 glioma cells are 
highly capable to deal with an excess amount of IONPs supporting the view of a slow 
degradation of the iron oxide core of internalized IONPs.  
An approach to study the intracellular localization of IONPs is the immunocytochemical 
costaining for fluorescent IONPs and intracellular marker proteins for different stages of 
the intracellular pathway. For example, staining for Rab7 as late endosome-/lysosome-
associated small GTPase, for the lysosomal associated membrane protein 1 (LAMP1), 
for calnexin as integral protein of the endoplasmic reticulum or for the early endosome 
antigen 1 (EEA1) were done in other studies (Iversen et al., 2012, Schweiger et al., 2012, 
Granger et al., 2014, Kasten et al., 2014). For all these markers successful 
immunocytochemical stainings were observed in untreated C6 cells (data not shown), but 
the respective costainings failed for cells that had been exposed to OG-IONPs. The 
permeabilization of the cell membrane, that is necessary to allow the access of the 
antibodies to the desired intracellular antigen, caused rapid and almost complete loss of 
the fluorescence of the internalized fluorescent IONPs after paraformaldehyde fixation 
(Fig. 3.3A,B). This loss in OG-fluorescence was observed for all time points of the chase 
period, for all types of fixation and permeabilization applied as well as for conditions that 
caused inhibition of intracellular vesicle transport by microtubules disruption (data not 
shown). Several different combination of fixation and permeabilization were tested 
(supplementary data Table 4.1), but  failed to prevent the loss in OG-fluorescence pattern. 
As example the fluorescence and iron staining of OG-IONPs-treated C6 cells, the most 
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frequently used combination of paraformaldehyde fixation and Triton X-100 
permeabilization (Ohsaki et al., 2005) is shown (Fig. 3.3A,B). In contrast the 
cyctochemical iron staining was not affected by the permeabilization procedure 
(Fig. 3.3E,F). Similar problems with the maintenance of the fluorescence pattern were 
also observed in primary rich-astrocytes cultures that had been exposed to OG-IONPs or 
TMR-IONPs (data not shown). 
Fig. 3.3 Effects of permeablisation and fixation procedures on the fluorescence and iron pattern 
of accumulated OG-IONPs in C6 glioma cells. C6 glioma cells were incubated with 1 mM OG-
IONPs for 1 h at 37°C. Cells were washed twice and fixation with 3.5% (w/v) paraformaldehyde 
(PFA) for 15 min at RT was performed (A, E). Subsequent to the PFA fixation, cells were washed 
twice with 0.9% NaCl (w/v) solution and additionally fixated with 2% (w/v) 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide (EDC) in 0.9% (w/v) NaCl  for 30 min at RT (C-G). The 
cells were subsequently exposed in the absence (A,E,C,G) or presence of 0.1% Triton X-100 for 
5 min at RT (B,F,D,H). Fluorescence microscopy (A-D) and cytochemical iron stainings (E-H) 
were performed as previously described (Geppert et al., 2009, chapter 2.2). The cell nuclei were 
stained with DAPI (blue). The size bar in panel A represents 10 μm and applies for all panels. 
 
The loss of the fluorescence pattern from permeabilized C6 cells that had been exposed 
to OG-IONPs could be partially prevented by applying the cross-linking agent 1-ethyl-3-
(3-dimethylaminopropyl)carbodiimide hydrochlorid (EDC) after the PFA fixation 
(Fig. 3.3C,D,G,H). In contrast to PFA, EDC crosslinks carboxyl groups to primary amine 
groups (Tymianski et al., 1997), and thus the free carboxyl groups of the DMSA-coat are 
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likely to be coupled to proteins surrounding the particle. However, a huge drawback of 
this method was that the fixation with EDC led to an increased unspecific binding of the 
antibodies for vesicle identification despite of the use of additional blocking and washing 
steps (data not shown). 
Taken together, these results suggest that as soon as the OG-IONPs are internalized into 
the cells, a rapid separation of the OG-DMSA coat and the iron core takes place which 
prevents immunocytochemical colocalization studies of the intact fluorescent IONPs and 
cellular structures.  
For DMSA-coated IONPs the separation of core and coat seems to be an early event, 
whereas the degradation of the core is rather slow, consistent with data for non-
phagocytic cells (Hohnholt et al., 2011, Geppert et al., 2012, Mazuel et al., 2016, Petters 
et al., 2016) and the prolonged retention of IONPs in the human body for time periods up 
to 11 months (Storey et al., 2012, Pham et al., 2018). Skotland et al. (2002) observed in 
cell-free experiments that the solubilisation of IONPs is accelerated in the present of 
citrate and that a low pH of 4.5 solubilized the particle in 4-7 days, while an increase to 
a pH of 5.5 drastically reduced and the substitution citrate with acetate inhibited the 
disintegration of the IONPs (Skotland et al., 2002). This indicates that the composition 
of the vesicular environment is a crucial factor for the disintegration of the IONPs in 
cells. Fig. 3.4 shows a predicted mechanism of the disassembly of fluorescent DMSA-
IONPs after the uptake into C6 glioma cells. 
Fig. 3.4 Model of the disintegration of fluorescent DMSA-IONPs after uptake into C6 glioma 
cells and astrocytes. Intact fluorescent IONPs are taken up into vesicles. In an early event 
(1-5 min) the coat is released from the core in the vesicles and slowy permeates into the cytosol 
by unknow processes.The disintegration of the iorn oxide core is a slow process that takes days 
up to weeks (Skotland et al., 2002, Geppert et al., 2012, Mazuel et al., 2016). 
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The mechanism of disintegration of the coat and the fate of the DMSA-coat after 
separation from the core remains to be examined. An overall cellular distribution of OG 
fluorescence signal was detected after more than 120 min of chase period (chapter 2.2.) 
and 6 h after loading the cells for proliferations studies (supplementary data Fig.4.2) 
suggesting a release of the disassembled coating material from the vesicles into the 
cytosol seems to be most likely. In line with this, Zhang et al. (2015) observed that the 
accumulation of DMSA-coated IONPs in various cell types led in the transcriptional 
changes of many cysteine-rich proteins coding genes presumably due to the interaction 
of DMSA with cytosolic cysteine-rich proteins. They predicted that the DMSA is released 
into the cytosol after the lysosomal thiol reductase (GLIT) disintegrated the coat of 
DMSA-coated IONPs that reached the lysosomes (Zhang et al., 2015a). Interestingly, 
during the proliferation study in C6 glioma cells (supplementary data Fig. 4.2) the OG 
signal was still detectable within the cells after 24 h and 72 h leading to the suggestion 
that the components of disassembled coat may remain within in the cells and will be 
distributed during cell proliferation to the daughter cells. 
3.6 Future perspective 
The fluorescent OG- and TMR-IONPs synthesized in this thesis have been proven to be 
a suitable tool for the visualization of IONPs in neural cells. However, due to the 
disintegration of the coat, just in a limited time frame. To overcome this limitation a 
different approach of coating could be performed to increase the stability of the 
fluorescence-coat of the IONPs. A commonly used approach for fluorescent IONPs is the 
formation of a covalently attached and stable silica shell around IONPs, which could also 
be further functionalized which fluorophores (Chekina et al., 2011, Kacenka et al., 2015). 
However, the non-degradability of the silica also limits the use of such particle for in vivo 
biomedical applications (Chekina et al., 2011). Furthermore, the change of the surface 
material could also influence the uptake mechanism and the intracellular fate of the 
IONPs in comparison to the DMSA-coated IONPs. This possible disadvantage could be 
addressed by coincubation studies of fluorescent DMSA-coated IONPs and fluorescent 
silica-coated IONPs with fluorophores of different spectra to investigate whether the two 
types of fluorescent particles follow the same route of uptake and internalization. 
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Additionally, this attempt could also give more information about the time scale of coat 
and core separation in the case of DMSA-coated IONPs.  
As cellular uptake mainly depends on the size of the particles and the surface chemistry 
(and less on the core), DMSA-coated silver NPs (AgNP) could be synthesized, as here 
the coat would be covalently attached to the surface through Ag-S bonds (Battocchio et 
al., 2012). If these DMSA-coated AgNPs are taken up by the cells by identical pathways 
as the DMSA-coated IONPs which could be verified by colocalization studies as 
described above and if the fluorescence coating of the AgNPs remains with the Ag core, 
these particles could be used to continue the study of uptake mechanisms and the 
intracellular fate of DMSA-coated NPs in neural cells.  
The nanoparticle pulse-chase protocols have been proven to be useful approaches to 
investigate the uptake and intracellular fate of IONPs in C6 glioma cells and astrocytes 
with an improved time and spatial resolution (chapter 2.2.). With help of this methods 
the importance of the cytoskeleton for IONP uptake and trafficking was demonstrated by 
the dependence of NP internalization on actin polymerization and the need of an intact 
microtubule network for the intracellular trafficking of the internalized NPs. However, 
as these studies were performed so far only on C6 glioma cells, a verification of these 
results for cultured astrocytes and other types of brain cells is required. Additionally, the 
establishment of the nanoparticle pulse-chase protocols for cultured microglia would be 
of great value, as microglia severely differ from other brain cells regarding uptake and 
toxicity of IONPs (Fleige et al., 2001, Petters et al., 2016). The nanoparticle pulse-chase 
experiments applied for this thesis were limited to a chasing period of maximal 8 h (data 
not shown). As the release of iron ions from the iron core is slow (Geppert et al., 2012, 
Mazuel et al., 2016), prolonged time frames should be applied to study the long term fate 
of IONPs in neural cells, also addressing the potential degradation of the core, the 
production of reactive oxygen species and the upregulation of the iron storage protein 
ferritin as reported previously (Hohnholt et al., 2011, Geppert et al., 2012). 
The differences in uptake of IONPs in the absence or presence of serum should be 
investigated further. A possible approach would be a sequential pulse at 4°C with IONPs 
and protein-coated IONPs containing different fluorescence dyes in the DMSA-coat, 
followed by the simultaneous start of chase at 37°C in presence or absence of certain 
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inhibitors of the endocytotic pathways monitoring differences in internalization and 
localization of the IONPs by fluorescence microscopy.  
To follow up the nanoparticle pulse-chase experiments, two questions should to be 
addressed: (1) the fate of the core and (2) the fate of the coating material. As long as core 
and coat of the IONPs are present in the same vesicles, the fluorescence signal of the coat 
could be used to investigate the uptake and intracellular fate of the core. This opens up a 
list of various possible colocalisation studies. For example, a common approach to 
elucidate the endocytotic pathways of NPs is the coincubation with fluorescent labeled 
proteins which are known as cargos of certain endocytotic pathways for example 
transferrin, cholera toxin B or Simian virus 40, but also here the specificity of the marker 
proteins has to be carefully analyzed and interpreted (Iversen et al., 2011).  
As immunocytochemical approaches are not suitable for colocalisation studies with OG-
IONPs (chapter 3.5.), an alternative could by the transfection of cells with fluorescent 
labeled marker proteins of the endocytotic pathways such as the late endosome-
/lysosome-associated small GTPase Rab9 or Rab7 to determine the colocalization of the 
OG-IONPs in certain endosomal vesicles (Sandin et al., 2012).  
Furthermore, the magnetic properties of the IONPs and the nanoparticle pulse-chase 
methodology allows subcellular compartmental isolation of endosomes and lysosomes, 
by a combination of homogenization, magnetic separation and ultracentrifugation 
(Thimiri Govinda Raj and Khan, 2016). Thereby, not only the localization of the iron-
core IONPs could be determined but also the release of the coat from the IONP-
containing vesicle could be investigated by isolation of the endosomal structures at 
different chasing time points and determination of the fluorescence of certain 
compartments. The distribution mechanism of the fluorescence material within the cell 
has not been addressed within this thesis. To gain more information about the fate of the 
DMSA-coat, IONPs-filled vesicles could be extracted as done for endosomes from 
human mesenchymal stem cells (Mazuel et al., 2016) and the degradation of the iron core 
in these single endosomes could be monitored by measuring the magnetism over time 
(Mazuel et al., 2016). Additionally, the leaking of the fluorescent coat of the IONPs from 
vesicles into the environment could be investigated to gain more information about the 
time scale and possible mechanisms.  
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During endocytosis the cargo is transported to more and more acidic environments. Using 
pH-dependent fluorescent dyes in the coat of the particles could provide information 
about the environmental pH and thereby the localization of the particle (Benjaminsen et 
al., 2011, Nazarenus et al., 2014). In this thesis two different types of fluorescent dyes 
were used, the pH-sensitive OG and the pH-insensitive TMR (supplier information). 
Simple fluorescence microscopy did not reveal striking difference in the signal intensity 
over time using the different fluorescence IONPs separately (data not shown). However, 
the usage of double labeled IONPs in combination with careful analyses of the 
fluorescence signals by establishing an in vitro calibration curve and by detailed image 
analysis could reveal additional information about the pH of the environment 
(Benjaminsen et al., 2011) the particles are captured at a certain chasing periods. To 
investigate the fate of the DMSA-coat over time, the incorporation of pH-sensitive dyes 
such as SNARF1, which emits red light in alkaline and green light in acidic environments, 
into the DMSA-coat could also be helpful to study the release of the dye into the cytosol 
(Semmling et al., 2008, Nazarenus et al., 2014).  
Very recently a Laser Scanning Microscope (LSM) with fluorescence lifetime imaging 
microscopy (FLIM) was purchased and is now available in our faculty. With this new 
equipment it is possible to perform life cell and continuous time-lapse imaging. This will 
increase the amount of information that can be gained and will improve the sensitivity of 
investigating the uptake and intracellular fate of fluorescent IONPs. Life cell studies 
would also avoid potential artifacts caused by fixation of cells (Schnell et al., 2012). 
Additional the suggested colocalisation studies could be analyzed with a better resolution 
and robust quantification could be performed.  
The adhesion of NPs to the membrane plays an important role in the cellular uptake 
(Lesniak et al., 2013, Mahmoudi et al., 2014) as 50-70% of the accumulated IONPs are 
absorbed to the cell membrane (chapter 2.1). Thus, the mechanism involved in the 
absorption should be investigated. The quantification of membrane-bound IONPs under 
certain conditions could be achieved by purification of the plasma membrane using the 
magnetic properties of the IONPs (Thimiri Govinda Raj et al., 2011). The isolation of the 
plasma membrane at certain time points of the nanoparticle pulse-chase protocol could 
also be used to gain information about the time frame of uptake of the adsorbed IONPs. 
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The effects of IONP attachment on the morphology of the cells, could also be investigated 
using scanning electron microscopy (Rivet et al., 2012).  
Furthermore, the force of interaction between the cell surface and the IONPs could be 
studied by using atomic force microscopy (AFM). In a recent master thesis (Klebert, 
2017), the OG-IONPs were successfully functionalized to AFM cantilevers via the 
coupling of free thiol-groups in the DMSA-coat to a maleimid-polyethylenglycol-N-
hydoxysuccinimid linker according to a protocol developed by the Hybrid Material 
Interface Group of the University of Bremen. This approach could now be used to analyze 
the interaction of the IONPs with the cell membrane in absence or presence of serum 
(Pyrgiotakis et al., 2014) as well as to characterize the endocytotic processes (Shan et al., 
2011, Ding et al., 2015) and the degradation of the coating material.  
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4.1 Supplementary data 
4.1.1 Potential uptake of coating material 
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Fig. 4.1 Comparison of fluorescent OG-DMSA and OG-DMSA-IONPs. OG-DMSA 
(142.5 μM of OG) was synthesized as described (chapter 2.1), diluted in 50 mM NaOH 
and fluorescence intensities of the different dilutions were compared to the fluorescence 
intensity of 1 mM OG-IONPs in 50 mM NaOH (A). A dilution of the coating material of 
1:500 in NaOH (28.5 nM dye) led to a similar fluorescence signal as that determined for 
1 mM OG-IONPs. The excitation (emission at 516 nm) and emission (excitation at 492 
nm) spectra of OG-DMSA (1:500 diltued) and OG-IONPs (1 mM) were recorded 
showing no differences in the excitation or emission peaks (B). C6 glioma cells were 
incubated with OG-DMSA in dilution up to 1:500 of the OG-DMSA in IB for 1 h at 37°C 
and intra- and extracellular LDH activity was measured as previously described (Dringen 
et al., 1998, Tulpule et al., 2014) showing no compromised viabilty compared to the 
control cells (C). Fluorescence microscopy picture were taken for cells exposed as 
previously described (chapter 2.1) for 1 h at 37°C to 1 mM OG-IONPs (D) or the given 
dilutions of OG-DMSA (E-I). Even incubation of C6 glioma cells with the highest 
concentration of OG-DMSA (I) did not cause any fluorescence staining in contrast to a 
strong perinuclear fluorescence pattern as observed in OG-IONPs treated cells (D). The 
cell nuclei were stained with DAPI (blue). The size bar in panel D represents 10 μm and 
applies for the panels D-I.  
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4.1.2 Influence of IONPs on C6 glioma cell proliferation 
 
Fig. 4.2 C6 glioma cells were seeded in a density of 25.000 cells/well and grown for 24 h. 
Cells were washed with IB, incubated with 1 mM OG-IONPs in IB for 1 h at 37°C, 
washed twice with IB and cultured for 6 h, 24 h or 48 h in IONP-free DMEM containing 
10% FCS at 37°C. Protein content (A) and iron content (B) were measured as previously 
described  (Lowry et al., 1951) (Geppert et al., 2009) and the specific cellular iron content 
was calculated (C). Cellular localization of OG was monitored by fluorescence 
microscopy (D-F) and the localization of cellular iron was analyzed by cyctochemical 
staining as previously described (Geppert et al., 2009, Rastedt et al., 2017) (G-I). The 
cell nuclei were stained with DAP (blue) (chapter 3.2.). The size bar in panel D represents 
10 μm and applies to the panels D-I. The data shown are means ± distance to the 
indivivual values of results obtained in two individual experiments. 
  
Apendix 162 
 
4.1.3 Influence of cell cycle on IONPs distribution in C6 glioma cells 
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Fig. 4.3 Cell cylce and accumulation of OG-IONPs in C6 glioma cells. The cells were 
preincubated for 24 h under appropiate conditions to capture the cells in certain cell cycle 
state prior to the incubation with 1 mM OG-IONPs in IB for 1 h at 37°C (A-E) and 4°C 
(F-J) as described in chapter 2.1. The preincubation in DMEM containing 10% FCS 
(A,F,K) functioned as control for normal cell culture conditions. Alternatively, the cell 
were arrested in the G0 phase by preincubation without serum (0% FCS) (B,G;L), in the 
M phase by preincubation in 0.05 μM colchicine in DMEM/FCS (C,H,M), in the early G1 
phase by preincubation in 2.5 μM simvastatin in DMEM/FCS (D,I,N) and at the G1/S 
boundary by preincubation in 1 mM hydroxyurea in DMEM/FCS (E,J). The cellular 
localization of OG was monitored by fluorescence microscopy (A-K) and cell morphology 
alteration were analyzed by immunohistochemistry staining as previously described 
(Stapelfeldt et al., 2017) against α-tubulin using a mouse anti-alpha-tubulin antibody 
(cloneDM1A) from Sigma-Aldrich (Steinheim, Germany) and the Cy3-conjugated goat 
anti mouse anitbody from Jackson ImmunoResearch (West Grove, Pennsyvania, USA) (K-
O). The cell nuclei were stained with DAPI (blue). The size bar in panel A represents 
10 μm and applies for all panels. Panels show representative images from two individually 
preformed experiments. 
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4.1.4 Nanopaticle pulse-chase experiment on astrocyte cultures 
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Fig. 4.4 Nanoparticle pulse-chase experiments with OG-IONPs on astrocyte-rich primary 
and secondary cultures. Astrocyte-rich primary and secondary cultures were obtained as 
previously described in (Petters and Dringen, 2014, Tulpule et al., 2014) and nanoparticle 
pulse-chase experiments were performed as previously described (chapter 2.2). The cells 
were incubated with 1 mM OG-IONPs for 10 min at 4°C (nanoparticle pulse), unbound 
IONPs were removed by washing and the cultures were incubated (chase period) for up 
to 240 min. At the indicated time points the cellular OG fluorescence (A-G; N-S) was 
visualized using fluorescence microscopy and the localization of cellular iron by 
cytochemical staining (H-M, T-Y) as previously described (chapter 2.2). The cell nuclei 
were stained with DAPI (blue). The size bars in panels A and N represent 10 μm and 
apply for the panels A-M and N-Y, respectively. 
  
Apendix 166 
 
4.1.5 Nanoparticle pulse-chase experiment on neuron cultures 
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4.1.6 Nanopaticle pulse-chase experiment on microglia cultures 
  
F
ig
. 4
.6
 N
an
op
ar
tic
le
 p
ul
se
-c
ha
se
 e
xp
er
im
en
ts
 w
ith
 O
G
-I
O
N
Ps
 o
n 
pr
im
ar
y 
m
ic
ro
gl
ia
. M
ic
ro
gl
ia
 c
ul
tu
re
s 
w
er
e 
pr
ep
ar
ed
 a
s 
re
ce
nt
ly
 
de
sc
ri
be
d 
(L
ut
he
r e
t a
l.,
 2
01
3)
 a
nd
 n
an
op
ar
tic
le
 p
ul
se
-c
ha
se
 e
xp
er
im
en
ts
 w
ith
 O
G
-I
O
N
PS
 w
er
e 
pe
rf
or
m
ed
 a
s 
de
sc
ri
be
d 
in
 c
ha
pt
er
 3
.2
. 
E
xt
ra
ce
llu
la
r L
D
H
 a
ct
iv
ity
 w
as
 d
et
er
m
in
ed
 a
s 
pr
ev
io
us
ly
 d
es
cr
ib
ed
 (D
ri
ng
en
 et
 a
l.,
 1
99
8)
 (A
) a
nd
 s
ev
er
e 
im
pa
ir
m
en
t o
f t
he
 m
em
br
an
e 
in
te
gr
it
y 
w
as
 o
bs
er
ve
d 
af
te
r 
12
0  
m
in
 o
f 
ch
as
e 
pe
ri
od
 i
n 
th
e 
pr
es
en
ce
 a
s 
w
el
l 
as
 i
n 
th
e 
ab
se
nc
e 
of
 I
O
N
Ps
 d
ur
in
g 
th
e 
pu
ls
e 
pe
ri
od
. 
C
el
lu
la
r 
lo
ca
liz
at
io
n 
of
 O
G
 w
as
 m
on
ito
re
d 
by
 f
lu
or
es
ce
nc
e 
m
ic
ro
sc
op
y 
(B
-F
) 
an
d 
th
e 
lo
ca
liz
at
io
n 
of
 c
el
lu
la
r 
ir
on
 w
as
 a
na
ly
ze
d 
by
 
cy
ct
oc
he
m
ic
al
 s
ta
in
in
g 
(G
-K
) 
as
 p
re
vi
uo
sl
y 
de
sc
ri
be
d 
(c
ha
pt
er
 2
.2
).
 T
he
 c
el
l n
uc
le
i w
er
e 
st
ai
ne
d 
w
ith
 D
A
P 
(b
lu
e)
 (
ch
ap
te
r 
3.
2.
).
 T
he
 
si
ze
 b
ar
 in
 p
an
el
 B
 r
ep
re
se
nt
s 
10
 μ
m
 a
nd
 a
pp
lie
s 
to
 t
he
 p
an
el
s 
(B
-K
).
 T
he
 d
at
a 
di
sp
la
ye
d 
re
pr
es
en
ts
 d
at
a 
ob
ta
in
ed
 in
 t
w
o 
in
di
vi
du
al
 
ex
pe
ri
m
en
ts
.
Apendix 168 
 
4.1.7 Fixation and permeabilization methods in immunocytochemistry 
Table 4.1 Fixation and permeabilization methods applied for immunocytochemical 
colocalization studies 
Fixation  
Permeabilization 
Mechanism  Procedure  
Cross-linking  
 
3.5% (w/v) paraformaldehyde in PBS, 
15 min, RT 
 0.1% Triton X-100 in PBS, 5-10 min, RT 
  0.01% Digitonin, 30 min, RT 
  100% Methanol, 5-10 min, -20°C 
  70% Ethanol, 5-10 min, RT 
  100 % Acetone, 5-10 min, -20°C 
 3.5% (w/v) paraformaldehyde + 0.05% 
(w/v) glutaraldehyde in PBS,15 min, RT 
 0.1% Triton X-100 in PBS, 5-10 min, RT 
  0.01% Digitonin in PBS, 30 min, RT 
Dehydration/ 
precipitation 
 100% Methanol, 10 min, -20°C  no additional permeabilization 
step   100% Acetone, 30 sec, -20°C  
To ensure good immunocytochemical stainings at least three main factors have to be address: (1) 
Preservation of the cell structure, (2) excess of the antibody to the desired antigen and (3) specific 
recognition of antibody and antigen to prevent unspecific background signal. For the preservation of the 
cell structures commonly used methods are based either on the cross-linking of proteins by using 
formaldehyde or glutaraldehyde or on the dehydration, and thereby precipitation of the proteins using 
organic solvents like alcohols and acetone (Van Ewijk et al., 1984, Williams et al., 1997, Glynn and 
McAllister, 2006). The fixation by cross-linking agents also requires an additional permeabilization step, 
whereas organic solvents already make the membrane permeable for small molecules like antibodies by 
dissolving membrane lipids (Ohsaki et al., 2005, Jamur and Oliver, 2010). 
  
Appendix 169 
 
4.1.8 References 
 
Dringen R, Kussmaul L & Hamprecht B (1998). Detoxification of exogenous hydrogen 
peroxide and organic hydroperoxides by cultured astroglial cells assessed by 
microtiter plate assay. Brain Res Brain Res Protoc, 2: 223-8. 
Geppert M, Hohnholt M, Gaetjen L, Grunwald I, Baumer M & Dringen R (2009). 
Accumulation of iron oxide nanoparticles by cultured brain astrocytes. J Biomed 
Nanotechnol, 5: 285-93. 
Glynn MW & McAllister AK (2006). Immunocytochemistry and quantification of 
protein colocalization in cultured neurons. Nat Protoc, 1: 1287-96. 
Jamur MC & Oliver C (2010). Permeabilization of cell membranes. Methods Mol Biol, 
588: 63-6. 
Lowry OH, Rosebrough NJ, Farr AL & Randall RJ (1951). Protein measurement with 
the Folin phenol reagent. J Biol Chem, 193: 265-75. 
Luther EM, Petters C, Bulcke F, Kaltz A, Thiel K, Bickmeyer U & Dringen R (2013). 
Endocytotic uptake of iron oxide nanoparticles by cultured brain microglial cells. 
Acta Biomater, 9: 8454-65. 
Ohsaki Y, Maeda T & Fujimoto T (2005). Fixation and permeabilization protocol is 
critical for the immunolabeling of lipid droplet proteins. Histochem Cell Biol, 
124: 445-52. 
Petters C & Dringen R (2014). Comparison of primary and secondary rat astrocyte 
cultures regarding glucose and glutathione metabolism and the accumulation of 
iron oxide nanoparticles. Neurochem Res, 39: 46-58. 
Rastedt W, Thiel K & Dringen R (2017). Uptake of fluorescent iron oxide nanoparticles 
in C6 glioma cells. Biomed Phys Eng Expr, 3: 035007. 
Stapelfeldt K, Ehrke E, Steinmeier J, Rastedt W & Dringen R (2017). Menadione-
mediated WST1 reduction assay for the determination of metabolic activity of 
cultured neural cells. Anal Biochem, 538: 42-52. 
Tulpule K, Hohnholt MC, Hirrlinger J & Dringen R (2014). Primary cultures of 
astrocytes and neurons as model systems to study the metabolism and metabolite 
export from brain cells. In: Hirrlinger J & Waagepetersen HS (eds.) Brain Energy 
Metabolism. New York: Springer. 
Van Ewijk W, Van Soest PL, Verkerk A & Jongkind JF (1984). Loss of antibody binding 
to prefixed cells: Fixation parameters for immunocytochemistry. Histochem J, 16: 
179-93. 
Williams JH, Mepham BL & Wright DH (1997). Tissue preparation for 
immunocytochemistry. J Clin Pathol, 50: 422-8. 
Apendix 170 
 
4.2 Curriculum vitae 
Personal information 
Name  Wiebke Willmann (Maiden name: Rastedt) 
Birthday  25/05/1988 in Barßel, Germany 
 
Education and work experience 
04/2015 – 04/2018  PhD thesis “Synthesis and Characterization of Fluorescent 
Iron Oxide Nanoparticles to Study Uptake and Intracellular 
trafficking of Nanoparticles in Neural Cells” in the research 
group of Prof. Ralf Dringen, Neurobiochemistry, University of 
Bremen, Germany 
07/2013 – 03/2015  Research assistant at Paul-Ehrlich-Institute (PEI), Federal Institute 
of Vaccines and Biomedicines, Langen, Germany 
Research topic: “Entry mechanism fo Hepatitis B Virus” in the 
research group of Prof. Eberhard Hildt, Virology, PEI 
10/2010 – 02/2013  Master studies in Biochemistry (M.Sc.)  
at Medizinische Hochschule Hannover (MHH), Germany 
Master thesis: “Viral Determinants for Utilization of Claudin 
Proteins for Cell Entry by Hepatitis C Virus.“ in the research 
group of Prof. Thomas Pietschmann, Virology, Twincore 
10/2011 – 03/2010  ERASMUS internship at the University of Dundee, Scotland 
Topic of research: “Characterizing the Role of GPR55 in Energy 
Metabolism” in the research group of Prof. Hari Hundal, 
Molecular Physiology, College of Life Science, University of 
Dundee 
10/2007 – 09/2010 
 
 Bachelor studies in Biochemistry (B.Sc.)  
at the Leibniz University of Hannover (Germany) 
Bachelor thesis: “Analyses of Lipotoxicity in Insulin-Producing 
Cells.” in the research group of Prof Sigurd Lenzen, Institute for 
Clinical Biochemistry, Medizinische Hochschule Hannover 
06/2007  
 
 Graduation (Abitur) at the Albertus Magnus Gymnasium, 
Friesoythe, Germany 
  
Appendix 171 
 
List of publications  
Willmann W & Dringen R. How to study the consequences of an exposure of cultured 
neural cells to nanoparticles: The Dos and Don’t forgets. Submitted for publication. 
 
Willmann W & Dringen R. Monitoring of the cytoskeleton-dependent intracellular 
trafficking of fluorescent iron oxide nanoparticle in C6 glioma cells by nanoparticle 
pulse-chase experiments. Submitted for publication. 
 
Rastedt W, Thiel K & Dringen R (2017). Uptake of fluorescent iron oxide nanoparticles 
in C6 glioma cells. Biomed Phys Eng Expr, 3: 035007. 
 
Rastedt W, Blumrich EM & Dringen R (2017). Metabolism of mannose in cultured 
primary rat neurons. Neurochem Res, 42: 2282-2293. 
 
Stapelfeldt K, Ehrke E, Steinmeier J, Rastedt W & Dringen R (2017). Menadione-
mediated WST1 reduction assay for the determination of metabolic activity of cultured 
neural cells. Anal Biochem, 538: 42-52. 
 
Joshi A, Rastedt W, Faber K, Schultz AG, Bulcke F & Dringen R (2016). Uptake and 
toxicity of copper oxide nanoparticles in C6 glioma cells. Neurochem Res, 41: 3004-
3019. 
 
Zhang YQ, Dringen R, Petters C, Rastedt W, Koser J, Filser J & Stolte S (2016). Toxicity 
of dimercaptosuccinate-coated and un-functionalized magnetic iron oxide nanoparticles 
towards aquatic organisms. Environ Sci-Nano, 3: 754-767. 
 
Lipina C, Rastedt W, Irving AJ & Hundal HS (2013). Endocannabinoids in obesity: 
brewing up the perfect metabolic storm? WIREs Membr Transp Signal 2: 49-63. 
 
Lipina C, Rastedt W, Irving AJ & Hundal HS (2012). New vistas for treatment of 
obesity and diabetes? Endocannabinoid signalling and metabolism in the modulation of 
energy balance. Bioessays 34(8): 681-91 
 
  
Apendix 172 
 
4.3 Versicherung an Eides Statt 
 
Ich, Wiebke Willmann (geb. Rastedt), Lange Straße 10, 26169 Friesoythe 
Versichere an Eides Statt durch meine Unterschrift, dass ich die vorstehende Arbeit 
selbständig und ohne fremde Hilfe angefertigt und alle Stellen, die ich wörtlich dem Sinne 
nach aus Veröffentlichungen entnommen habe, als solche kenntlich gemacht habe, mich 
auch keiner anderen als der angegebenen Literatur oder sonstiger Hilfsmittel bedient habe. 
Ich versichere an Eides Statt, dass ich die vorgenannten Angaben nach bestem Wissen und 
Gewissen gemacht habe und dass die Angaben der Wahrheit entsprechen und ich nichts 
verschwiegen hab. 
Die Strafbarkeit einer falschen eidesstattlichen Versicherung ist mir bekannt, namentlich 
die Strafandrohung gemäß § 156 StGB bis zu drei Jahren Freiheitsstrafe oder Geldstrafe 
bei vorsätzlicher Begehung der Tat bzw. gemäß § 161 Abs. 1 StGB bis zu einem Jahr 
Freiheitsstrafe oder Geldstrafe bei fahrlässiger Begehung. 
 
 
 
__________________________          ___________________________ 
Ort, Datum       Unterschrift 
 
 
